Gene	"Gene synonym"	Ensembl	"Gene description"	Uniprot	Chromosome	Position	"Protein class"	"Biological process"	"Molecular function"	"Disease involvement"	Evidence	"HPA evidence"	"UniProt evidence"	"NeXtProt evidence"	"MS evidence"	"RNA tissue specificity"	"RNA tissue distribution"	"RNA tissue specificity score"	"RNA tissue specific NX"	"RNA single cell type specificity"	"RNA single cell type distribution"	"RNA single cell type specificity score"	"RNA single cell type specific NX"	"RNA cancer specificity"	"RNA cancer distribution"	"RNA cancer specificity score"	"RNA cancer specific FPKM"	"RNA brain regional specificity"	"RNA brain regional distribution"	"RNA brain regional specificity score"	"RNA brain regional specific NX"	"RNA blood cell specificity"	"RNA blood cell distribution"	"RNA blood cell specificity score"	"RNA blood cell specific NX"	"RNA blood lineage specificity"	"RNA blood lineage distribution"	"RNA blood lineage specificity score"	"RNA blood lineage specific NX"	"RNA cell line specificity"	"RNA cell line distribution"	"RNA cell line specificity score"	"RNA cell line specific NX"	"RNA mouse brain regional specificity"	"RNA mouse brain regional distribution"	"RNA mouse brain regional specificity score"	"RNA mouse brain regional specific pTPM"	"RNA pig brain regional specificity"	"RNA pig brain regional distribution"	"RNA pig brain regional specificity score"	"RNA pig brain regional specific pTPM"	Antibody	"Reliability (IH)"	"Reliability (Mouse Brain)"	"Reliability (IF)"	"Subcellular location"	"Secretome location"	"CCD Protein"	"CCD Transcript"	"Blood concentration - Conc. blood IM [pg/L]"	"Blood concentration - Conc. blood MS [pg/L]"	"Subcellular main location"	"Subcellular additional location"	"Antibody RRID"	"Pathology prognostics - Breast cancer"	"Pathology prognostics - Cervical cancer"	"Pathology prognostics - Colorectal cancer"	"Pathology prognostics - Endometrial cancer"	"Pathology prognostics - Glioma"	"Pathology prognostics - Head and neck cancer"	"Pathology prognostics - Liver cancer"	"Pathology prognostics - Lung cancer"	"Pathology prognostics - Melanoma"	"Pathology prognostics - Ovarian cancer"	"Pathology prognostics - Pancreatic cancer"	"Pathology prognostics - Prostate cancer"	"Pathology prognostics - Renal cancer"	"Pathology prognostics - Stomach cancer"	"Pathology prognostics - Testis cancer"	"Pathology prognostics - Thyroid cancer"	"Pathology prognostics - Urothelial cancer"	"Tissue RNA - adipose tissue [NX]"	"Tissue RNA - adrenal gland [NX]"	"Tissue RNA - amygdala [NX]"	"Tissue RNA - appendix [NX]"	"Tissue RNA - basal ganglia [NX]"	"Tissue RNA - bone marrow [NX]"	"Tissue RNA - breast [NX]"	"Tissue RNA - cerebellum [NX]"	"Tissue RNA - cerebral cortex [NX]"	"Tissue RNA - cervix, uterine [NX]"	"Tissue RNA - colon [NX]"	"Tissue RNA - corpus callosum [NX]"	"Tissue RNA - ductus deferens [NX]"	"Tissue RNA - duodenum [NX]"	"Tissue RNA - endometrium 1 [NX]"	"Tissue RNA - epididymis [NX]"	"Tissue RNA - esophagus [NX]"	"Tissue RNA - fallopian tube [NX]"	"Tissue RNA - gallbladder [NX]"	"Tissue RNA - heart muscle [NX]"	"Tissue RNA - hippocampal formation [NX]"	"Tissue RNA - hypothalamus [NX]"	"Tissue RNA - kidney [NX]"	"Tissue RNA - liver [NX]"	"Tissue RNA - lung [NX]"	"Tissue RNA - lymph node [NX]"	"Tissue RNA - midbrain [NX]"	"Tissue RNA - olfactory region [NX]"	"Tissue RNA - ovary [NX]"	"Tissue RNA - pancreas [NX]"	"Tissue RNA - parathyroid gland [NX]"	"Tissue RNA - pituitary gland [NX]"	"Tissue RNA - placenta [NX]"	"Tissue RNA - pons and medulla [NX]"	"Tissue RNA - prostate [NX]"	"Tissue RNA - rectum [NX]"	"Tissue RNA - retina [NX]"	"Tissue RNA - salivary gland [NX]"	"Tissue RNA - seminal vesicle [NX]"	"Tissue RNA - skeletal muscle [NX]"	"Tissue RNA - skin 1 [NX]"	"Tissue RNA - small intestine [NX]"	"Tissue RNA - smooth muscle [NX]"	"Tissue RNA - spinal cord [NX]"	"Tissue RNA - spleen [NX]"	"Tissue RNA - stomach 1 [NX]"	"Tissue RNA - testis [NX]"	"Tissue RNA - thalamus [NX]"	"Tissue RNA - thymus [NX]"	"Tissue RNA - thyroid gland [NX]"	"Tissue RNA - tongue [NX]"	"Tissue RNA - tonsil [NX]"	"Tissue RNA - urinary bladder [NX]"	"Tissue RNA - vagina [NX]"	"Tissue RNA - B-cells [NX]"	"Tissue RNA - dendritic cells [NX]"	"Tissue RNA - granulocytes [NX]"	"Tissue RNA - monocytes [NX]"	"Tissue RNA - NK-cells [NX]"	"Tissue RNA - T-cells [NX]"	"Tissue RNA - total PBMC [NX]"	"Cell RNA - A-431 [NX]"	"Cell RNA - A549 [NX]"	"Cell RNA - AF22 [NX]"	"Cell RNA - AN3-CA [NX]"	"Cell RNA - ASC diff [NX]"	"Cell RNA - ASC TERT1 [NX]"	"Cell RNA - BEWO [NX]"	"Cell RNA - BJ [NX]"	"Cell RNA - BJ hTERT+ [NX]"	"Cell RNA - BJ hTERT+ SV40 Large T+ [NX]"	"Cell RNA - BJ hTERT+ SV40 Large T+ RasG12V [NX]"	"Cell RNA - CACO-2 [NX]"	"Cell RNA - CAPAN-2 [NX]"	"Cell RNA - Daudi [NX]"	"Cell RNA - EFO-21 [NX]"	"Cell RNA - fHDF/TERT166 [NX]"	"Cell RNA - GAMG [NX]"	"Cell RNA - HaCaT [NX]"	"Cell RNA - HAP1 [NX]"	"Cell RNA - HBEC3-KT [NX]"	"Cell RNA - HBF TERT88 [NX]"	"Cell RNA - HDLM-2 [NX]"	"Cell RNA - HEK 293 [NX]"	"Cell RNA - HEL [NX]"	"Cell RNA - HeLa [NX]"	"Cell RNA - Hep G2 [NX]"	"Cell RNA - HHSteC [NX]"	"Cell RNA - HL-60 [NX]"	"Cell RNA - HMC-1 [NX]"	"Cell RNA - HSkMC [NX]"	"Cell RNA - hTCEpi [NX]"	"Cell RNA - hTEC/SVTERT24-B [NX]"	"Cell RNA - hTERT-HME1 [NX]"	"Cell RNA - hTERT-RPE1 [NX]"	"Cell RNA - HUVEC TERT2 [NX]"	"Cell RNA - JURKAT [NX]"	"Cell RNA - K-562 [NX]"	"Cell RNA - Karpas-707 [NX]"	"Cell RNA - LHCN-M2 [NX]"	"Cell RNA - MCF7 [NX]"	"Cell RNA - MOLT-4 [NX]"	"Cell RNA - NB-4 [NX]"	"Cell RNA - NTERA-2 [NX]"	"Cell RNA - OE19 [NX]"	"Cell RNA - PC-3 [NX]"	"Cell RNA - REH [NX]"	"Cell RNA - RH-30 [NX]"	"Cell RNA - RPMI-8226 [NX]"	"Cell RNA - RPTEC TERT1 [NX]"	"Cell RNA - RT4 [NX]"	"Cell RNA - SCLC-21H [NX]"	"Cell RNA - SH-SY5Y [NX]"	"Cell RNA - SiHa [NX]"	"Cell RNA - SK-BR-3 [NX]"	"Cell RNA - SK-MEL-30 [NX]"	"Cell RNA - SuSa [NX]"	"Cell RNA - T-47d [NX]"	"Cell RNA - THP-1 [NX]"	"Cell RNA - TIME [NX]"	"Cell RNA - U-138 MG [NX]"	"Cell RNA - U-2 OS [NX]"	"Cell RNA - U-2197 [NX]"	"Cell RNA - U-251 MG [NX]"	"Cell RNA - U-266/70 [NX]"	"Cell RNA - U-266/84 [NX]"	"Cell RNA - U-698 [NX]"	"Cell RNA - U-87 MG [NX]"	"Cell RNA - U-937 [NX]"	"Cell RNA - WM-115 [NX]"	"Blood RNA - basophil [NX]"	"Blood RNA - classical monocyte [NX]"	"Blood RNA - eosinophil [NX]"	"Blood RNA - gdT-cell [NX]"	"Blood RNA - intermediate monocyte [NX]"	"Blood RNA - MAIT T-cell [NX]"	"Blood RNA - memory B-cell [NX]"	"Blood RNA - memory CD4 T-cell [NX]"	"Blood RNA - memory CD8 T-cell [NX]"	"Blood RNA - myeloid DC [NX]"	"Blood RNA - naive B-cell [NX]"	"Blood RNA - naive CD4 T-cell [NX]"	"Blood RNA - naive CD8 T-cell [NX]"	"Blood RNA - neutrophil [NX]"	"Blood RNA - NK-cell [NX]"	"Blood RNA - non-classical monocyte [NX]"	"Blood RNA - plasmacytoid DC [NX]"	"Blood RNA - T-reg [NX]"	"Blood RNA - total PBMC [NX]"	"Brain RNA - amygdala [NX]"	"Brain RNA - basal ganglia [NX]"	"Brain RNA - cerebellum [NX]"	"Brain RNA - cerebral cortex [NX]"	"Brain RNA - hippocampal formation [NX]"	"Brain RNA - hypothalamus [NX]"	"Brain RNA - midbrain [NX]"	"Brain RNA - olfactory region [NX]"	"Brain RNA - pons and medulla [NX]"	"Brain RNA - thalamus [NX]"	"Single Cell Type RNA - Alveolar cells type 1 [NX]"	"Single Cell Type RNA - Alveolar cells type 2 [NX]"	"Single Cell Type RNA - B-cells [NX]"	"Single Cell Type RNA - Basal glandular cells [NX]"	"Single Cell Type RNA - Basal keratinocytes [NX]"	"Single Cell Type RNA - Bipolar cells [NX]"	"Single Cell Type RNA - Cardiomyocytes [NX]"	"Single Cell Type RNA - Cholangiocytes [NX]"	"Single Cell Type RNA - Ciliated cells [NX]"	"Single Cell Type RNA - Club cells [NX]"	"Single Cell Type RNA - Collecting duct cells [NX]"	"Single Cell Type RNA - Cone photoreceptor cells [NX]"	"Single Cell Type RNA - Cytotrophoblasts [NX]"	"Single Cell Type RNA - Distal tubular cells [NX]"	"Single Cell Type RNA - Ductal cells [NX]"	"Single Cell Type RNA - Early spermatids [NX]"	"Single Cell Type RNA - Endothelial cells [NX]"	"Single Cell Type RNA - Enterocytes [NX]"	"Single Cell Type RNA - Erythroid cells [NX]"	"Single Cell Type RNA - Exocrine glandular cells [NX]"	"Single Cell Type RNA - Extravillous trophoblasts [NX]"	"Single Cell Type RNA - Fibroblasts [NX]"	"Single Cell Type RNA - Glandular cells [NX]"	"Single Cell Type RNA - granulocytes [NX]"	"Single Cell Type RNA - Hepatocytes [NX]"	"Single Cell Type RNA - Hofbauer cells [NX]"	"Single Cell Type RNA - Horizontal cells [NX]"	"Single Cell Type RNA - Intestinal endocrine cells [NX]"	"Single Cell Type RNA - Ito cells [NX]"	"Single Cell Type RNA - Kupffer cells [NX]"	"Single Cell Type RNA - Late spermatids [NX]"	"Single Cell Type RNA - Leydig cells [NX]"	"Single Cell Type RNA - Macrophages [NX]"	"Single Cell Type RNA - Melanocytes [NX]"	"Single Cell Type RNA - monocytes [NX]"	"Single Cell Type RNA - Mucus-secreting cells [NX]"	"Single Cell Type RNA - Muller glia cells [NX]"	"Single Cell Type RNA - Pancreatic endocrine cells [NX]"	"Single Cell Type RNA - Paneth cells [NX]"	"Single Cell Type RNA - Peritubular cells [NX]"	"Single Cell Type RNA - Proximal tubular cells [NX]"	"Single Cell Type RNA - Rod photoreceptor cells [NX]"	"Single Cell Type RNA - Sertoli cells [NX]"	"Single Cell Type RNA - Smooth muscle cells [NX]"	"Single Cell Type RNA - Spermatocytes [NX]"	"Single Cell Type RNA - Spermatogonia [NX]"	"Single Cell Type RNA - Suprabasal keratinocytes [NX]"	"Single Cell Type RNA - Syncytiotrophoblasts [NX]"	"Single Cell Type RNA - T-cells [NX]"	"Single Cell Type RNA - Undifferentiated cells [NX]"	"Single Cell Type RNA - Urothelial cells [NX]"
AC104662.2		ENSG00000281028			4	25160663-25277306	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"				"Low tissue specificity"	"Detected in many"			"Cell type enriched"	"Detected in single"	14	"Ciliated cells: 1.4"	"Not detected"	"Not detected"							"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"											HPA004099	Uncertain		Uncertain	Cytosol		NA	NA			Cytosol		"HPA004099: AB_1855353"					"unprognostic (3.59e-2)"													1.7	2.3	6.7	5.5	11.1	6.7	3.7	9.7	9.3	2.0	4.1	4.3	5.0	7.8	1.7	2.5	5.4	3.5	1.6	1.5	7.3		2.8	10.1	4.0	4.4	10.0	2.4	1.5	1.8	2.9	14.9	2.8	7.1	1.1	5.4	2.1	4.5	2.5	1.8	0.0	6.0	2.6	11.3	2.5	3.6	9.2	10.6	6.1	5.3	1.6	5.3	3.1	4.8	2.1	2.0	7.5	1.9	1.4	4.3	0.9	5.3	3.7	4.4	2.4	3.2	6.1	4.1	8.9	9.1	11.4	12.2	4.0	7.5	13.5	2.1	11.4	10.7	2.9	9.3	3.8	6.9	5.8	2.6	6.3	9.1	3.8	0.6	12.4	3.6	3.1	0.7	4.5	4.6	2.2	3.9	6.0	4.2	15.7	3.5	6.1	10.8	0.9	3.6	6.7	2.4	6.3	12.0	5.9	2.7	9.8	5.0	1.0	3.6	1.3	2.6	4.4	2.9	1.7	7.4	6.3	1.8	2.9	5.2	10.6	12.0	19.1	5.4	6.5	4.6	7.5	1.9	6.2	2.4	1.8	1.6	2.1	2.4	2.3	1.4	1.9	1.8	2.1	3.2	1.4	1.3	2.0	4.3	0.9											0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
ASB12	FLJ39577	ENSG00000198881	"Ankyrin repeat and SOCS box containing 12"	Q8WXK4	X	64224196-64230631	"Predicted intracellular proteins"	"Ubl conjugation pathway"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Group enriched"	"Detected in some"	5	"skeletal muscle: 43.4;tongue: 11.5"	"Cell type enriched"	"Detected in some"	4	"Late spermatids: 14.2"	"Low cancer specificity"	"Detected in single"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	5	"basophil: 4.0;naive B-cell: 1.1;T-reg: 1.0"	"Group enriched"	"Detected in many"	6	"B-cells: 1.1;granulocytes: 4.0;T-cells: 1.0"	"Cell line enhanced"	"Detected in some"		"AF22: 3.8;HEK 293: 2.1;HL-60: 2.2;HMC-1: 2.7;JURKAT: 2.2;NB-4: 2.2;NTERA-2: 2.3;REH: 2.1;THP-1: 3.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA049542	Uncertain					NA	NA					"HPA049542: AB_2680810"	"unprognostic (6.52e-2)"	"unprognostic (2.31e-1)"	"unprognostic (1.48e-2)"	"unprognostic (1.06e-3)"	"unprognostic (6.76e-2)"	"unprognostic (4.23e-2)"	"unprognostic (6.50e-2)"	"unprognostic (8.25e-2)"	"unprognostic (6.75e-2)"	"unprognostic (9.69e-3)"	"unprognostic (6.75e-3)"	"unprognostic (5.18e-2)"	"unprognostic (5.12e-2)"	"unprognostic (5.15e-2)"	"unprognostic (1.35e-1)"	"unprognostic (4.32e-2)"	"unprognostic (4.63e-2)"	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	2.0	1.0	0.7	0.0	5.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.6	0.2	43.4	0.0	0.0	0.1	0.0	0.0	0.0	0.4	0.0	0.0	0.6	11.5	0.7	0.0	0.0	1.1	0.0	4.0	0.3	0.1	1.0	0.3	0.0	0.2	3.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.6	0.5	0.6	0.0	0.0	0.0	0.9	0.0	0.4	0.0	2.1	1.8	0.0	0.0	0.0	2.2	2.7	0.0	0.5	0.0	0.0	0.0	0.0	2.2	0.3	1.2	0.0	0.1	0.5	2.2	2.3	0.5	0.4	2.1	0.0	0.0	0.1	0.0	0.0	0.6	0.0	0.0	0.0	0.8	0.0	3.5	0.0	0.0	0.1	0.6	0.0	0.0	0.1	0.6	0.0	0.0	0.0	4.0	0.0	0.0	0.3	0.3	0.4	0.0	0.4	0.2	0.0	1.1	0.3	0.2	0.0	0.1	0.0	0.0	1.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	3.5	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	14.2	0.3	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.4	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0
CTDSPL2	"FLJ10523, HSPC129"	ENSG00000137770	"CTD small phosphatase like 2"	Q05D32	15	44427234-44529038	"Predicted intracellular proteins"		"Hydrolase, Protein phosphatase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	7	"Early spermatids: 155.1;Late spermatids: 125.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA040763, HPA062198"	Approved		Approved	Nucleoplasm		NA	NA			Nucleoplasm		"HPA040763: AB_10960989, HPA062198: AB_2684708"	"unprognostic (6.64e-2)"	"unprognostic (4.30e-2)"	"unprognostic (1.43e-1)"	"unprognostic (2.06e-1)"	"unprognostic (7.39e-3)"	"unprognostic (5.20e-2)"	"unprognostic (7.40e-2)"	"unprognostic (1.23e-1)"	"unprognostic (5.37e-2)"	"unprognostic (2.54e-2)"	"unprognostic (3.68e-3)"	"unprognostic (5.35e-2)"	"unprognostic (8.36e-3)"	"unprognostic (7.49e-2)"	"unprognostic (1.37e-1)"	"unprognostic (1.53e-1)"	"unprognostic (1.16e-1)"	17.4	11.1	13.0	15.9	16.3	19.8	17.0	33.2	18.4	17.7	14.2	11.6	15.7	11.2	21.3	13.3	14.6	15.4	13.3	11.8	11.5	9.3	12.8	11.5	14.3	20.1	13.4	10.7	22.7	13.0	13.4	21.1	17.6	11.6	14.7	12.8	12.2	15.6	12.7	17.9	16.0	14.9	16.0	11.6	16.5	11.8	21.7	13.8	35.5	17.4	9.7	20.9	18.4	15.8	12.3	16.0	10.3	13.1	17.0	16.5	11.2	11.0	5.5	23.3	11.7	3.6	8.3	12.9	11.4	9.9	14.9	19.0	11.2	10.4	11.7	11.0	8.1	8.4	15.7	13.4	7.8	17.6	11.6	6.3	14.6	14.5	6.9	5.2	25.1	13.0	6.6	5.9	10.4	13.8	6.5	11.5	15.2	16.9	13.2	10.8	4.7	29.8	8.7	12.3	11.9	7.9	33.4	32.1	10.8	7.9	14.8	10.6	15.7	14.1	11.6	6.5	9.0	15.6	22.8	9.8	18.5	20.1	17.7	19.3	7.8	29.5	36.0	8.7	19.9	14.2	6.0	12.8	10.3	12.7	13.1	11.9	12.3	12.4	11.5	16.0	12.1	13.4	15.0	9.0	17.0	9.9	10.2	16.5	11.2	13.0	16.3	33.2	18.4	11.5	9.3	13.4	10.7	11.6	13.8	17.9	29.4	18.2	12.4	21.9	22.2	21.8	12.7	22.7	43.3	12.2	9.8	15.1	14.9	10.2	155.1	21.2	12.0	0.0	12.6	16.2	20.7	15.1	33.7	11.5	11.8	28.6	8.6	17.8	21.6	125.2	18.7	17.5	15.1	18.0	12.7	18.4	13.2	8.6	12.4	9.8	28.3	25.8	14.1	18.1	34.2	19.2	12.2	22.4	13.8	12.9
DUSP11	PIR1	ENSG00000144048	"Dual specificity phosphatase 11"	O75319	2	73762184-73780157	"Predicted intracellular proteins"		"Hydrolase, Protein phosphatase, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			HPA021052			Supported	"Nucleoplasm,Nucleoli fibrillar center,Cytokinetic bridge"		Yes	Yes			"Nucleoplasm, Nucleoli fibrillar center"	"Cytokinetic bridge"	"HPA021052: AB_2670577"	"unprognostic (2.45e-3)"	"unprognostic (1.06e-1)"	"unprognostic (2.19e-2)"	"unprognostic (7.87e-3)"	"unprognostic (9.14e-2)"	"unprognostic (5.28e-3)"	"prognostic unfavorable (2.10e-7)"	"unprognostic (7.20e-2)"	"unprognostic (5.43e-2)"	"unprognostic (5.85e-2)"	"unprognostic (8.67e-3)"	"unprognostic (3.84e-2)"	"unprognostic (7.56e-3)"	"unprognostic (1.41e-1)"	"unprognostic (1.47e-1)"	"unprognostic (1.47e-3)"	"unprognostic (1.46e-1)"	19.6	16.1	15.1	15.1	17.9	29.5	21.4	31.8	21.5	23.1	16.8	16.4	16.2	16.3	29.9	19.8	38.7	37.4	15.2	15.2	17.2	13.9	19.3	16.5	17.2	21.5	12.7	15.8	26.4	14.9	11.6	28.2	19.1	14.0	18.2	16.8	16.5	22.3	20.3	16.2	27.9	19.7	18.9	13.4	21.5	15.4	19.7	13.8	28.7	16.8	16.2	29.3	20.4	27.3	29.9	20.9	42.6	19.1	28.0	37.6	29.2	19.4	8.4	9.1	9.6	16.5	20.7	16.3	14.3	18.7	18.6	19.1	12.1	14.8	25.3	9.2	15.4	16.7	13.6	11.2	28.8	18.0	17.4	11.7	15.5	6.4	18.5	17.3	17.4	14.6	16.7	35.0	16.6	23.1	16.2	20.6	12.4	16.4	14.9	20.6	10.8	16.7	18.6	14.6	18.3	11.7	6.7	24.5	22.7	15.0	16.2	13.5	7.3	13.2	15.8	16.8	11.4	8.4	9.3	11.7	13.3	16.4	15.2	16.8	15.9	12.6	33.4	12.3	17.7	12.9	24.7	19.1	42.6	26.8	16.9	34.6	29.9	31.7	31.6	20.9	28.1	33.9	31.8	29.1	28.0	16.9	15.9	37.6	29.2	15.1	17.9	31.8	21.5	17.2	13.9	12.7	15.8	14.0	13.8	8.9	11.8	34.3	47.9	73.8	9.4	6.9	33.1	26.8	22.7	12.2	3.9	27.8	43.1	24.2	5.9	29.2	13.5	23.3	24.2	35.1	26.6	23.0	41.4	12.9	27.5	4.8	11.5	29.4	22.3	5.6	26.7	20.5	21.9	42.3	19.0	9.3	22.5	17.8	24.1	38.5	13.9	6.5	22.8	23.6	31.8	72.5	32.3	32.4	17.2	54.2
FIG4	"ALS11, CMT4J, dJ249I4.1, hSac3, KIAA0274, SAC3"	ENSG00000112367	"FIG4 phosphoinositide 5-phosphatase"	Q92562	6	109691312-109825428	"Disease related genes, Predicted intracellular proteins, Predicted membrane proteins"		Hydrolase	"Amyotrophic lateral sclerosis, Charcot-Marie-Tooth disease, Disease mutation, Neurodegeneration, Neuropathy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB017823, HPA068859"	Approved		Supported	"Vesicles,Lipid droplets"		NA	NA			"Vesicles, Lipid droplets"		"CAB017823: , HPA068859: AB_2686049"	"prognostic unfavorable (5.91e-4)"	"unprognostic (4.12e-2)"	"prognostic favorable (8.42e-4)"	"unprognostic (3.17e-2)"	"unprognostic (1.66e-1)"	"unprognostic (1.16e-1)"	"prognostic unfavorable (4.73e-4)"	"unprognostic (7.06e-2)"	"unprognostic (2.69e-1)"	"unprognostic (8.67e-2)"	"unprognostic (3.44e-3)"	"unprognostic (4.22e-2)"	"prognostic favorable (8.19e-4)"	"unprognostic (1.48e-1)"	"unprognostic (2.02e-1)"	"unprognostic (5.45e-2)"	"unprognostic (2.00e-2)"	11.0	13.5	14.5	12.2	30.3	14.0	14.4	13.5	35.3	12.4	13.2	11.0	5.0	8.3	11.3	17.0	11.7	10.5	13.4	10.1	14.5	18.5	13.2	8.7	19.2	16.6	17.6	17.7	12.2	9.9	25.4	15.4	12.6	19.0	11.6	14.6	9.7	17.0	12.0	12.1	9.2	10.7	14.7	16.0	17.3	11.4	12.6	12.9	18.1	12.6	8.5	15.0	12.5	10.5	15.5	15.9	12.8	20.0	8.0	7.7	9.8	6.2	6.5	9.8	11.7	10.4	14.4	6.2	8.1	11.7	6.7	18.0	4.8	6.6	16.8	5.2	13.1	12.4	4.7	9.6	6.4	15.6	10.2	11.7	9.4	6.5	4.8	9.6	8.8	8.4	7.4	8.4	11.4	7.9	17.2	13.6	11.1	5.5	7.2	9.4	5.8	9.0	7.6	5.1	9.3	3.2	6.3	4.5	5.8	11.3	15.5	10.9	10.2	5.3	7.8	16.4	12.5	5.6	14.7	9.5	4.2	3.6	6.1	6.9	3.4	2.4	8.1	22.3	6.3	3.8	11.5	20.0	12.8	7.7	19.7	6.0	14.6	5.7	7.3	15.9	15.5	7.0	6.8	8.7	8.0	13.5	6.9	6.6	9.8	14.5	30.3	13.5	35.3	14.5	18.5	17.6	17.7	19.0	12.9	14.9	7.0	5.9	6.5	4.0	6.1	5.1	5.1	9.4	4.5	8.7	2.0	11.5	5.0	8.9	13.3	5.0	5.3	0.0	9.9	5.8	4.4	4.5	8.1	3.8	20.0	1.6	9.8	6.2	20.5	13.8	3.1	13.5	8.5	9.0	8.8	7.5	6.8	6.8	6.3	6.3	6.0	0.0	6.6	4.9	11.7	3.9	10.3	10.7	6.1	7.6
HCST	"DAP10, DKFZP586C1522, KAP10, PIK3AP"	ENSG00000126264	"Hematopoietic cell signal transducer"	Q9UBK5	19	35902480-35904377	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in many"		"blood: 134.0;bone marrow: 84.0;lymphoid tissue: 79.1"	"Group enriched"	"Detected in many"	5	"granulocytes: 237.5;Hofbauer cells: 491.9;Kupffer cells: 329.9;Macrophages: 424.4;T-cells: 835.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in some"		"HEL: 52.9;HL-60: 30.5;HMC-1: 35.3;THP-1: 40.0;U-937: 60.0"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"CAB034435, HPA063026"	Enhanced		Supported	"Golgi apparatus,Vesicles,Plasma membrane"		NA	NA			"Golgi apparatus, Plasma membrane"	Vesicles	"CAB034435: AB_2117803, HPA063026: "	"unprognostic (1.40e-3)"	"unprognostic (3.07e-2)"	"unprognostic (3.04e-2)"	"unprognostic (7.27e-3)"	"unprognostic (1.23e-1)"	"unprognostic (8.23e-3)"	"unprognostic (1.85e-1)"	"unprognostic (2.54e-1)"	"prognostic favorable (6.70e-4)"	"unprognostic (5.97e-2)"	"unprognostic (1.94e-3)"	"unprognostic (1.02e-1)"	"prognostic unfavorable (1.59e-10)"	"unprognostic (3.78e-1)"	"unprognostic (3.25e-2)"	"unprognostic (1.65e-1)"	"unprognostic (1.56e-1)"	29.4	4.0	6.5	19.9	5.2	84.0	5.9	1.4	3.1	3.9	4.9	4.8	0.5	4.5	5.4	6.0	3.0	4.5	6.3	7.3	5.7	5.9	5.6	6.9	38.4	79.1	7.7	2.2	3.4	2.9	0.7	4.3	10.6	4.9	5.5	3.6	7.1	6.2	3.7	2.4	2.8	10.9	4.5	12.7	49.5	5.6	1.7	4.4	56.8	3.4	3.3	26.7	5.2	3.6	6.1	66.6	15.9	57.0	96.4	134.0	89.5	0.2	0.0	0.0	0.1	0.2	0.0	0.0	0.4	0.2	0.0	0.1	0.2	0.2	5.7	0.3	0.4	0.1	0.2	0.0	0.0	0.0	0.1	0.0	52.9	0.1	0.1	0.1	30.5	35.3	0.3	0.0	0.0	0.0	0.1	0.0	3.2	0.4	7.6	0.1	0.0	3.5	11.9	0.0	0.0	0.1	0.1	0.1	0.4	0.1	0.0	0.2	0.0	0.2	0.1	0.1	0.0	0.1	40.0	0.1	0.3	0.4	0.0	0.0	0.3	0.2	8.7	0.3	60.0	0.0	7.3	57.0	7.9	134.0	42.0	99.3	6.1	57.4	108.5	32.6	3.7	48.3	96.4	15.9	96.4	23.0	66.6	48.5	89.5	6.5	5.2	1.4	3.1	5.7	5.9	7.7	2.2	4.9	4.4	6.0	65.6	87.2	1.1	25.3	0.2	0.8	5.1	8.1	11.4	8.7	0.0	3.2	0.0	2.1	0.3	9.0	1.4	0.0	1.0	3.2	13.1	0.6	237.5	11.3	491.9	1.6	0.0	19.6	329.9	1.8	2.0	424.4	42.2	31.5	0.7	0.2	1.1	0.9	0.0	4.4	1.9	19.4	1.9	1.7	2.8	18.3	5.0	835.8	1.7	0.8
IMPA1	IMPA	ENSG00000133731	"Inositol monophosphatase 1"	P29218	8	81657961-81686693	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"		Hydrolase	"Mental retardation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA037489	Approved					NA	No		390000			"HPA037489: AB_10671757"	"unprognostic (1.78e-1)"	"unprognostic (3.59e-2)"	"unprognostic (6.95e-3)"	"unprognostic (2.15e-3)"	"unprognostic (1.31e-1)"	"unprognostic (6.27e-2)"	"unprognostic (3.80e-1)"	"unprognostic (2.46e-2)"	"unprognostic (1.06e-1)"	"unprognostic (4.68e-2)"	"unprognostic (7.78e-2)"	"unprognostic (6.26e-2)"	"unprognostic (2.52e-2)"	"unprognostic (5.87e-2)"	"unprognostic (1.84e-1)"	"unprognostic (2.42e-1)"	"unprognostic (5.41e-3)"	10.8	10.9	16.2	10.5	20.9	20.8	9.2	11.2	29.7	9.4	22.4	15.3	4.7	20.1	10.8	12.0	17.2	10.3	11.0	22.3	17.6	19.7	25.5	29.4	9.8	14.3	18.9	20.7	12.1	8.5	8.6	20.1	7.2	27.3	10.6	25.4	14.8	8.9	7.3	11.2	5.0	23.5	15.0	19.1	12.9	12.2	30.5	13.8	16.2	20.3	12.0	13.7	10.5	10.7	13.2	8.2	24.1	7.5	13.6	12.9	7.2	5.7	16.0	11.1	8.4	6.5	10.3	4.6	16.8	12.1	15.1	18.2	7.5	9.2	22.0	13.4	11.9	22.5	4.5	12.9	5.8	20.3	23.0	13.1	16.6	8.8	9.3	11.7	16.6	17.0	9.8	8.4	11.5	22.8	14.1	16.3	17.1	15.0	18.7	15.0	3.6	21.0	9.6	4.8	14.6	17.1	9.9	8.4	9.0	17.4	18.8	4.5	19.2	11.0	3.0	20.1	19.6	9.6	13.3	12.6	12.5	15.9	9.5	20.7	21.9	26.0	30.8	14.5	10.0	16.9	24.1	4.7	19.5	9.9	6.6	12.1	13.2	10.1	10.7	5.0	9.5	10.7	12.6	7.5	13.6	7.5	8.2	12.9	7.2	16.2	20.9	11.2	29.7	17.6	19.7	18.9	20.7	27.3	13.8	14.9	10.1	13.7	15.3	12.2	16.6	34.7	15.3	20.1	15.9	8.7	13.7	7.9	26.6	13.3	3.5	15.0	29.2	0.0	17.7	8.2	9.7	14.8	32.3	31.0	12.5	23.8	20.6	13.5	13.2	6.4	14.4	14.2	11.8	28.9	15.6	22.6	14.4	51.8	14.2	23.5	14.6	12.9	15.6	46.8	16.2	7.5	2.5	20.8	17.2	15.7
IMPA2		ENSG00000141401	"Inositol monophosphatase 2"	O14732	18	11981025-12030883	"Enzymes, Predicted intracellular proteins"		Hydrolase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"pancreas: 90.1"	"Cell type enhanced"	"Detected in many"	8	"Distal tubular cells: 373.0;Extravillous trophoblasts: 196.1;Proximal tubular cells: 383.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"eosinophil: 14.4;neutrophil: 18.7"	"Group enriched"	"Detected in many"	14	"dendritic cells: 5.3;granulocytes: 18.7;monocytes: 6.8"	"Cell line enhanced"	"Detected in many"		"BEWO: 60.5;OE19: 67.8;RPTEC TERT1: 29.2;SiHa: 36.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			HPA029561	Approved		Approved	Nucleoplasm,Mitochondria		Yes	No			Nucleoplasm	Mitochondria	"HPA029561: AB_10601932"	"unprognostic (1.16e-1)"	"unprognostic (1.28e-2)"	"unprognostic (4.76e-3)"	"unprognostic (2.50e-2)"	"unprognostic (4.25e-2)"	"unprognostic (3.25e-3)"	"unprognostic (4.26e-3)"	"unprognostic (4.08e-2)"	"unprognostic (1.87e-1)"	"unprognostic (1.96e-2)"	"unprognostic (4.56e-2)"	"unprognostic (4.24e-3)"	"prognostic favorable (0.00e+0)"	"unprognostic (1.95e-1)"	"unprognostic (1.19e-1)"	"unprognostic (2.08e-2)"	"unprognostic (3.35e-2)"	6.2	2.8	1.5	5.2	1.9	6.9	10.7	0.3	1.5	6.8	12.2	0.7	1.6	5.6	7.3	3.0	40.3	4.1	17.5	20.1	1.4	0.5	41.3	21.0	6.5	4.6	2.2	0.3	3.1	90.1	1.0	5.7	35.6	1.3	17.5	7.8	3.4	9.8	2.5	55.0	30.4	9.2	40.0	1.4	4.8	13.5	1.5	2.0	3.1	8.0	31.4	10.3	22.6	14.7	0.7	5.3	18.7	6.8	0.1	0.6	1.8	6.2	9.7	2.6	4.6	3.4	2.5	60.5	1.6	4.3	0.7	1.0	7.8	5.0	1.3	3.8	2.3	5.7	4.3	3.1	1.6	0.2	7.4	3.8	0.0	12.7	6.7	2.0	10.7	0.5	5.8	8.7	2.3	1.2	2.0	0.9	7.0	1.5	0.0	2.5	6.2	4.3	5.6	9.1	67.8	7.3	7.3	7.3	6.4	29.2	3.5	3.5	0.0	36.5	8.3	3.5	3.4	7.8	13.4	0.0	1.3	2.5	17.9	1.6	5.0	13.3	3.7	5.8	7.2	2.2	3.3	6.8	14.4	0.4	4.9	0.2	0.7	0.4	0.1	5.3	0.2	0.2	0.3	18.7	0.1	3.0	3.7	0.6	1.8	1.5	1.9	0.3	1.5	1.4	0.5	2.2	0.3	1.3	2.0	17.9	25.4	6.9	15.2	93.8	0.2	10.6	45.9	9.4	9.1	21.0	0.0	35.5	373.0	57.8	2.3	5.8	44.1	0.0	96.5	196.1	13.1	33.2	2.3	62.3	36.5	0.0	16.8	8.6	39.4	4.7	4.4	16.7	13.5	4.6	70.8	21.8	73.4	51.8	3.5	383.7	0.9	103.5	9.5	0.4	11.7	123.6	88.9	4.4	78.2	45.7
IMPAD1	"FLJ20421, gPAPP, IMPA3"	ENSG00000104331	"Inositol monophosphatase domain containing 1"	Q9NX62	8	56957933-56993844	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"		Hydrolase	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA009411	Supported		Supported	"Nucleoplasm,Golgi apparatus,Cytosol"		NA	NA		560000	"Golgi apparatus"	"Nucleoplasm, Cytosol"	"HPA009411: AB_1079138"	"unprognostic (1.62e-2)"	"unprognostic (7.89e-3)"	"unprognostic (6.58e-2)"	"unprognostic (6.42e-2)"	"unprognostic (2.00e-1)"	"unprognostic (8.59e-2)"	"unprognostic (1.88e-1)"	"unprognostic (1.67e-2)"	"unprognostic (2.09e-1)"	"unprognostic (4.53e-2)"	"unprognostic (4.24e-3)"	"unprognostic (1.41e-1)"	"unprognostic (1.43e-2)"	"unprognostic (1.68e-3)"	"unprognostic (2.89e-1)"	"unprognostic (1.68e-1)"	"unprognostic (1.05e-1)"	30.6	33.9	17.8	13.9	23.7	9.6	17.6	23.6	33.1	24.7	17.7	30.9	17.8	11.7	23.2	15.2	17.7	15.6	18.0	25.2	19.9	21.6	21.3	32.6	16.5	10.3	23.6	21.1	16.0	25.2	30.4	20.4	23.3	27.2	28.8	16.2	25.2	28.7	22.5	41.4	13.4	12.3	23.0	21.7	13.0	14.7	19.0	19.5	12.0	24.4	18.1	13.0	17.2	14.9	1.9	2.0	6.1	4.6	6.8	2.4	0.6	17.4	14.5	11.2	11.5	34.5	23.7	15.4	26.6	25.9	19.1	16.7	7.2	12.5	10.9	20.4	28.2	13.6	14.3	13.5	17.9	28.4	15.0	9.7	21.3	10.3	12.9	21.5	13.5	15.2	19.0	18.0	17.1	27.8	17.7	25.3	10.3	9.1	19.9	20.9	9.3	16.4	8.1	8.3	20.0	5.4	11.5	10.1	12.3	19.8	10.4	4.3	12.2	14.9	18.4	15.1	12.3	16.4	9.9	21.1	25.9	14.9	25.5	19.0	20.5	17.1	11.7	35.4	11.3	15.8	2.9	1.9	1.1	2.0	1.2	1.6	1.3	1.3	1.2	1.4	1.9	1.5	2.4	6.1	6.8	4.6	2.0	0.9	0.6	17.8	23.7	23.6	33.1	19.9	21.6	23.6	21.1	27.2	19.5	20.8	18.6	9.0	24.5	48.3	29.9	43.1	25.5	8.1	12.5	45.4	15.7	15.1	5.0	17.1	13.5	27.0	19.0	0.0	23.5	68.2	45.0	43.5	9.2	61.6	24.1	38.1	33.4	38.1	25.6	4.2	23.6	23.8	15.1	5.4	33.4	25.1	24.0	17.5	33.6	16.8	27.4	32.3	38.9	34.6	22.2	52.2	28.3	14.9	16.0	33.9
INPP1		ENSG00000151689	"Inositol polyphosphate-1-phosphatase"	P49441	2	190343470-190371665	"Enzymes, Predicted intracellular proteins"		Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	12	"Early spermatids: 658.4;Late spermatids: 591.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in many"	5	"eosinophil: 36.6"	"Lineage enriched"	"Detected in all"	5	"granulocytes: 36.6"	"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA036698, HPA036699"	Supported		Approved	"Centriolar satellite,Cytosol"		NA	NA		15000	"Centriolar satellite"	Cytosol	"HPA036698: AB_10672226, HPA036699: AB_2675260"	"unprognostic (1.08e-3)"	"unprognostic (4.50e-3)"	"unprognostic (3.87e-2)"	"unprognostic (2.70e-1)"	"unprognostic (7.85e-2)"	"unprognostic (3.67e-3)"	"unprognostic (4.44e-2)"	"unprognostic (1.17e-1)"	"unprognostic (1.75e-1)"	"unprognostic (2.96e-2)"	"unprognostic (7.28e-2)"	"unprognostic (2.41e-1)"	"unprognostic (2.54e-1)"	"unprognostic (3.74e-1)"	"unprognostic (1.55e-1)"	"prognostic favorable (1.12e-5)"	"prognostic favorable (5.70e-4)"	14.9	25.8	18.3	9.1	26.5	10.3	32.5	17.4	25.1	15.0	19.8	20.4	11.5	27.4	12.0	10.8	42.7	9.8	20.6	17.7	21.2	17.9	11.0	24.8	19.9	8.8	21.0	16.5	10.0	25.6	32.3	17.0	10.4	18.6	10.0	16.8	12.0	9.9	16.0	13.1	28.3	28.0	15.5	23.6	15.7	13.9	31.4	17.1	4.6	12.9	14.0	15.4	19.2	18.8	1.8	3.5	36.6	3.4	6.2	8.0	1.9	10.9	3.1	6.0	0.0	6.5	14.1	0.1	13.2	17.6	12.4	16.3	11.9	7.0	0.0	15.8	12.6	4.0	15.2	2.4	8.5	15.2	13.5	4.6	8.2	9.7	7.1	13.8	6.1	2.6	9.6	13.1	14.1	8.2	8.9	23.1	0.1	19.6	6.9	21.8	0.0	0.4	5.8	1.8	17.5	17.0	0.2	4.9	0.1	9.6	26.1	8.9	3.3	9.1	0.5	12.8	6.5	0.0	8.8	21.3	7.9	5.6	14.2	7.6	1.3	1.4	0.1	2.5	2.4	6.3	8.1	3.4	36.6	3.0	3.1	2.7	1.4	1.9	2.0	3.5	1.8	1.0	1.5	1.6	6.2	1.8	0.1	8.0	1.9	18.3	26.5	17.4	25.1	21.2	17.9	21.0	16.5	18.6	17.1	3.0	5.6	13.4	129.9	76.7	14.5	19.3	28.1	8.1	20.5	10.4	5.9	5.3	6.6	24.1	658.4	50.2	44.8	0.0	75.1	2.7	22.1	67.5	8.1	17.8	8.6	15.9	29.9	60.2	6.9	591.7	24.7	15.4	25.3	5.4	20.3	68.5	42.2	20.4	22.3	14.6	11.6	25.8	20.2	15.3	7.6	85.1	3.3	17.0	22.6	190.1
INPP4A	INPP4	ENSG00000040933	"Inositol polyphosphate-4-phosphatase type I A"	Q96PE3	2	98444854-98594390	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins"		Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Bipolar cells: 46.8;Kupffer cells: 37.8;T-cells: 39.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in all"		"Karpas-707: 34.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA001628	Approved		Supported	"Nucleoplasm,Nuclear membrane"		NA	NA			"Nucleoplasm, Nuclear membrane"		"HPA001628: AB_10961254"	"unprognostic (3.45e-1)"	"unprognostic (2.39e-2)"	"unprognostic (1.74e-2)"	"prognostic unfavorable (3.70e-6)"	"unprognostic (1.58e-1)"	"unprognostic (3.10e-2)"	"unprognostic (1.15e-3)"	"unprognostic (9.44e-2)"	"unprognostic (1.37e-2)"	"unprognostic (1.23e-1)"	"unprognostic (9.65e-2)"	"unprognostic (3.70e-2)"	"unprognostic (2.90e-2)"	"unprognostic (4.89e-2)"	"unprognostic (1.20e-1)"	"unprognostic (1.08e-2)"	"unprognostic (1.97e-2)"	9.0	15.0	11.4	13.5	23.1	12.3	7.0	24.0	28.4	7.5	8.5	8.3	3.8	7.7	8.2	5.7	8.4	6.7	11.0	10.8	12.9	7.8	8.1	7.2	13.5	17.0	6.1	19.8	8.3	8.2	12.7	7.0	8.6	17.9	6.8	8.6	16.1	9.3	7.2	13.6	7.3	12.1	10.5	10.4	24.0	8.4	6.4	6.8	17.6	8.4	2.7	13.4	16.8	6.9	0.8	5.9	3.8	5.1	5.8	6.4	1.8	6.4	5.4	10.0	8.0	5.7	6.5	10.0	5.6	5.0	6.0	6.2	6.9	5.7	4.1	6.4	8.2	7.3	6.0	7.1	5.5	4.9	13.7	6.1	4.8	4.9	3.2	5.1	9.1	17.8	5.8	5.2	5.7	5.1	5.1	8.4	23.3	4.4	34.2	4.4	7.8	13.8	8.1	9.4	3.6	5.3	6.0	7.0	26.7	2.9	19.8	6.6	8.6	6.4	5.2	5.1	10.7	2.4	7.3	7.9	7.0	8.9	5.5	3.8	24.3	14.1	2.8	5.7	8.7	6.0	2.0	1.8	3.8	5.5	3.9	6.4	0.8	3.1	3.7	1.9	0.2	4.3	4.9	2.0	5.8	5.1	5.9	1.6	1.8	11.4	23.1	24.0	28.4	12.9	7.8	6.1	19.8	17.9	6.8	6.0	9.6	10.0	4.7	7.1	46.8	10.5	2.5	0.0	10.3	5.2	7.9	7.2	3.3	3.9	12.8	10.1	1.7	0.0	1.3	6.6	7.2	4.6	0.0	3.2	9.0	31.8	5.2	14.7	37.8	5.4	8.6	17.7	10.1	4.6	5.4	9.2	3.8	3.4	11.3	2.2	13.8	6.5	9.0	9.7	11.2	5.4	7.9	39.8	3.5	5.4
INPP4B		ENSG00000109452	"Inositol polyphosphate-4-phosphatase type II B"	O15327	4	142023160-142847432	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins"		Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	11	"Early spermatids: 163.6;Late spermatids: 196.7;Sertoli cells: 84.1"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"memory CD4 T-cell: 19.2"	"Group enriched"	"Detected in many"	6	"NK-cells: 9.1;T-cells: 19.2"	"Cell line enhanced"	"Detected in many"		"CAPAN-2: 52.6;SK-MEL-30: 23.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA037681, HPA037682"	Approved		Approved	Centrosome		NA	NA			Centrosome		"HPA037681: AB_10670389, HPA037682: AB_10671377"	"unprognostic (9.79e-2)"	"unprognostic (1.11e-1)"	"unprognostic (1.95e-1)"	"unprognostic (9.25e-2)"	"unprognostic (1.77e-1)"	"unprognostic (8.24e-2)"	"unprognostic (3.03e-3)"	"unprognostic (5.76e-3)"	"unprognostic (1.95e-2)"	"unprognostic (3.16e-1)"	"prognostic unfavorable (1.03e-4)"	"unprognostic (8.58e-2)"	"unprognostic (1.26e-2)"	"unprognostic (2.79e-2)"	"unprognostic (1.30e-1)"	"unprognostic (4.58e-1)"	"unprognostic (1.39e-2)"	15.4	4.7	8.4	8.5	12.5	2.2	21.2	5.1	10.3	28.1	7.1	1.8	5.6	5.0	19.7	18.4	9.1	9.2	8.7	18.4	5.9	6.1	6.1	2.0	9.9	10.8	5.5	8.9	15.4	4.0	2.3	3.8	6.2	4.6	8.3	5.8	1.7	4.9	6.8	10.8	4.7	7.3	10.2	3.1	7.0	7.0	19.6	2.4	8.2	6.5	4.9	7.4	15.8	14.6	0.0	0.0	2.2	0.1	9.1	19.2	3.7	9.3	3.9	2.6	1.2	2.0	1.2	0.5	11.3	13.3	2.9	5.5	1.0	52.6	0.2	3.2	10.1	4.5	14.3	0.0	13.2	6.9	0.0	0.4	2.2	1.5	0.0	0.6	0.4	1.8	2.1	1.8	2.0	7.0	8.8	1.6	0.0	0.0	0.5	6.3	16.7	0.3	0.0	0.1	5.7	2.8	0.1	8.7	0.4	4.0	17.4	0.2	0.2	1.3	4.0	23.4	1.6	12.0	1.6	1.0	6.7	8.2	9.9	0.1	0.1	0.0	0.0	1.5	10.3	17.4	2.2	0.1	0.0	3.3	0.0	6.5	0.0	19.2	8.5	0.0	0.0	13.2	5.7	0.2	9.1	0.0	0.0	9.8	3.7	8.4	12.5	5.1	10.3	5.9	6.1	5.5	8.9	4.6	2.4	0.0	1.1	0.0	9.8	6.0	7.3	36.2	7.6	17.4	9.1	8.7	0.0	1.4	5.0	12.2	163.6	10.8	8.4	0.0	26.9	3.9	4.1	13.4	5.8	0.0	6.2	6.4	8.5	3.7	4.4	196.7	12.7	1.9	69.2	0.0	3.4	0.8	47.4	0.0	6.0	0.8	0.6	84.1	43.7	3.1	2.0	2.3	1.6	16.6	3.4	41.0
INPP5A	5PTASE	ENSG00000068383	"Inositol polyphosphate-5-phosphatase A"	Q14642	10	132537820-132783480	"Enzymes, Predicted intracellular proteins"		Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in some"	5	"basophil: 8.4"	"Lineage enriched"	"Detected in single"	21	"granulocytes: 8.4"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA012285	Enhanced		Approved	"Plasma membrane,Cytosol"	"Intracellular and membrane"	NA	NA			Cytosol	"Plasma membrane"	"HPA012285: AB_1851802"	"prognostic unfavorable (7.47e-4)"	"unprognostic (2.38e-1)"	"unprognostic (2.54e-1)"	"unprognostic (1.68e-3)"	"unprognostic (1.43e-1)"	"unprognostic (3.25e-2)"	"unprognostic (2.08e-1)"	"unprognostic (1.16e-1)"	"unprognostic (5.65e-2)"	"unprognostic (4.35e-1)"	"unprognostic (4.70e-2)"	"unprognostic (1.70e-2)"	"prognostic favorable (3.15e-4)"	"unprognostic (2.14e-1)"	"unprognostic (1.44e-1)"	"unprognostic (8.91e-3)"	"unprognostic (8.66e-2)"	13.6	11.8	10.3	11.3	49.8	5.8	10.3	40.7	20.8	17.4	24.0	10.1	11.5	12.9	25.8	13.9	20.3	15.2	13.6	48.8	9.5	8.5	9.4	7.2	13.8	6.0	9.2	10.4	13.1	11.6	8.9	9.4	19.0	9.1	17.1	11.7	17.1	8.5	16.9	43.7	11.5	14.8	27.9	10.6	8.9	14.8	14.9	16.6	4.2	9.5	12.1	7.8	19.4	22.4	0.3	0.1	8.4	0.2	0.0	0.3	0.6	18.7	7.5	12.6	12.1	19.3	13.6	10.3	19.9	15.3	13.0	8.7	17.7	7.7	1.7	7.7	21.1	8.5	10.7	13.6	8.3	15.7	5.7	7.9	2.7	9.4	24.0	14.0	6.8	6.6	9.2	8.3	8.3	15.9	10.5	9.0	3.6	3.9	10.1	6.9	15.2	1.9	21.9	5.7	11.3	13.4	4.0	8.3	3.0	10.8	10.7	3.0	10.3	9.9	14.7	12.0	12.0	9.5	16.5	7.5	8.4	9.7	11.2	11.6	2.0	9.3	5.8	8.1	4.7	3.6	8.4	0.2	1.1	0.0	0.0	0.0	0.3	0.0	0.1	0.1	0.2	0.0	0.0	1.5	0.0	0.2	0.0	0.3	0.6	10.3	49.8	40.7	20.8	9.5	8.5	9.2	10.4	9.1	16.6	8.9	22.4	1.4	3.6	4.7	10.7	9.0	5.1	2.7	9.1	7.0	0.0	3.3	0.0	5.7	9.4	6.4	18.4	0.0	7.9	3.3	6.2	6.4	8.1	16.0	2.6	7.9	5.8	19.0	6.3	11.2	6.6	3.1	1.7	0.0	9.3	7.8	9.9	11.5	11.0	3.8	4.9	6.5	20.0	5.5	6.6	5.1	2.1	1.9	10.9	5.0
INPP5B		ENSG00000204084	"Inositol polyphosphate-5-phosphatase B"	P32019	1	37860697-37947057	"Enzymes, Predicted intracellular proteins"		Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA028803	Approved		Supported	Cytosol		NA	NA			Cytosol		"HPA028803: AB_10612121"	"unprognostic (2.28e-2)"	"unprognostic (8.91e-3)"	"unprognostic (7.67e-2)"	"unprognostic (2.27e-1)"	"unprognostic (4.30e-2)"	"prognostic favorable (1.11e-4)"	"unprognostic (1.67e-2)"	"unprognostic (1.52e-2)"	"unprognostic (4.75e-2)"	"unprognostic (1.85e-1)"	"prognostic favorable (5.33e-4)"	"unprognostic (8.27e-2)"	"prognostic unfavorable (6.11e-5)"	"unprognostic (1.03e-1)"	"unprognostic (2.00e-1)"	"unprognostic (2.51e-1)"	"unprognostic (1.28e-1)"	14.5	10.2	11.7	15.9	18.2	22.3	12.8	25.4	16.1	15.3	18.3	21.0	9.4	9.3	19.5	13.7	9.9	15.0	13.7	14.3	12.2	9.0	11.7	16.2	18.7	21.1	23.2	11.4	28.7	11.4	13.1	14.4	14.3	15.9	12.0	13.7	18.9	9.4	16.0	9.7	12.0	13.9	17.5	18.5	19.0	14.7	8.6	21.8	17.4	13.8	4.7	22.3	17.4	13.2	6.7	5.3	19.1	4.7	5.3	9.1	3.8	3.7	2.8	6.7	10.7	8.4	10.8	11.8	4.7	8.3	6.0	8.6	4.4	5.7	14.0	2.2	8.6	3.0	5.2	8.8	3.4	7.8	9.0	3.8	21.3	9.2	2.9	12.2	11.3	31.1	12.6	2.1	6.2	4.0	6.2	7.1	9.4	7.3	18.3	8.1	3.2	9.1	12.0	9.4	5.7	2.2	11.1	13.2	6.6	3.5	3.5	2.6	4.5	5.0	2.4	12.2	9.9	3.0	10.0	7.1	6.0	5.6	5.6	4.3	14.9	7.2	11.3	7.1	10.6	5.1	19.1	2.5	13.2	6.3	2.0	9.1	6.5	4.5	6.1	5.3	6.7	5.8	5.3	3.4	5.3	4.7	4.8	5.6	3.8	11.7	18.2	25.4	16.1	12.2	9.0	23.2	11.4	15.9	21.8	26.8	22.9	10.2	5.0	1.9	15.6	2.4	0.0	5.3	9.1	1.8	23.6	3.4	0.0	1.9	8.1	4.3	3.1	0.0	3.7	12.1	4.3	3.5	8.1	6.4	4.3	22.3	3.4	6.2	6.5	12.4	7.8	6.7	6.8	10.0	4.1	4.5	2.4	3.7	8.5	2.2	20.1	6.5	5.3	4.1	7.5	2.9	3.9	10.7	4.3	3.4
INPP5D	"hp51CN, SHIP, SHIP1"	ENSG00000168918	"Inositol polyphosphate-5-phosphatase D"	Q92835	2	233059967-233207903	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"Apoptosis, Immunity"	Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 40.9"	"Cell type enhanced"	"Detected in many"	9	"B-cells: 58.1;Kupffer cells: 48.3;T-cells: 51.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HBEC3-KT: 15.4;HEL: 31.9;HMC-1: 33.5;hTCEpi: 30.7;NB-4: 29.9;THP-1: 21.4"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"CAB016300, HPA070455"	Enhanced		Approved	Cytosol		No	No			Cytosol		"CAB016300: AB_628250, HPA070455: AB_2686267"	"unprognostic (5.29e-2)"	"unprognostic (2.05e-3)"	"unprognostic (1.99e-2)"	"unprognostic (6.71e-3)"	"unprognostic (1.10e-1)"	"prognostic favorable (2.03e-5)"	"unprognostic (1.57e-1)"	"unprognostic (1.08e-1)"	"unprognostic (2.29e-2)"	"unprognostic (3.74e-1)"	"unprognostic (2.56e-1)"	"unprognostic (1.23e-1)"	"unprognostic (1.14e-2)"	"unprognostic (1.66e-1)"	"unprognostic (4.82e-2)"	"unprognostic (6.58e-2)"	"unprognostic (6.54e-2)"	7.1	3.1	7.2	33.0	10.7	24.6	4.7	1.7	6.9	3.6	3.7	12.5	0.7	3.5	4.1	2.9	3.3	3.3	6.7	3.2	6.6	9.1	5.1	3.3	8.0	26.1	8.8	2.6	1.9	2.1	1.6	3.4	7.4	7.6	4.5	4.5	3.3	18.8	3.0	1.9	3.4	15.8	3.4	17.6	40.9	4.1	2.4	9.5	16.7	3.1	3.4	32.3	6.2	3.5	14.5	12.0	10.5	18.2	11.9	16.7	14.0	0.0	0.0	0.2	0.0	0.0	0.1	1.7	0.0	0.0	0.0	0.0	0.0	0.4	6.0	0.0	0.0	0.0	0.0	0.0	15.4	0.0	5.1	0.0	31.9	0.0	3.0	0.2	9.6	33.5	0.6	30.7	0.1	3.4	0.1	4.4	0.9	0.1	2.8	0.1	0.0	4.4	29.9	1.0	0.0	0.0	9.3	0.0	2.2	0.0	1.8	0.0	0.0	0.0	0.6	0.0	4.1	0.0	21.4	3.6	0.0	0.5	0.0	0.0	0.0	1.7	9.2	0.0	12.4	0.0	9.8	9.8	10.5	16.7	15.8	11.4	14.5	7.5	12.3	12.0	13.9	6.3	8.8	9.9	11.9	18.2	6.0	10.2	14.0	7.2	10.7	1.7	6.9	6.6	9.1	8.8	2.6	7.6	9.5	3.0	25.7	58.1	1.2	1.4	0.1	3.2	2.5	4.0	4.5	3.5	0.0	0.4	0.0	0.3	12.8	17.5	0.0	0.0	0.4	0.6	1.0	0.4	14.0	1.3	24.6	0.0	0.0	13.5	48.3	10.6	0.0	20.7	0.0	13.6	0.2	0.0	0.2	0.9	1.1	0.3	0.0	0.0	1.2	0.4	0.7	1.0	0.9	51.0	0.4	1.0
INPP5E	"CORS1, JBTS1, pharbin, PPI5PIV"	ENSG00000148384	"Inositol polyphosphate-5-phosphatase E"	Q9NRR6	9	136428619-136439823	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Lipid metabolism"	Hydrolase	"Ciliopathy, Disease mutation, Joubert syndrome, Mental retardation, Obesity"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA065758	Approved		Supported	"Nucleoplasm,Golgi apparatus,Focal adhesion sites"		NA	NA			"Golgi apparatus, Focal adhesion sites"	Nucleoplasm	"HPA065758: AB_2685554"	"unprognostic (1.99e-1)"	"unprognostic (8.68e-2)"	"unprognostic (1.87e-2)"	"unprognostic (1.23e-2)"	"unprognostic (4.00e-1)"	"unprognostic (6.92e-2)"	"unprognostic (9.60e-3)"	"unprognostic (3.21e-1)"	"unprognostic (5.81e-2)"	"unprognostic (2.65e-2)"	"prognostic favorable (1.82e-4)"	"unprognostic (2.03e-1)"	"unprognostic (3.04e-2)"	"unprognostic (3.76e-1)"	"unprognostic (5.48e-2)"	"unprognostic (4.64e-1)"	"unprognostic (2.66e-2)"	14.3	11.2	14.9	15.3	10.4	8.9	19.2	19.9	19.1	10.5	10.7	11.5	11.1	10.3	13.1	10.1	8.4	17.2	9.4	11.9	12.6	12.0	10.2	9.0	10.1	13.5	8.4	12.3	14.7	11.6	11.4	12.3	9.8	13.2	9.9	5.2	11.0	14.4	12.9	11.6	18.2	10.7	10.7	6.6	19.4	8.6	15.2	10.3	8.5	12.5	6.2	10.7	8.8	19.3	2.6	1.0	1.9	0.5	0.0	2.4	0.6	6.2	7.2	8.5	8.4	4.3	5.6	10.5	7.5	4.4	5.8	3.7	7.4	4.4	7.8	7.7	6.3	8.3	17.5	3.7	5.1	2.2	24.3	14.7	5.2	12.4	4.9	7.3	6.1	8.5	6.0	4.8	6.4	5.7	6.9	5.6	10.0	8.8	7.2	4.9	10.3	7.8	13.4	5.5	3.9	12.0	14.3	6.5	5.8	5.2	6.1	8.9	8.0	7.2	6.8	5.2	6.1	10.9	9.1	8.0	17.9	6.7	7.2	13.0	7.8	6.3	3.3	9.2	5.4	6.5	0.0	0.5	1.9	2.0	0.0	1.3	2.6	2.3	1.5	0.5	1.7	0.8	1.6	0.4	0.0	0.3	1.0	2.4	0.6	14.9	10.4	19.9	19.1	12.6	12.0	8.4	12.3	13.2	10.3	3.0	5.8	2.9	1.5	4.8	7.1	4.1	7.6	6.7	3.4	3.5	2.0	2.0	1.7	4.5	0.3	5.8	2.8	0.0	4.8	2.0	3.9	2.0	9.2	3.0	2.6	14.3	5.8	2.5	3.8	0.7	6.9	3.5	5.0	4.6	2.9	8.5	5.3	0.0	5.3	2.2	11.4	0.0	4.8	9.8	7.8	4.3	0.7	4.3	4.3	1.6
INPP5F	"hSac2, KIAA0966, SAC2"	ENSG00000198825	"Inositol polyphosphate-5-phosphatase F"	Q9Y2H2	10	119726097-119829278	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins"		Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 69.7"	"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"AF22: 30.5;SH-SY5Y: 24.2;SK-MEL-30: 46.0;SuSa: 63.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA042605			Supported	Vesicles		NA	NA			Vesicles		"HPA042605: AB_10793886"	"unprognostic (2.65e-2)"	"unprognostic (3.23e-1)"	"unprognostic (3.42e-2)"	"unprognostic (5.84e-2)"	"unprognostic (1.87e-2)"	"unprognostic (1.57e-3)"	"unprognostic (2.46e-3)"	"unprognostic (2.21e-1)"	"unprognostic (1.12e-1)"	"unprognostic (8.09e-2)"	"unprognostic (2.09e-1)"	"unprognostic (6.46e-2)"	"unprognostic (7.78e-2)"	"unprognostic (1.02e-1)"	"unprognostic (9.91e-2)"	"unprognostic (2.96e-2)"	"unprognostic (6.21e-2)"	4.6	12.3	17.5	5.9	50.4	3.2	5.7	37.0	52.9	10.9	5.0	5.5	2.2	3.1	11.8	18.0	4.5	4.2	5.5	4.1	24.6	53.1	7.3	2.0	4.2	7.6	23.7	29.1	9.8	4.6	8.9	34.0	8.2	69.7	8.3	6.1	3.4	7.1	8.4	7.5	10.4	3.8	10.8	19.2	4.1	3.8	10.1	7.3	1.4	8.4	1.4	9.3	5.3	4.5	12.2	7.4	1.5	4.5	3.8	6.7	2.2	3.9	2.7	30.5	4.4	3.3	3.4	2.7	5.5	3.0	2.6	2.6	4.0	5.0	2.5	2.1	6.9	3.6	4.4	3.3	3.2	4.0	1.6	3.0	1.7	1.4	4.1	4.6	1.1	5.6	4.1	3.0	5.2	5.2	5.4	8.8	2.0	1.5	4.1	6.2	2.2	1.5	4.6	2.9	3.6	3.5	2.1	5.4	0.6	4.4	2.0	2.2	24.2	6.1	1.9	46.0	63.8	1.3	1.2	5.8	2.6	3.4	3.4	5.3	4.6	2.0	1.1	3.3	3.9	10.7	1.1	4.0	1.5	1.3	3.5	1.6	8.1	2.8	1.9	7.4	12.2	3.2	1.4	1.0	3.8	4.5	1.8	6.7	2.2	17.5	50.4	37.0	50.5	24.6	53.1	23.7	29.1	69.7	7.3	6.0	4.5	10.0	9.8	8.0	24.8	5.3	0.0	2.7	5.7	12.2	15.7	7.7	10.0	3.1	28.7	7.4	6.4	0.0	3.9	7.2	6.7	8.4	2.3	2.8	8.6	39.7	1.2	4.9	5.7	18.7	4.9	11.5	18.6	21.6	5.8	18.8	5.5	5.5	3.5	16.7	21.0	6.5	7.5	10.3	40.3	9.2	11.1	4.3	6.0	10.2
INPP5J	"INPP5, PIB5PA, PIPP"	ENSG00000185133	"Inositol polyphosphate-5-phosphatase J"	Q15735	22	31122731-31134696	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins"		Hydrolase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"parathyroid gland: 65.2;thyroid gland: 71.2"	"Cell type enhanced"	"Detected in many"	11	"Collecting duct cells: 33.2;Enterocytes: 31.9;Muller glia cells: 20.3"	"Cancer enriched"	"Detected in many"	6	"thyroid cancer: 63.1"	"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in single"		"myeloid DC: 2.4"	"Lineage enriched"	"Detected in single"	5	"dendritic cells: 2.4"	"Cell line enhanced"	"Detected in many"		"HL-60: 12.3;SK-BR-3: 26.8;T-47d: 16.9;U-698: 11.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA034539			Approved	Nucleoli,Cytosol		NA	NA			Cytosol	Nucleoli	"HPA034539: AB_10670974"	"unprognostic (1.76e-1)"	"unprognostic (2.09e-1)"	"unprognostic (1.73e-1)"	"unprognostic (7.05e-2)"	"unprognostic (1.68e-1)"	"unprognostic (1.19e-2)"	"unprognostic (2.21e-3)"	"prognostic favorable (1.47e-5)"	"unprognostic (6.81e-2)"	"unprognostic (1.86e-2)"	"unprognostic (4.29e-4)"	"unprognostic (1.47e-1)"	"prognostic favorable (1.12e-7)"	"unprognostic (2.79e-3)"	"unprognostic (3.65e-2)"	"unprognostic (2.14e-1)"	"unprognostic (1.39e-2)"	0.8	0.9	4.6	0.8	6.3	0.5	3.7	27.4	13.4	1.5	6.4	0.8	16.7	7.9	1.3	0.8	1.0	1.0	1.0	9.5	7.4	2.0	9.5	0.5	1.5	0.7	2.3	4.6	0.8	5.3	65.2	3.7	0.5	5.5	3.5	2.2	5.6	15.5	19.2	1.6	1.7	21.7	1.2	0.9	0.6	3.8	1.6	1.1	0.0	71.2	0.0	0.7	1.1	0.9	0.3	2.4	0.0	0.4	0.0	0.0	0.2	1.3	1.3	0.8	1.5	0.2	0.2	0.7	0.5	0.5	2.7	2.6	0.8	0.8	0.0	0.6	0.2	0.3	1.6	1.6	0.7	1.1	0.0	4.3	0.0	5.6	0.2	0.5	12.3	0.1	0.1	0.8	2.2	0.2	1.8	0.1	0.0	1.1	1.9	0.0	4.1	0.1	0.0	1.5	1.7	0.2	0.0	0.3	2.9	1.1	1.6	6.5	4.9	1.0	26.8	0.3	0.7	16.9	1.0	0.0	0.1	4.9	0.5	0.3	0.0	2.1	11.6	0.4	0.0	2.0	0.0	0.4	0.0	0.0	0.3	0.0	0.3	0.0	0.0	2.4	0.0	0.0	0.0	0.0	0.0	0.4	0.9	0.0	0.2	4.6	6.3	27.4	13.4	7.4	2.0	2.3	4.6	5.5	1.1	0.0	2.6	0.0	2.3	0.8	7.9	4.8	0.0	0.0	1.2	33.2	0.0	0.0	10.0	1.2	0.3	0.0	31.9	0.0	1.9	0.1	0.2	3.7	0.0	0.0	0.1	4.8	0.0	0.0	0.0	0.0	0.0	0.2	0.0	1.0	5.0	20.3	1.0	10.5	0.0	0.6	2.3	0.0	0.3	1.7	0.9	1.1	0.1	0.0	6.8	0.9
INPP5K	SKIP	ENSG00000132376	"Inositol polyphosphate-5-phosphatase K"	Q9BT40	17	1494571-1516888	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"		Hydrolase	"Cataract, Congenital muscular dystrophy, Disease mutation, Mental retardation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"retina: 114.9"	"Cell type enhanced"	"Detected in many"	11	"Late spermatids: 261.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"									NA	NA						"unprognostic (7.47e-2)"	"prognostic favorable (3.91e-4)"	"unprognostic (8.91e-2)"	"prognostic favorable (2.33e-5)"	"unprognostic (3.25e-1)"	"unprognostic (9.22e-2)"	"unprognostic (1.50e-1)"	"unprognostic (7.50e-2)"	"unprognostic (2.00e-1)"	"unprognostic (2.77e-2)"	"prognostic favorable (1.47e-6)"	"unprognostic (4.71e-2)"	"unprognostic (9.35e-3)"	"unprognostic (3.01e-2)"	"unprognostic (7.20e-2)"	"unprognostic (4.28e-3)"	"unprognostic (1.04e-1)"	27.9	10.5	12.7	13.8	13.5	25.9	37.0	14.9	17.7	13.4	13.4	14.9	9.8	9.1	12.8	12.2	12.0	10.4	12.9	17.5	12.8	12.6	11.6	10.5	20.8	14.3	12.8	12.0	14.3	18.9	12.0	10.8	15.9	21.2	13.5	11.4	114.9	12.9	12.2	26.4	22.3	13.9	10.9	10.7	16.2	12.8	20.8	11.3	22.1	27.3	13.8	16.4	12.5	14.1	12.1	16.5	36.4	27.0	17.0	30.8	24.6	9.5	13.2	5.4	10.4	14.1	7.9	8.1	8.0	13.5	9.1	11.6	8.2	5.7	8.5	15.4	12.2	7.5	12.5	13.0	5.2	9.3	22.0	21.8	5.3	10.1	3.2	17.9	5.0	10.3	9.3	13.8	9.1	9.0	5.8	14.4	14.5	5.7	15.3	6.0	6.8	15.1	4.1	2.3	14.3	9.0	11.6	4.3	8.0	7.3	5.9	4.3	10.9	6.3	12.3	14.3	8.4	10.4	4.1	10.2	8.0	8.2	11.5	10.3	8.1	13.5	4.5	9.0	5.2	10.0	36.4	19.9	31.9	22.2	18.7	18.2	12.1	20.7	22.4	16.5	11.3	17.7	18.9	33.3	17.0	27.0	11.9	30.8	24.6	12.7	13.5	14.9	17.7	12.8	12.6	12.8	12.0	21.2	11.3	29.8	13.1	9.5	13.9	26.7	7.5	31.5	5.1	5.3	7.9	22.7	2.0	11.5	11.6	15.2	90.2	27.4	20.9	0.0	21.2	13.3	15.4	14.1	19.6	8.9	10.7	19.1	16.7	21.5	19.1	261.4	10.6	16.0	30.4	48.7	17.0	20.3	21.3	21.0	7.1	9.0	7.6	19.4	16.4	31.6	16.7	26.5	26.0	36.3	11.0	14.4
INPPL1	SHIP2	ENSG00000165458	"Inositol polyphosphate phosphatase like 1"	O15357	11	72223701-72239105	"Cancer-related genes, Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Cell adhesion, Immunity"	"Actin-binding, Hydrolase"	"Cancer-related genes, Diabetes mellitus, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA037601	Approved		Supported	"Golgi apparatus,Cytosol"		NA	NA			Cytosol	"Golgi apparatus"	"HPA037601: AB_10672281"	"unprognostic (2.68e-1)"	"unprognostic (2.69e-2)"	"unprognostic (1.12e-1)"	"unprognostic (1.12e-1)"	"unprognostic (3.68e-3)"	"unprognostic (1.58e-1)"	"prognostic unfavorable (7.37e-4)"	"unprognostic (2.49e-2)"	"unprognostic (3.54e-2)"	"unprognostic (1.51e-2)"	"unprognostic (1.64e-1)"	"unprognostic (4.34e-2)"	"unprognostic (3.66e-2)"	"unprognostic (2.33e-1)"	"unprognostic (2.88e-1)"	"unprognostic (1.99e-3)"	"unprognostic (2.07e-1)"	20.9	23.7	22.2	20.4	19.5	25.1	18.6	11.1	18.9	25.2	32.0	22.7	28.8	19.8	24.7	18.4	17.4	24.3	29.6	29.5	24.1	10.3	23.9	17.1	24.9	19.0	27.6	10.4	30.1	22.7	21.6	26.9	31.9	20.4	28.7	13.5	30.7	27.5	24.2	60.0	17.7	23.0	34.7	27.5	28.3	24.5	11.8	24.3	16.0	29.1	19.3	18.3	25.0	18.1	2.6	5.2	7.0	7.6	4.2	4.5	3.3	6.5	14.0	16.8	11.4	8.3	9.9	30.0	30.2	14.1	18.9	12.1	19.1	16.5	18.6	30.8	23.0	13.5	24.9	13.8	8.5	6.5	24.1	14.3	19.3	70.9	7.0	16.3	12.7	43.3	14.0	9.0	18.3	7.3	23.5	10.1	6.9	13.6	8.0	10.3	17.6	9.4	51.6	17.2	4.6	21.9	44.5	38.2	4.1	22.0	11.0	8.2	11.9	32.4	19.6	42.1	8.9	20.7	24.2	17.2	20.3	23.8	31.1	9.8	23.2	3.8	18.2	5.7	12.1	11.0	5.2	7.6	7.0	4.5	4.4	3.7	2.2	3.7	3.0	5.2	2.6	2.7	3.7	5.2	4.2	7.0	3.9	3.3	3.3	22.2	19.5	11.1	18.9	24.1	10.3	27.6	10.4	20.4	24.3	3.0	13.8	2.4	4.6	6.4	1.2	11.2	5.1	5.3	10.3	12.2	25.5	20.7	1.7	10.7	1.1	6.3	16.0	0.0	10.6	12.5	9.8	6.8	7.0	8.6	18.9	9.5	21.8	10.4	26.9	1.5	9.2	18.1	10.1	3.6	15.4	14.3	13.4	17.5	13.1	12.5	17.2	6.5	9.2	1.2	4.1	4.3	27.1	6.7	17.5	5.2
IP6K1	"IHPK1, KIAA0263"	ENSG00000176095	"Inositol hexakisphosphate kinase 1"	Q92551	3	49724294-49786542	"Enzymes, Predicted intracellular proteins"		"Kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"	4	"Cone photoreceptor cells: 84.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA040825	Approved		Supported	"Nucleoplasm,Nucleoli fibrillar center,Cytosol"		NA	NA			"Nucleoli fibrillar center"	"Nucleoplasm, Cytosol"	"HPA040825: AB_10960426"	"unprognostic (6.18e-2)"	"unprognostic (1.33e-1)"	"unprognostic (3.58e-2)"	"unprognostic (4.71e-2)"	"unprognostic (1.99e-1)"	"prognostic favorable (2.08e-4)"	"unprognostic (9.97e-3)"	"unprognostic (8.45e-2)"	"unprognostic (1.16e-1)"	"unprognostic (2.11e-1)"	"prognostic favorable (6.85e-4)"	"unprognostic (1.29e-2)"	"prognostic favorable (5.77e-5)"	"unprognostic (8.75e-2)"	"unprognostic (1.67e-1)"	"unprognostic (9.24e-2)"	"unprognostic (1.64e-2)"	14.2	17.5	23.5	12.9	26.9	12.1	15.8	38.6	40.4	17.7	16.1	20.7	16.1	13.6	21.4	14.5	19.6	20.0	14.7	13.7	23.8	23.5	16.3	15.9	16.9	16.3	17.9	18.3	30.2	21.9	30.3	16.7	18.3	21.2	14.3	13.2	18.6	18.3	21.1	9.0	18.2	12.7	19.5	16.9	16.9	13.7	27.3	14.8	22.3	17.1	8.4	14.4	16.3	15.6	6.8	4.1	24.0	4.8	6.9	9.7	6.0	12.3	15.0	17.6	20.6	18.4	14.2	14.2	16.5	17.4	27.1	23.8	19.5	12.9	10.8	10.7	18.2	18.4	9.2	24.8	14.9	15.4	21.7	19.8	24.4	23.0	13.1	20.4	14.9	17.1	16.5	18.6	29.2	17.7	15.3	22.6	12.6	16.0	12.7	13.3	11.0	18.1	15.6	18.9	9.8	25.0	11.5	12.5	21.6	17.5	18.9	9.5	19.0	21.0	13.7	18.9	10.6	11.0	22.0	20.2	15.2	15.3	20.8	19.1	15.5	20.8	11.5	13.9	17.3	15.5	2.5	4.8	8.2	8.7	3.9	8.8	4.6	8.0	9.6	4.1	6.8	9.7	9.5	24.0	6.9	4.8	2.9	8.2	6.0	23.5	26.9	38.6	40.4	23.8	23.5	17.9	18.3	21.2	14.8	23.8	10.5	11.8	13.7	13.9	37.4	8.9	15.3	17.4	10.3	12.2	84.4	15.7	5.0	12.1	69.3	16.6	12.9	23.3	11.3	13.2	13.6	16.1	19.6	10.6	10.8	28.6	26.5	17.8	11.8	11.8	19.5	10.7	18.6	14.4	12.2	22.0	16.3	8.6	15.6	10.3	70.3	19.4	11.5	17.9	22.6	16.4	23.0	23.5	11.0	13.3
IP6K2	IHPK2	ENSG00000068745	"Inositol hexakisphosphate kinase 2"	Q9UHH9	3	48688003-48740353	"Enzymes, Predicted intracellular proteins"	"Lipid metabolism, Phospholipid metabolism"	"Kinase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA007532, HPA070811"	Approved		Approved	"Nucleoplasm,Nucleoli fibrillar center,Cell Junctions"		NA	NA			"Nucleoplasm, Nucleoli fibrillar center"	"Cell Junctions"	"HPA007532: AB_1851542, HPA070811: AB_2732165"	"prognostic favorable (1.25e-4)"	"unprognostic (2.55e-2)"	"unprognostic (8.86e-2)"	"unprognostic (6.69e-3)"	"unprognostic (1.01e-1)"	"unprognostic (1.49e-2)"	"unprognostic (1.76e-3)"	"prognostic favorable (2.95e-4)"	"unprognostic (6.57e-3)"	"unprognostic (1.56e-1)"	"unprognostic (1.92e-3)"	"unprognostic (1.99e-2)"	"unprognostic (1.24e-1)"	"unprognostic (1.35e-1)"	"unprognostic (1.64e-1)"	"unprognostic (3.50e-2)"	"prognostic favorable (1.83e-4)"	18.3	31.1	40.4	20.0	55.9	51.7	28.2	74.1	37.3	29.5	32.5	23.7	34.0	36.9	34.6	56.1	30.0	28.1	24.0	19.0	30.7	19.2	32.4	24.3	18.4	22.5	35.4	27.6	33.9	28.1	23.5	42.3	20.7	29.4	34.9	41.9	22.2	28.3	32.1	19.1	50.0	31.6	21.1	28.3	25.5	27.6	26.0	37.4	31.7	35.7	21.6	19.5	24.1	34.0	27.3	22.8	50.7	25.7	27.9	35.1	19.0	8.5	16.7	34.7	24.4	19.6	24.5	25.1	16.3	18.3	18.7	21.7	13.8	22.9	15.1	13.4	15.2	23.5	22.3	17.3	24.4	17.5	17.8	15.2	17.3	51.7	29.6	15.9	16.4	16.9	23.2	35.6	25.4	21.0	24.9	25.9	49.1	12.9	19.0	21.7	19.0	35.0	22.5	26.6	16.7	31.0	14.7	11.5	16.5	25.4	41.0	21.7	32.8	35.3	24.0	17.3	28.8	23.2	27.7	18.4	20.4	20.3	12.8	16.1	17.6	20.8	21.3	18.5	19.2	17.8	50.7	22.5	38.5	29.7	21.6	26.5	27.3	25.8	27.7	21.7	25.7	24.2	24.9	35.3	27.9	25.7	22.8	35.1	19.0	40.4	55.9	74.1	37.3	30.7	19.2	35.4	27.6	29.4	37.4	65.5	38.7	24.2	78.6	73.7	63.9	10.1	33.1	69.6	69.4	94.2	37.3	101.3	64.6	51.7	30.9	42.0	85.6	0.0	41.6	64.1	64.4	60.2	53.1	20.7	35.7	19.1	105.7	35.0	15.3	14.2	75.1	31.2	25.3	34.3	96.2	28.0	50.1	90.2	64.3	55.6	50.0	51.8	35.7	56.7	54.0	72.5	103.7	47.2	78.7	75.6
IP6K3	"IHPK3, INSP6K3"	ENSG00000161896	"Inositol hexakisphosphate kinase 3"	Q96PC2	6	33721670-33746905	"Enzymes, Predicted intracellular proteins"		"Kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Group enriched"	"Detected in many"	5	"brain: 22.5;skeletal muscle: 87.9"	"Cell type enhanced"	"Detected in some"	12	"Cardiomyocytes: 10.9;Hepatocytes: 5.8;Horizontal cells: 9.5;Proximal tubular cells: 3.6;Sertoli cells: 6.5"	"Low cancer specificity"	"Detected in many"			"Group enriched"	"Detected in many"	4	"basal ganglia: 13.0;cerebral cortex: 6.2;midbrain: 22.5;pons and medulla: 7.7;thalamus: 15.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HHSteC: 16.2;HSkMC: 5.8;LHCN-M2: 25.7;RH-30: 11.3"	"Low region specificity"	"Detected in some"			"Not detected"	"Not detected"			"HPA053644, HPA062531"	Approved		Approved	Nucleoplasm,Cytosol		Yes	NA			Nucleoplasm	Cytosol	"HPA053644: AB_2682214, HPA062531: "	"unprognostic (3.23e-2)"	"unprognostic (2.87e-1)"	"unprognostic (2.07e-5)"	"unprognostic (1.07e-3)"	"unprognostic (2.20e-1)"	"unprognostic (5.10e-3)"	"unprognostic (1.38e-1)"	"unprognostic (1.75e-1)"	"unprognostic (2.45e-1)"	"unprognostic (2.47e-2)"	"unprognostic (1.24e-2)"	"unprognostic (2.94e-3)"	"prognostic unfavorable (6.09e-4)"	"unprognostic (1.63e-2)"	"unprognostic (2.01e-1)"	"unprognostic (2.66e-3)"	"unprognostic (1.33e-1)"	2.2	1.0	2.1	0.8	13.0	0.5	0.9	0.6	6.2	1.2	2.2	11.8	1.4	0.8	1.6	1.4	5.2	1.3	0.6	10.0	3.2	1.3	4.7	7.7	2.0	0.6	22.5	1.1	0.6	0.7	0.5	0.5	3.8	7.7	2.8	1.0	1.2	1.4	1.8	87.9	0.5	1.1	1.8	9.2	1.4	0.9	0.6	15.2	0.0	9.9	8.1	0.5	1.5	1.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	2.6	0.1	0.2	0.2	1.9	0.0	0.0	0.0	0.4	0.0	0.1	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.1	16.2	0.0	0.0	5.8	0.8	0.1	0.4	0.0	0.0	0.0	0.0	0.0	25.7	0.0	0.0	0.0	0.1	0.0	0.0	0.0	11.3	0.0	0.0	0.0	0.3	0.1	0.0	0.5	0.4	4.0	0.0	0.2	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	2.1	13.0	0.6	6.2	3.2	1.3	22.5	1.1	7.7	15.2	0.0	0.0	0.0	0.0	0.0	2.2	10.9	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	1.1	0.0	0.0	5.8	0.2	9.5	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.0	3.6	0.1	6.5	0.4	0.0	0.0	0.0	0.6	0.0	0.0	0.1
IPMK		ENSG00000151151	"Inositol polyphosphate multikinase"	Q8NFU5	10	58191517-58267934	"Enzymes, Predicted intracellular proteins"	"Lipid metabolism, Phospholipid metabolism"	"Kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Basal keratinocytes: 48.0;Suprabasal keratinocytes: 50.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"neutrophil: 6.4"	"Group enriched"	"Detected in many"	4	"granulocytes: 6.4;monocytes: 2.1"	"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA037837, HPA057542"	Uncertain		Enhanced	Nucleoplasm		NA	NA			Nucleoplasm		"HPA037837: AB_10670166, HPA057542: AB_2683460"	"unprognostic (4.52e-2)"	"unprognostic (3.29e-2)"	"unprognostic (4.22e-3)"	"unprognostic (6.85e-2)"	"unprognostic (2.41e-2)"	"unprognostic (1.99e-1)"	"unprognostic (1.39e-3)"	"unprognostic (2.10e-1)"	"unprognostic (9.39e-2)"	"unprognostic (2.23e-1)"	"unprognostic (1.55e-1)"	"unprognostic (8.56e-2)"	"prognostic unfavorable (9.96e-7)"	"unprognostic (1.79e-1)"	"unprognostic (4.33e-1)"	"unprognostic (1.27e-3)"	"unprognostic (9.02e-3)"	12.2	4.1	5.4	6.8	5.6	2.8	6.7	8.7	5.6	5.9	19.4	3.5	2.1	9.5	3.2	5.6	10.8	3.8	8.6	7.4	5.2	5.5	5.3	21.3	11.0	13.8	4.9	3.3	4.8	6.0	22.5	6.1	13.8	4.3	4.4	7.5	4.8	6.4	4.4	9.8	9.0	28.1	4.9	6.0	14.1	4.4	2.9	3.8	11.7	5.9	4.9	5.9	10.4	12.3	0.7	1.0	6.4	2.1	0.4	0.9	0.4	14.7	3.8	5.6	5.4	5.5	6.5	4.9	3.9	8.4	3.4	6.8	7.6	9.5	11.8	8.0	4.6	3.2	4.6	4.7	5.2	10.8	5.4	3.6	2.9	3.8	7.2	3.3	4.6	6.7	7.1	4.7	5.7	11.5	3.8	7.2	3.5	1.9	6.1	5.9	3.7	6.2	8.9	3.5	6.0	3.6	0.4	12.1	5.5	6.2	3.8	3.9	6.8	5.1	13.6	3.9	9.6	11.3	5.6	6.2	3.7	7.1	7.7	4.9	13.1	7.7	9.4	6.9	4.9	1.4	2.3	1.5	3.3	0.4	1.6	0.4	0.7	0.4	0.2	1.0	0.4	0.9	0.3	6.4	0.4	2.1	0.4	0.1	0.4	5.4	5.6	8.7	5.6	5.2	5.5	4.9	3.3	4.3	3.8	6.0	3.4	9.7	9.1	48.0	9.1	2.4	5.1	17.4	7.9	1.8	5.9	8.5	3.3	3.2	1.9	3.2	22.2	0.0	4.2	17.8	16.0	7.8	6.9	11.4	9.0	12.7	8.1	8.6	27.1	1.0	2.6	17.3	25.3	1.0	11.7	3.7	6.2	16.4	1.8	7.3	5.4	6.5	12.2	9.8	4.3	50.7	7.9	4.3	9.0	14.3
IPPK	"C9orf12, FLJ13163, INSP5K2, IP5K, IPK1"	ENSG00000127080	"Inositol-pentakisphosphate 2-kinase"	Q9H8X2	9	92613184-92670265	"Enzymes, Predicted intracellular proteins"		"Kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	4	"Late spermatids: 26.7"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA020603	Uncertain		Approved	Cytosol		NA	NA			Cytosol		"HPA020603: AB_1851853"	"unprognostic (3.51e-2)"	"unprognostic (4.66e-2)"	"unprognostic (6.26e-2)"	"unprognostic (1.26e-1)"	"unprognostic (3.63e-2)"	"unprognostic (2.08e-1)"	"unprognostic (4.88e-2)"	"unprognostic (3.13e-2)"	"unprognostic (4.40e-2)"	"unprognostic (1.10e-1)"	"unprognostic (2.68e-1)"	"unprognostic (1.98e-1)"	"unprognostic (6.26e-9)"	"unprognostic (1.28e-2)"	"unprognostic (4.23e-2)"	"unprognostic (2.83e-1)"	"prognostic unfavorable (1.28e-4)"	5.0	7.5	7.6	5.2	12.3	8.3	7.5	13.4	14.1	7.9	4.7	9.7	6.8	3.7	6.0	5.9	29.7	6.4	5.3	8.1	7.9	5.9	5.2	5.8	4.9	6.0	7.1	5.7	6.5	4.2	11.3	11.0	7.1	10.0	5.1	5.3	6.0	10.8	4.3	6.9	31.5	4.6	6.3	6.4	5.8	4.8	12.0	7.7	5.7	5.5	17.8	16.1	4.9	13.7	4.2	3.9	5.8	3.2	1.4	7.5	3.1	11.9	6.4	5.9	5.1	7.3	5.5	19.7	8.6	5.3	8.8	5.0	4.0	4.7	7.5	4.3	11.9	7.8	17.2	10.4	11.9	7.4	9.2	6.7	6.1	13.6	6.1	5.2	10.3	7.2	5.4	11.8	10.5	8.2	8.0	6.5	6.2	8.2	9.1	8.6	16.3	5.9	4.8	10.1	13.2	9.5	5.2	6.4	3.0	5.2	7.3	12.4	7.3	6.9	28.7	5.0	6.1	6.8	2.6	12.6	6.5	7.4	18.3	8.9	8.4	9.7	4.2	8.5	4.7	6.3	0.0	2.3	5.8	6.4	3.1	7.3	4.1	5.6	5.7	3.6	4.2	4.4	4.8	3.6	1.4	3.2	3.9	7.5	3.1	7.6	12.3	13.4	14.1	7.9	5.9	7.1	5.7	10.0	7.7	3.0	4.3	1.5	5.2	22.6	8.3	0.3	0.0	0.0	3.4	1.8	5.9	7.8	5.0	5.2	8.3	5.8	3.3	0.0	6.9	11.0	4.3	5.0	0.0	2.6	4.4	14.3	6.4	10.4	5.9	26.7	2.8	3.9	3.3	1.8	3.4	4.5	6.5	0.0	2.8	3.1	4.1	6.5	2.7	15.7	16.8	25.7	19.1	4.4	3.3	9.0
ISYNA1	"Ino1, INOS, IPS"	ENSG00000105655	"Inositol-3-phosphate synthase 1"	Q9NPH2	19	18434388-18438301	"Enzymes, Predicted intracellular proteins"	"Inositol biosynthesis, Lipid biosynthesis, Lipid metabolism, Phospholipid biosynthesis, Phospholipid metabolism"	Isomerase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"testis: 83.6"	"Cell type enhanced"	"Detected in many"	14	"Cytotrophoblasts: 829.0;Sertoli cells: 310.4;Syncytiotrophoblasts: 865.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Group enriched"	"Detected in many"	4	"B-cells: 4.0;NK-cells: 11.9;T-cells: 8.5"	"Cell line enriched"	"Detected in many"	4	"BEWO: 103.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA007931, HPA008232, CAB020720"	Enhanced		Approved	Nucleoplasm,Cytosol		NA	NA			Nucleoplasm	Cytosol	"CAB020720: , HPA007931: AB_2667940, HPA008232: AB_2668018"	"unprognostic (1.87e-2)"	"unprognostic (1.86e-1)"	"unprognostic (2.98e-2)"	"unprognostic (3.16e-2)"	"unprognostic (3.88e-1)"	"unprognostic (1.81e-2)"	"unprognostic (2.49e-1)"	"unprognostic (3.12e-1)"	"unprognostic (1.74e-1)"	"unprognostic (2.28e-2)"	"unprognostic (2.73e-2)"	"unprognostic (5.08e-2)"	"prognostic unfavorable (9.23e-4)"	"unprognostic (2.23e-2)"	"unprognostic (9.26e-2)"	"unprognostic (1.19e-2)"	"unprognostic (1.50e-1)"	7.9	8.4	7.1	3.0	5.7	4.5	7.1	2.7	6.7	9.9	3.5	10.0	44.2	3.4	13.9	12.3	4.5	20.0	6.5	8.0	5.7	7.4	12.7	4.1	4.7	3.8	4.1	4.1	31.6	25.5	7.7	12.6	44.2	16.2	9.5	1.3	19.3	8.8	34.4	8.2	3.4	3.9	3.0	2.3	10.5	3.7	83.6	3.5	3.0	5.6	3.8	3.3	5.9	7.8	4.0	1.9	0.9	0.2	11.9	8.5	4.9	2.8	8.6	20.5	6.1	0.1	0.0	103.8	1.3	0.2	0.1	0.0	4.9	5.2	0.0	7.0	0.6	0.0	7.4	0.6	0.0	0.0	7.7	23.6	10.3	0.5	15.9	2.2	0.1	0.2	1.6	0.1	0.6	0.1	0.0	1.3	0.2	21.1	0.4	0.0	16.6	0.7	0.7	10.7	2.6	6.9	14.2	0.0	4.8	1.7	0.0	6.3	15.8	0.3	1.9	10.5	4.4	14.0	1.1	3.9	0.1	0.2	0.1	0.3	3.3	1.4	0.6	0.6	0.4	3.6	0.9	0.1	0.0	7.6	0.2	5.9	4.0	7.4	6.7	0.7	2.3	6.1	8.5	0.8	11.9	0.1	1.9	5.2	4.9	7.1	5.7	2.7	6.7	5.7	7.4	4.1	4.1	16.2	3.5	3.0	0.6	2.2	67.1	10.6	0.0	4.2	7.6	4.0	4.5	45.4	2.0	829.0	44.7	34.8	81.2	19.7	1.3	0.0	7.5	57.3	25.4	8.5	13.9	0.9	73.6	0.0	62.2	19.0	5.3	178.1	34.5	3.7	21.9	7.2	2.6	7.2	4.6	0.0	47.4	4.7	0.5	310.4	167.1	59.2	21.8	5.0	865.2	9.6	4.6	31.8
ITPK1		ENSG00000100605	"Inositol-tetrakisphosphate 1-kinase"	Q13572	14	92936914-93116320	"Enzymes, Predicted intracellular proteins"		"Hydrolase, Isomerase, Kinase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Enterocytes: 79.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"neutrophil: 24.2"	"Group enriched"	"Detected in all"	5	"granulocytes: 24.2;monocytes: 13.0"	"Cell line enhanced"	"Detected in all"		"WM-115: 42.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA055230	Approved		Approved	Mitochondria		NA	NA			Mitochondria		"HPA055230: AB_2682748"	"unprognostic (1.93e-3)"	"unprognostic (2.50e-1)"	"unprognostic (2.15e-1)"	"prognostic favorable (8.56e-4)"	"unprognostic (4.27e-1)"	"unprognostic (2.04e-2)"	"unprognostic (6.97e-2)"	"unprognostic (1.32e-1)"	"unprognostic (1.24e-2)"	"unprognostic (2.86e-2)"	"unprognostic (8.14e-2)"	"unprognostic (2.27e-1)"	"unprognostic (1.37e-3)"	"unprognostic (2.39e-1)"	"unprognostic (2.02e-1)"	"unprognostic (4.20e-1)"	"unprognostic (7.25e-3)"	32.0	10.2	44.3	11.9	49.5	12.2	14.4	19.3	50.5	23.8	20.0	29.7	9.6	34.9	20.2	10.2	18.7	15.9	16.1	18.4	49.0	30.6	11.4	13.4	13.0	7.6	42.1	27.1	11.4	15.0	13.2	5.3	11.2	18.5	15.1	13.6	14.5	8.3	19.1	9.4	5.5	36.6	19.4	44.8	14.1	11.9	9.4	26.1	3.4	10.0	3.2	5.5	16.7	16.2	1.9	3.9	24.2	13.0	1.3	1.9	2.4	10.3	21.5	4.0	10.2	9.0	5.0	10.8	4.4	6.7	8.9	5.4	12.3	18.7	6.6	22.2	7.0	3.4	12.3	11.5	19.1	2.8	24.4	5.0	14.5	5.7	10.6	6.7	6.6	16.2	3.2	11.5	4.5	10.4	3.9	8.7	6.9	7.9	7.6	4.3	27.9	5.6	9.4	8.4	13.6	9.7	10.8	5.9	9.8	6.0	17.5	10.9	13.8	11.2	22.8	19.0	3.2	30.6	8.1	6.8	6.2	6.8	10.4	7.0	7.5	6.8	4.2	5.7	5.2	42.6	2.5	5.2	9.5	1.9	8.6	1.1	1.9	1.2	1.2	3.9	0.7	0.7	1.3	24.2	1.3	13.0	1.9	1.7	2.4	44.3	49.5	19.3	50.5	49.0	30.6	42.1	27.1	18.5	26.1	11.9	12.0	6.7	6.5	6.5	9.7	21.5	15.3	4.0	5.7	27.9	17.7	6.9	11.6	20.4	8.3	10.1	79.1	0.0	23.9	8.8	7.8	13.3	16.1	25.9	18.3	6.4	27.6	12.3	38.1	17.6	13.8	26.0	25.3	15.4	25.6	15.5	29.8	38.6	45.3	17.0	9.3	19.4	15.3	2.8	12.8	3.9	5.7	9.6	25.9	7.9
ITPKA	"IP3-3KA, IP3KA"	ENSG00000137825	"Inositol-trisphosphate 3-kinase A"	P23677	15	41493393-41503551	"Enzymes, Predicted intracellular proteins"		"Calmodulin-binding, Kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	4	"brain: 28.8;intestine: 19.8;stomach 1: 10.7"	"Cell type enhanced"	"Detected in some"	23	"Early spermatids: 36.6;Enterocytes: 34.8;Late spermatids: 119.2"	"Low cancer specificity"	"Detected in many"			"Group enriched"	"Detected in many"	5	"amygdala: 12.3;basal ganglia: 21.2;cerebral cortex: 28.8;hippocampal formation: 10.4;olfactory region: 8.2"	"Cell type enriched"	"Detected in single"	8	"MAIT T-cell: 4.7"	"Lineage enriched"	"Detected in single"	13	"T-cells: 4.7"	"Cell line enhanced"	"Detected in many"		"Hep G2: 22.7;OE19: 12.5"	"Group enriched"	"Detected in many"	13	"amygdala: 120.1;basal ganglia: 97.6;cerebellum: 62.9;cerebral cortex: 164.4;hippocampal formation: 162.9"	"Group enriched"	"Detected in many"	7	"amygdala: 12.1;basal ganglia: 40.8;cerebral cortex: 32.2;hippocampal formation: 28.6"	HPA040454	Enhanced	Approved	Approved	"Vesicles,Plasma membrane"		No	No			Vesicles	"Plasma membrane"	"HPA040454: AB_10672897"	"unprognostic (5.91e-2)"	"unprognostic (2.16e-3)"	"unprognostic (4.19e-1)"	"unprognostic (3.57e-3)"	"prognostic unfavorable (6.77e-4)"	"unprognostic (2.25e-2)"	"unprognostic (2.69e-2)"	"unprognostic (1.01e-1)"	"unprognostic (3.58e-1)"	"unprognostic (1.28e-1)"	"unprognostic (1.21e-1)"	"unprognostic (2.06e-1)"	"prognostic unfavorable (3.76e-9)"	"unprognostic (2.15e-1)"	"unprognostic (2.87e-1)"	"unprognostic (1.12e-3)"	"unprognostic (2.10e-2)"	0.4	3.0	12.3	1.1	21.2	0.8	0.4	3.0	28.8	0.6	8.5	0.3	0.0	19.8	0.6	0.5	0.4	0.6	0.6	0.7	10.4	0.9	0.4	0.8	0.4	0.4	1.6	8.2	0.6	2.5	1.7	0.0	0.7	0.3	0.8	3.4	0.0	2.1	0.8	1.4	0.4	19.7	0.7	0.2	0.4	10.7	3.5	0.6	0.0	0.4	0.0	0.4	0.4	0.2	0.0	0.0	0.0	0.0	0.3	4.7	0.0	4.7	1.3	0.2	5.6	0.0	1.8	10.2	3.0	2.4	2.0	2.1	11.2	0.2	0.0	2.5	0.2	4.5	0.5	2.4	0.2	0.1	4.5	3.0	6.8	3.0	22.7	9.2	2.3	0.3	0.1	0.1	1.9	0.6	1.1	0.1	0.9	8.6	1.3	0.7	3.1	0.2	4.4	0.6	12.5	4.0	1.1	1.0	0.4	0.2	0.3	0.5	1.1	2.2	0.0	0.2	0.0	0.6	3.4	0.2	4.9	5.1	5.4	8.1	0.7	7.1	0.0	9.1	9.0	1.6	0.0	0.0	0.0	0.3	0.0	4.7	0.0	0.3	0.5	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	12.3	21.2	3.0	28.8	10.4	0.9	1.6	8.2	0.3	0.6	0.0	0.0	0.0	0.4	0.1	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	36.6	0.0	34.8	0.0	0.6	0.4	0.2	0.2	0.0	0.0	0.2	0.0	0.0	0.6	0.0	119.2	2.3	0.0	0.0	0.0	12.0	7.3	0.4	19.3	1.4	0.0	0.1	6.5	0.7	1.9	3.0	0.0	0.1	0.0	14.4	0.1
ITPKB	"IP3-3KB, IP3KB"	ENSG00000143772	"Inositol-trisphosphate 3-kinase B"	P27987	1	226631690-226739323	"Cancer-related genes, Enzymes, Predicted intracellular proteins"		"Calmodulin-binding, Kinase, Transferase"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 63.1"	"Cell type enhanced"	"Detected in many"	5	"Endothelial cells: 35.8;Ito cells: 27.0;Smooth muscle cells: 32.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"SK-MEL-30: 28.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA030273, HPA072923"	Enhanced		Approved	Nucleoplasm		NA	NA			Nucleoplasm		"HPA030273: AB_10601127, HPA072923: AB_2686558"	"unprognostic (4.54e-2)"	"unprognostic (3.85e-2)"	"unprognostic (8.41e-3)"	"unprognostic (9.37e-3)"	"unprognostic (1.53e-1)"	"prognostic favorable (1.72e-5)"	"unprognostic (1.24e-1)"	"prognostic favorable (6.65e-4)"	"unprognostic (2.29e-1)"	"unprognostic (9.57e-2)"	"unprognostic (1.41e-2)"	"unprognostic (1.75e-2)"	"unprognostic (3.23e-3)"	"unprognostic (2.90e-2)"	"unprognostic (7.46e-2)"	"unprognostic (6.54e-3)"	"unprognostic (7.87e-2)"	23.8	4.2	34.7	13.0	35.1	14.8	15.2	11.1	33.6	14.3	19.7	32.4	8.5	6.0	27.1	15.6	12.6	15.3	8.9	7.8	27.9	24.8	9.7	3.2	13.4	22.7	50.4	16.3	8.8	4.8	10.1	4.2	13.5	40.0	13.1	6.3	20.8	24.9	21.3	9.8	10.5	12.5	32.6	63.1	19.0	12.4	3.2	34.0	20.0	5.9	4.3	17.1	19.6	8.5	3.1	0.9	7.7	3.5	3.0	7.9	2.6	2.8	3.0	4.9	5.7	3.9	2.5	1.3	0.8	3.4	1.6	3.7	0.5	3.6	13.1	4.7	0.7	0.3	4.2	6.3	2.5	0.8	1.8	4.3	5.8	3.4	0.0	1.5	5.4	10.3	2.8	3.7	1.7	1.6	4.4	10.7	6.7	0.0	1.8	0.2	2.7	9.9	7.3	10.9	2.1	4.9	3.8	8.9	2.9	11.5	4.6	2.9	3.8	2.3	1.7	28.6	5.1	7.3	6.1	7.4	2.1	1.6	1.8	4.6	0.1	4.6	16.0	0.5	4.9	7.5	1.2	1.4	7.7	4.4	2.1	3.9	1.9	5.3	4.5	0.9	3.1	7.9	5.7	5.4	3.0	3.5	0.8	3.0	2.6	34.7	35.1	11.1	27.9	27.9	24.8	50.4	16.3	40.0	34.0	0.0	6.1	11.1	3.8	10.9	0.3	5.6	0.0	2.7	5.7	7.0	0.0	0.5	3.3	2.0	2.0	35.8	1.3	0.0	2.0	1.1	8.5	6.5	9.3	0.9	16.4	0.0	4.1	27.0	17.7	16.5	6.6	8.6	18.6	2.8	2.6	1.4	2.3	3.2	8.9	0.5	0.0	0.0	32.0	0.9	2.3	8.8	0.3	22.3	2.9	2.1
ITPKC	"IP3-3KC, IP3KC"	ENSG00000086544	"Inositol-trisphosphate 3-kinase C"	Q96DU7	19	40717103-40740860	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"		"Calmodulin-binding, Kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Alveolar cells type 1: 80.4;Basal glandular cells: 76.3;Glandular cells: 89.9;Urothelial cells: 88.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"hTCEpi: 24.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA050760, HPA053003"	Approved		Supported	"Nuclear speckles"		No	No			"Nuclear speckles"		"HPA050760: AB_2681227, HPA053003: AB_2682011"	"unprognostic (4.27e-2)"	"unprognostic (3.73e-2)"	"unprognostic (8.31e-2)"	"unprognostic (9.12e-3)"	"unprognostic (1.10e-2)"	"unprognostic (9.81e-2)"	"unprognostic (6.06e-2)"	"prognostic unfavorable (4.91e-4)"	"unprognostic (1.48e-1)"	"unprognostic (1.54e-3)"	"unprognostic (1.84e-3)"	"unprognostic (2.63e-1)"	"unprognostic (2.59e-1)"	"unprognostic (1.70e-1)"	"unprognostic (2.86e-2)"	"unprognostic (3.45e-2)"	"unprognostic (3.32e-1)"	26.0	8.2	6.6	9.8	10.9	2.4	13.4	4.4	7.7	14.2	9.3	3.7	7.6	8.5	8.8	5.2	46.8	11.0	17.1	10.8	13.2	3.7	7.3	7.7	18.4	6.9	4.4	2.7	6.8	16.4	6.4	9.9	10.8	23.8	12.1	5.2	6.0	15.4	8.4	8.1	21.6	9.8	11.9	17.8	6.5	11.4	3.8	5.2	3.2	7.8	31.4	28.0	10.6	17.1	3.3	2.3	3.9	3.2	0.9	3.5	1.7	6.6	6.3	3.9	6.1	17.7	15.4	6.2	3.9	8.3	4.1	3.6	8.9	6.9	1.8	4.6	5.0	3.1	7.0	3.8	17.1	1.7	3.4	4.0	1.4	2.2	6.3	17.5	1.5	1.9	21.3	24.9	3.8	14.3	5.5	10.0	2.6	5.3	3.2	4.0	8.1	2.2	2.3	2.0	15.2	2.9	2.4	1.9	2.5	6.4	11.2	2.8	3.4	4.0	16.3	3.7	4.7	7.5	3.9	6.4	2.6	4.0	1.8	2.6	1.8	0.4	1.9	4.1	1.6	2.8	3.9	3.2	1.7	3.5	1.6	1.4	1.4	2.7	1.9	1.5	3.3	1.9	2.2	1.6	0.9	2.2	2.3	2.6	1.7	6.6	10.9	4.4	7.7	13.2	3.7	4.4	2.7	23.8	5.2	80.4	35.7	2.2	76.3	53.7	8.9	3.8	10.2	16.0	28.4	3.5	0.0	6.0	1.7	12.8	2.0	14.2	35.9	0.0	10.8	4.4	10.8	89.9	3.5	4.9	2.4	4.8	16.0	26.4	7.5	1.9	10.9	7.0	18.6	3.6	9.4	3.1	18.0	17.5	7.1	3.3	4.4	0.0	9.4	1.2	1.7	46.7	14.1	5.4	8.0	88.5
MDP1	"FN6Pase, MGC5987"	ENSG00000213920	"Magnesium dependent phosphatase 1"	Q86V88	14	24213937-24216070	"Enzymes, Predicted intracellular proteins"		"Hydrolase, Protein phosphatase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	4	"monocytes: 29.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"							"HPA003064, HPA070338"	Uncertain		Approved	Nucleoplasm		NA	NA		34000	Nucleoplasm		"HPA003064: AB_10602350, HPA070338: AB_2686256"	"unprognostic (2.70e-1)"	"unprognostic (3.68e-1)"	"unprognostic (2.51e-1)"	"unprognostic (2.11e-1)"	"unprognostic (3.09e-1)"	"unprognostic (5.46e-2)"	"unprognostic (5.48e-2)"	"unprognostic (1.12e-1)"	"unprognostic (6.27e-2)"	"unprognostic (8.02e-2)"	"unprognostic (2.00e-3)"	"unprognostic (1.02e-1)"	"prognostic favorable (5.96e-4)"	"unprognostic (6.39e-2)"	"unprognostic (1.32e-1)"	"unprognostic (3.82e-1)"	"unprognostic (3.19e-2)"	12.2	17.6	18.5	8.3	15.0	8.1	18.7	18.6	18.3	13.3	10.2	13.1	21.0	6.7	10.6	19.0	8.9	14.3	12.0	17.8	13.8	13.9	16.6	14.7	8.7	13.5	15.1	14.5	12.9	20.2	14.8	18.3	9.4	16.6	13.3	8.6	13.5	14.3	16.3	11.4	10.6	9.8	10.9	13.9	10.4	10.0	6.6	17.0	14.3	14.6	10.6	10.8	10.0	9.6	10.1	23.0	12.2	11.1	9.0	11.9	7.9	3.1	7.9	6.0	3.9	6.0	5.6	0.2	3.4	7.4	6.9	7.2	4.2	9.1	12.8	8.8	3.5	2.1	3.1	2.9	6.8	4.3	4.3	3.2	4.9	2.9	9.6	5.8	6.2	3.6	3.9	6.3	4.2	8.0	7.1	4.9	9.3	1.5	9.6	6.2	17.2	8.8	10.2	1.7	6.3	14.2	6.3	4.2	10.1	6.7	4.6	7.4	7.2	5.4	11.6	7.2	3.4	7.0	3.3	2.9	7.6	7.3	3.2	3.4	15.6	6.2	9.3	7.1	3.1	5.8	3.1	10.9	12.2	6.3	11.1	5.9	10.1	8.1	7.3	12.4	9.5	9.9	8.2	3.8	9.0	9.4	23.0	11.9	7.9	18.5	15.0	18.6	18.3	13.8	13.9	15.1	14.5	16.6	17.0	6.0	11.7	7.5	2.8	4.0	3.4	0.0	5.1	21.4	0.0	5.2	0.0	3.1	11.6	10.4	3.0	5.2	8.1	0.0	17.0	4.4	5.6	2.4	4.7	5.0	7.0	3.2	11.1	6.2	2.2	2.9	5.8	11.0	16.9	29.7	11.1	3.1	12.6	2.9	7.1	15.7	2.7	12.9	7.2	1.9	3.2	4.0	2.1	5.1	10.7	2.0
MINPP1	MIPP	ENSG00000107789	"Multiple inositol-polyphosphate phosphatase 1"	Q9UNW1	10	87504875-87553460	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"		Hydrolase	"Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	6	"Erythroid cells: 70.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA026859	Approved				"Intracellular and membrane"	NA	NA		320000000			"HPA026859: AB_1853961"	"unprognostic (9.15e-2)"	"unprognostic (8.76e-3)"	"unprognostic (2.08e-2)"	"unprognostic (2.97e-1)"	"unprognostic (1.35e-1)"	"unprognostic (5.20e-3)"	"unprognostic (3.47e-2)"	"unprognostic (1.74e-1)"	"unprognostic (4.55e-1)"	"unprognostic (2.07e-2)"	"unprognostic (6.54e-2)"	"unprognostic (6.50e-3)"	"prognostic unfavorable (6.98e-5)"	"unprognostic (2.43e-1)"	"unprognostic (2.09e-1)"	"unprognostic (2.07e-1)"	"unprognostic (7.01e-2)"	9.9	27.6	8.5	8.0	8.9	24.6	14.2	12.0	9.2	9.1	13.3	8.0	12.8	16.7	12.1	10.0	5.4	8.4	9.5	7.2	8.5	10.0	19.4	28.9	9.5	10.1	8.2	6.3	11.1	18.2	10.2	18.5	31.4	7.6	11.6	12.4	9.3	8.9	12.2	5.9	9.5	19.4	7.4	8.2	8.2	8.9	8.8	8.5	13.5	13.1	5.3	6.5	8.7	13.9	8.9	13.5	8.5	12.9	10.4	16.4	9.3	8.3	12.9	12.9	18.9	22.0	18.2	10.9	13.6	23.3	13.5	18.1	6.8	16.4	7.2	12.7	16.0	9.0	13.0	13.6	12.4	15.4	16.5	16.2	18.5	5.2	25.2	16.5	7.9	16.9	15.9	16.0	15.0	9.1	24.4	16.9	6.5	10.8	35.3	15.6	6.2	5.2	11.2	9.3	6.3	9.3	0.0	7.4	4.9	17.7	4.7	4.7	14.8	12.9	2.7	22.6	15.2	7.8	6.6	14.8	8.7	10.5	10.3	13.0	11.5	11.8	1.9	13.9	12.2	6.3	8.5	10.3	4.6	11.6	12.9	10.3	8.9	11.0	13.2	13.5	7.3	10.6	11.9	0.7	10.4	10.8	7.8	16.4	9.3	8.5	8.9	12.0	9.2	8.5	10.0	8.2	6.3	7.6	8.5	6.0	13.8	10.7	7.2	2.5	13.2	3.9	20.4	14.7	5.7	7.0	2.0	16.9	5.0	13.7	11.4	7.8	12.6	70.0	14.6	15.3	13.1	7.1	24.3	50.4	11.9	9.5	12.6	18.4	13.7	0.5	8.6	10.1	10.1	12.6	19.4	11.8	10.8	17.3	7.8	23.5	14.1	0.0	9.2	9.5	13.2	3.0	6.8	8.7	10.4	4.3
MIOX	ALDRL6	ENSG00000100253	"Myo-inositol oxygenase"	Q9UGB7	22	50486784-50490648	"Enzymes, Predicted intracellular proteins"		Oxidoreductase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	43	"kidney: 136.7"	"Cell type enriched"	"Detected in some"	5	"Proximal tubular cells: 1814.0"	"Cancer enriched"	"Detected in many"	16	"renal cancer: 56.0"	"Not detected"	"Not detected"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"HDLM-2: 21.8;Hep G2: 4.9;Karpas-707: 11.6;U-266/70: 7.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA039451, HPA039562"	Enhanced					NA	NA					"HPA039451: AB_2676513, HPA039562: AB_2676574"	"unprognostic (2.11e-1)"	"unprognostic (4.32e-2)"	"unprognostic (2.22e-2)"	"unprognostic (1.30e-2)"	"unprognostic (9.83e-2)"	"unprognostic (5.25e-2)"	"unprognostic (1.61e-2)"	"unprognostic (3.84e-3)"	"unprognostic (2.84e-1)"	"unprognostic (4.72e-2)"	"unprognostic (1.85e-2)"	"unprognostic (9.83e-2)"	"prognostic favorable (2.60e-6)"	"unprognostic (1.77e-1)"	"unprognostic (1.50e-1)"	"unprognostic (1.36e-2)"	"unprognostic (2.23e-2)"	0.1	0.0	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.0	0.8	0.1	0.1	0.0	136.7	0.1	0.1	0.1	0.1	0.1	0.1	0.2	0.0	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.4	2.7	0.1	0.1	0.1	0.1	1.3	0.6	3.1	0.7	0.4	1.4	0.4	0.0	0.0	0.1	0.3	0.2	0.1	1.8	0.2	0.0	0.0	0.1	0.1	0.3	0.1	0.6	0.4	0.0	0.1	0.1	0.0	0.0	21.8	0.0	0.1	0.3	4.9	2.9	0.0	0.2	0.0	0.0	0.1	0.4	0.0	0.0	1.0	0.1	11.6	0.0	1.1	0.0	0.1	0.2	0.5	0.4	0.1	0.1	0.1	2.3	0.1	0.1	0.3	0.0	0.0	0.4	0.4	0.0	1.2	0.0	0.0	0.5	0.1	0.0	7.0	0.6	0.3	0.1	0.0	0.2	3.1	0.4	0.6	0.5	0.3	0.2	1.3	0.5	1.4	0.1	0.9	0.5	0.6	1.8	0.4	0.7	0.6	0.4	0.4	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.0	1.7	2.4	0.8	0.7	0.5	0.0	0.0	0.0	0.0	94.2	0.0	0.0	359.8	0.0	0.0	0.1	0.0	0.0	0.8	0.1	0.2	0.4	0.0	0.2	0.1	0.0	1.2	0.6	0.0	0.0	0.0	0.8	0.0	0.0	0.4	0.2	0.0	0.0	0.0	1814.0	0.2	0.0	0.2	0.1	0.4	0.1	0.2	0.9	0.0	0.6
MTM1		ENSG00000171100	"Myotubularin 1"	Q13496	X	150568619-150673322	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Lipid metabolism, Protein transport, Transport"	"Hydrolase, Protein phosphatase"	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA010008, HPA010665"	Approved		Supported	"Plasma membrane"		NA	NA			"Plasma membrane"		"HPA010008: AB_1079426, HPA010665: AB_1079425"	"unprognostic (3.66e-3)"	"unprognostic (8.43e-3)"	"unprognostic (3.52e-3)"	"unprognostic (2.13e-1)"	"unprognostic (1.08e-1)"	"unprognostic (6.45e-2)"	"unprognostic (4.98e-2)"	"unprognostic (1.22e-1)"	"unprognostic (4.74e-1)"	"unprognostic (2.35e-2)"	"unprognostic (1.08e-1)"	"unprognostic (4.59e-2)"	"prognostic favorable (7.40e-7)"	"unprognostic (4.46e-2)"	"unprognostic (1.25e-1)"	"unprognostic (4.99e-2)"	"unprognostic (2.46e-1)"	10.7	17.9	15.0	10.2	16.4	11.1	9.2	10.6	10.8	9.1	21.5	12.5	12.7	12.8	10.9	10.9	11.1	11.1	8.0	9.0	14.3	12.0	17.9	19.9	12.2	12.4	17.3	9.3	13.8	7.5	21.4	11.9	21.5	12.9	9.5	21.6	8.3	10.2	12.9	11.2	10.2	21.0	8.0	17.2	15.3	8.6	12.1	16.4	14.5	12.7	8.3	13.9	8.5	9.1	6.9	7.9	18.4	7.2	10.1	7.7	4.6	8.5	3.9	5.5	2.0	5.1	5.0	3.5	4.1	5.6	4.7	5.2	3.0	4.8	13.8	7.3	5.2	14.8	6.1	4.0	7.9	5.8	3.7	3.5	3.7	3.7	9.1	3.8	15.3	12.6	3.0	9.5	3.8	8.1	4.7	6.1	6.0	2.4	12.8	5.7	2.9	4.2	15.9	2.8	8.5	5.1	5.1	3.1	2.7	8.1	4.8	1.4	1.5	3.5	7.4	5.2	8.1	2.6	22.3	5.3	3.2	1.9	8.1	4.2	2.6	5.9	13.1	4.0	9.4	5.1	17.6	6.3	18.4	1.5	7.2	4.9	5.5	6.8	5.2	7.9	6.9	6.5	3.9	8.5	10.1	6.2	5.1	7.7	4.6	15.0	16.4	10.6	10.8	14.3	12.0	17.3	9.3	12.9	16.4	8.9	18.3	3.7	5.8	13.5	0.0	12.3	2.5	9.4	5.7	3.5	0.0	1.9	1.7	2.8	27.7	7.8	12.8	0.0	3.8	2.2	4.2	4.9	8.1	10.5	7.2	0.0	9.2	17.2	13.4	15.8	5.8	11.0	5.0	6.4	18.9	0.0	3.6	7.0	12.0	10.8	0.0	0.0	2.7	4.4	2.5	16.7	6.1	7.5	10.3	8.1
MTMR1		ENSG00000063601	"Myotubularin related protein 1"	Q13613	X	150692971-150765103	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"Lipid metabolism"	Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"U-698: 44.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA002977, HPA018502"	Approved		Approved	Centrosome		NA	NA			Centrosome		"HPA002977: AB_2666735, HPA018502: AB_1854185"	"unprognostic (2.37e-2)"	"unprognostic (1.64e-3)"	"unprognostic (2.07e-1)"	"unprognostic (1.05e-2)"	"unprognostic (4.34e-2)"	"unprognostic (1.14e-1)"	"unprognostic (1.97e-1)"	"unprognostic (1.34e-1)"	"unprognostic (4.35e-2)"	"unprognostic (3.16e-1)"	"unprognostic (7.48e-2)"	"unprognostic (1.41e-2)"	"unprognostic (1.67e-2)"	"unprognostic (1.32e-2)"	"unprognostic (1.93e-1)"	"unprognostic (3.19e-1)"	"unprognostic (8.40e-2)"	6.9	6.8	20.4	14.0	17.9	9.9	11.8	14.5	15.6	8.3	8.6	8.7	7.2	8.3	9.4	9.2	19.7	9.3	9.0	12.0	17.8	13.4	8.1	10.2	9.7	18.7	12.1	11.5	7.4	11.7	16.3	10.2	37.9	8.8	10.8	9.1	7.9	12.1	13.0	22.2	19.8	10.9	8.3	8.2	18.0	9.7	11.0	9.3	32.6	9.6	10.7	23.1	10.4	7.7	3.3	7.8	7.4	1.5	6.2	4.8	1.8	13.2	8.5	9.2	7.5	2.1	2.5	12.4	11.8	15.2	12.0	17.1	8.2	10.5	29.0	17.5	9.5	11.6	12.1	18.5	17.1	18.8	11.7	11.2	1.8	13.2	3.5	6.4	8.5	6.3	6.8	11.9	13.2	0.2	11.5	7.2	9.7	5.6	7.5	8.6	11.4	12.4	2.2	4.2	14.8	12.9	6.6	14.6	12.8	9.4	15.2	13.7	8.5	4.5	10.1	3.7	7.6	12.9	4.9	9.1	7.9	6.3	1.0	17.5	9.6	9.8	44.2	1.6	5.5	6.1	0.0	0.9	7.4	3.5	1.5	2.6	2.7	3.9	3.2	2.2	3.3	3.5	4.7	2.4	6.2	1.3	7.8	4.8	1.8	20.4	17.9	14.5	15.6	17.8	13.4	12.1	11.5	8.8	9.3	14.9	6.2	3.4	9.6	10.0	0.0	7.9	2.5	1.4	5.7	5.2	0.0	8.8	0.0	5.1	0.0	3.6	2.8	0.0	5.7	6.0	4.3	6.1	1.1	8.1	4.0	0.0	9.2	3.1	8.2	0.4	5.2	5.2	3.3	1.0	7.6	0.0	8.1	6.5	4.9	2.9	0.0	6.5	2.7	1.2	2.3	14.6	8.7	6.9	5.2	10.8
MTMR12	"3-PAP, 3PAP, FLJ20476, KIAA1682, PIP3AP"	ENSG00000150712	"Myotubularin related protein 12"	Q9C0I1	5	32226994-32313009	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA051333	Supported					NA	NA					"HPA051333: AB_2681445"	"unprognostic (3.18e-3)"	"unprognostic (6.29e-2)"	"unprognostic (3.65e-2)"	"unprognostic (1.50e-1)"	"unprognostic (2.26e-1)"	"unprognostic (9.39e-3)"	"unprognostic (6.15e-2)"	"unprognostic (1.39e-3)"	"unprognostic (3.15e-1)"	"unprognostic (1.09e-1)"	"unprognostic (7.46e-3)"	"unprognostic (8.77e-2)"	"prognostic favorable (1.29e-7)"	"unprognostic (2.30e-2)"	"unprognostic (3.22e-1)"	"unprognostic (9.95e-2)"	"unprognostic (2.09e-1)"	21.7	11.8	19.6	14.4	18.1	12.3	34.1	15.7	22.1	13.4	16.4	11.3	11.2	10.1	21.8	12.8	15.5	23.3	14.5	11.2	11.8	8.3	17.6	17.9	16.8	17.3	8.9	14.3	20.3	28.9	30.1	15.5	12.7	10.5	15.9	9.6	13.3	24.8	19.8	8.1	18.8	11.7	19.1	12.3	12.9	20.7	20.0	10.7	16.0	15.9	9.6	17.8	13.6	12.3	4.5	5.0	10.2	7.9	3.6	5.6	3.7	9.7	9.1	9.8	19.0	11.2	6.6	13.3	8.8	7.4	11.7	7.4	8.8	7.2	36.2	11.5	9.5	20.1	6.7	16.5	9.0	14.3	12.6	7.6	11.9	18.8	14.5	7.9	8.5	9.0	5.8	8.5	11.8	12.3	8.5	13.8	7.9	8.6	13.7	7.7	7.2	9.1	6.5	12.6	10.8	9.2	9.3	14.0	4.7	9.4	9.1	3.4	6.4	25.0	15.5	11.1	10.7	12.8	8.9	11.4	9.1	12.6	9.0	12.6	11.9	18.4	20.7	9.4	14.3	11.0	10.2	3.2	5.0	5.6	7.9	4.4	4.5	2.6	3.8	4.0	3.5	2.2	2.6	5.1	3.6	3.7	5.0	3.1	3.7	19.6	18.1	15.7	22.1	11.8	8.3	8.9	14.3	10.5	10.7	29.8	37.3	16.0	5.4	6.3	0.0	12.9	22.9	13.4	19.4	14.0	0.0	6.3	6.6	23.1	1.4	18.0	7.4	0.0	20.2	6.4	8.0	13.6	15.0	23.8	8.5	0.0	11.5	28.3	17.5	2.5	6.1	11.1	3.3	4.6	6.5	0.0	19.0	6.8	6.7	16.1	0.0	6.5	7.6	17.0	24.0	7.3	6.3	6.7	6.4	6.0
MTMR14	"C3orf29, FLJ22405, FLJ90311, hEDTP, hJumpy"	ENSG00000163719	"Myotubularin related protein 14"	Q8NCE2	3	9649433-9702393	"Disease related genes, Predicted intracellular proteins"		Hydrolase	"Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	4	"monocytes: 77.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA054063	Approved				"Intracellular and membrane"	NA	NA					"HPA054063: AB_2682365"	"unprognostic (9.50e-2)"	"unprognostic (5.60e-3)"	"unprognostic (9.28e-2)"	"unprognostic (1.31e-1)"	"unprognostic (8.81e-3)"	"unprognostic (2.34e-2)"	"prognostic unfavorable (3.95e-4)"	"unprognostic (2.42e-1)"	"unprognostic (2.00e-1)"	"unprognostic (3.51e-3)"	"unprognostic (7.04e-2)"	"unprognostic (1.37e-1)"	"prognostic favorable (2.74e-4)"	"unprognostic (1.25e-2)"	"unprognostic (1.89e-1)"	"unprognostic (1.29e-1)"	"unprognostic (1.01e-3)"	16.7	16.9	9.7	15.6	12.2	36.6	13.8	16.3	16.3	12.3	13.8	17.4	16.1	13.3	19.3	13.1	14.1	10.9	14.3	25.7	11.1	9.5	15.4	19.9	16.1	25.2	12.1	9.6	11.6	10.0	11.5	11.6	20.8	13.6	11.0	14.3	21.5	13.2	8.7	37.1	17.1	18.0	10.4	11.5	26.0	12.2	15.9	12.0	24.5	14.1	13.4	30.3	13.3	11.2	22.9	50.1	28.7	41.1	14.9	15.2	27.3	7.8	12.4	8.3	4.7	11.3	7.7	46.4	6.4	12.3	12.8	14.7	9.3	11.8	16.0	7.0	10.2	16.5	4.8	10.1	14.5	11.0	14.4	14.0	16.7	10.4	13.0	20.3	14.6	30.8	14.3	9.9	16.0	16.9	8.7	14.3	12.2	10.2	14.6	8.7	25.0	10.7	11.7	13.6	11.8	10.2	11.2	10.1	17.0	11.3	13.6	4.4	12.6	7.1	9.3	12.1	11.8	12.4	24.0	11.1	6.0	9.6	10.8	9.0	16.2	25.5	20.9	13.6	18.5	7.8	27.9	39.3	28.7	13.5	41.1	13.2	22.9	13.1	13.5	50.1	18.2	12.2	12.3	24.8	14.9	37.3	27.4	15.2	27.3	9.7	12.2	16.3	16.3	11.1	9.5	12.1	9.6	13.6	12.0	14.9	5.4	45.4	10.3	9.6	0.0	19.9	15.3	5.3	3.4	8.7	0.0	40.5	24.9	31.8	9.4	15.0	23.1	0.0	24.8	31.0	11.3	12.1	19.6	12.7	61.2	0.0	12.0	20.3	48.5	8.5	12.0	37.4	11.8	77.5	13.5	0.0	30.9	23.2	12.4	27.9	0.0	6.5	8.2	14.4	34.1	15.7	54.1	27.7	16.1	10.7
MTMR2	"CMT4B, KIAA1073"	ENSG00000087053	"Myotubularin related protein 2"	Q13614	11	95832882-95925315	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Lipid metabolism"	Hydrolase	"Charcot-Marie-Tooth disease, Disease mutation, Neurodegeneration, Neuropathy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	7	"Late spermatids: 87.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA049831	Approved		Supported	Vesicles		NA	NA			Vesicles		"HPA049831: AB_2680904"	"unprognostic (1.71e-2)"	"unprognostic (2.55e-3)"	"unprognostic (7.81e-3)"	"unprognostic (4.16e-1)"	"unprognostic (4.18e-3)"	"unprognostic (5.36e-2)"	"prognostic unfavorable (1.61e-8)"	"unprognostic (3.23e-3)"	"unprognostic (3.42e-2)"	"unprognostic (1.77e-2)"	"prognostic unfavorable (3.60e-4)"	"unprognostic (1.12e-1)"	"unprognostic (2.34e-2)"	"unprognostic (1.54e-1)"	"unprognostic (1.50e-1)"	"unprognostic (1.14e-1)"	"unprognostic (8.03e-3)"	16.4	10.4	14.2	12.1	19.9	5.3	15.4	14.9	23.3	14.1	13.5	22.6	4.9	8.0	14.1	7.5	15.5	13.3	15.4	13.8	18.1	13.9	16.9	4.5	14.3	13.6	27.5	13.6	14.5	11.0	15.9	8.2	25.1	21.3	17.6	14.5	19.6	18.8	12.3	6.8	9.7	9.5	18.2	30.0	10.5	13.6	29.0	21.8	12.2	11.3	7.7	11.7	13.4	14.3	5.4	6.6	9.7	4.9	11.8	14.2	6.6	9.4	10.1	23.3	16.9	8.2	12.7	19.5	17.7	15.8	17.6	15.9	23.9	19.2	6.8	21.2	18.6	14.9	13.1	19.0	19.3	15.9	12.4	9.2	14.1	25.3	13.4	18.8	23.9	11.7	10.6	12.9	23.1	23.2	18.0	26.5	15.3	17.4	6.5	16.5	7.0	11.9	11.1	18.9	22.8	14.3	10.0	13.6	6.4	18.1	50.8	14.9	17.4	17.5	14.8	7.9	15.3	11.7	10.2	27.1	20.6	18.9	15.0	16.3	6.1	16.8	6.2	8.6	6.6	20.8	9.7	3.3	1.4	11.4	3.9	12.3	5.4	7.7	14.2	6.6	4.8	4.1	11.0	0.9	11.8	4.9	3.4	6.9	6.6	14.2	19.9	14.9	23.3	18.1	13.9	27.5	13.6	21.3	21.8	3.0	7.5	5.1	13.3	9.2	0.0	14.0	0.0	9.4	12.5	8.7	0.0	8.0	8.3	15.9	48.9	19.5	7.3	0.0	14.6	26.0	14.0	13.2	18.5	0.9	11.0	0.0	15.5	10.4	9.1	87.8	10.3	7.5	3.3	9.0	9.1	0.0	14.2	2.9	11.3	20.7	0.0	32.3	20.0	34.6	16.4	5.3	7.6	7.9	8.4	13.2
MTMR6		ENSG00000139505	"Myotubularin related protein 6"	Q9Y217	13	25246201-25288009	"Plasma proteins, Predicted intracellular proteins"	"Endocytosis, Lipid metabolism"	Hydrolase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	4	"Spermatocytes: 60.6"	"Low cancer specificity"	"Detected in all"							"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"									NA	NA						"unprognostic (8.68e-2)"	"unprognostic (1.50e-2)"	"unprognostic (1.21e-2)"	"unprognostic (2.31e-3)"	"unprognostic (1.91e-1)"	"unprognostic (9.19e-2)"	"unprognostic (3.21e-1)"	"unprognostic (1.45e-1)"	"unprognostic (3.41e-2)"	"unprognostic (1.82e-2)"	"unprognostic (1.69e-1)"	"unprognostic (2.94e-1)"	"unprognostic (1.71e-3)"	"unprognostic (2.04e-1)"	"unprognostic (1.18e-1)"	"unprognostic (5.06e-2)"	"unprognostic (1.30e-1)"	5.2	10.2	6.1	5.3	7.6	11.9	4.9	6.8	8.2	4.4	4.3			2.9	4.9	2.8	4.1	3.6	5.0	6.0	7.6	7.3	6.1	5.1	5.0	5.2	6.0		3.7	5.9	4.6	3.7	4.6		5.3	4.8		5.9	5.7	6.2	3.3	3.3	6.4	6.6	5.2	4.1	7.2			6.3		5.4	4.6	3.7	5.8	6.7	16.1	11.9	4.8	7.4	7.2	5.8	6.1	10.1	8.5	10.8	11.3	4.9	18.6	21.0	18.4	14.6	4.0	10.5	9.0	5.5	17.3	9.4	7.3	6.4	11.0	21.5	10.8	4.2	11.1	4.5	3.3	13.0	22.9	20.5	8.1	13.0	13.4	18.1	10.6	14.9	12.2	5.1	10.4	18.5	4.1	13.0	6.2	3.0	11.3	4.6	5.6	14.2	12.4	13.4	6.9	5.4	7.6	6.0	10.8	9.7	10.1	4.2	14.6	19.2	11.4	5.8	12.6	10.8	5.6	6.5	11.9	5.7	9.0	18.5	15.1	8.2	6.6	5.3	11.9	6.7	5.8	5.6	5.6	6.7	3.6	5.8	5.8	16.1	4.8	10.4	4.0	7.4	7.2											14.9	30.9	18.2	6.5	9.7	0.0	27.0	12.7	20.1	10.3	15.7	0.0	4.8	11.6	11.3	48.3	16.6	7.4	0.0	12.9	5.6	12.3	11.3	18.5	19.2	14.5	0.0	16.0	25.8	35.5	15.6	11.5	27.8	18.6	9.0	14.7	0.0	17.9	8.7	18.7	20.7	0.0	0.0	16.2	60.6	20.6	10.5	6.9	20.3	10.2	10.1
MTMR7		ENSG00000003987	"Myotubularin related protein 7"	Q9Y216	8	17298030-17413528	"Predicted intracellular proteins"		Hydrolase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 25.8;parathyroid gland: 17.9"	"Cell type enhanced"	"Detected in some"	16	"Early spermatids: 9.5;Intestinal endocrine cells: 3.5;Late spermatids: 3.1;Sertoli cells: 6.5"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in single"			"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in some"		"NTERA-2: 5.4;SCLC-21H: 14.3;SH-SY5Y: 8.3"	"Low region specificity"	"Detected in all"							HPA075682			Approved	Nucleoplasm,Cytosol		NA	NA			"Nucleoplasm, Cytosol"		"HPA075682: "	"unprognostic (1.01e-1)"	"unprognostic (6.10e-2)"	"unprognostic (1.05e-2)"	"unprognostic (1.44e-1)"	"unprognostic (1.67e-1)"	"unprognostic (1.31e-2)"	"unprognostic (4.15e-2)"	"unprognostic (1.41e-2)"	"unprognostic (1.92e-1)"	"unprognostic (2.45e-1)"	"unprognostic (2.07e-4)"	"unprognostic (1.46e-2)"	"unprognostic (1.97e-7)"	"unprognostic (1.12e-1)"	"unprognostic (1.42e-1)"	"unprognostic (4.17e-2)"	"unprognostic (2.66e-3)"	1.4	4.9	10.9	1.9	16.7	3.4	0.9	16.2	25.8	1.2	1.3	16.0	0.0	2.0	1.8	0.8	1.5	1.5	1.6	1.7	7.5	7.8	2.4	2.2	1.4	1.7	9.2	9.5	3.5	2.6	17.9	10.3	1.8	19.5	1.2	1.3	4.7	1.4	1.1	2.1	2.6	1.9	1.1	11.2	1.4	1.8	2.9	9.4	0.0	6.5	0.0	0.8	1.4	0.7	0.7	0.2	0.8	0.2	0.3	1.4	0.1	0.8	0.7	1.2	1.0	0.0	0.0	0.9	1.8	0.0	0.0	0.0	0.9	0.2	0.9	0.5	0.0	0.8	0.4	4.1	0.1	0.0	0.1	3.0	1.2	1.6	0.5	1.0	0.7	0.9	0.2	0.0	0.1	0.0	0.8	0.2	0.4	0.6	0.7	0.0	0.6	1.3	1.7	5.4	0.7	0.6	0.4	1.8	0.5	0.0	3.4	14.3	8.3	0.6	0.8	0.9	2.0	0.4	0.9	1.5	0.9	0.5	2.0	1.1	0.4	0.4	0.7	2.6	1.3	0.7	0.0	0.1	0.7	0.2	0.2	0.1	0.7	0.1	0.2	0.1	0.0	0.5	0.3	0.8	0.3	0.2	0.2	1.4	0.1	10.9	16.7	16.2	15.2	7.5	7.8	9.2	9.5	19.5	9.4	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.0	9.5	0.0	0.0	0.0	0.5	0.2	0.0	0.0	0.0	0.0	0.3	0.0	3.5	0.0	0.0	3.1	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	6.5	0.5	0.6	1.6	0.1	1.1	0.0	0.0	0.0
MTMR8	FLJ20126	ENSG00000102043	"Myotubularin related protein 8"	Q96EF0	X	64268081-64395431	"Predicted intracellular proteins"		Hydrolase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"retina: 16.4"	"Cell type enhanced"	"Detected in single"	5	"Urothelial cells: 1.0"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"Daudi: 6.8;JURKAT: 7.0;NTERA-2: 6.4;U-2197: 5.6"					"Low region specificity"	"Detected in all"									NA	NA						"unprognostic (1.73e-2)"	"unprognostic (2.53e-2)"	"unprognostic (2.95e-3)"	"unprognostic (1.87e-2)"	"unprognostic (1.29e-1)"	"unprognostic (3.31e-2)"	"unprognostic (3.41e-3)"	"unprognostic (1.41e-2)"	"unprognostic (2.67e-1)"	"unprognostic (2.08e-1)"	"unprognostic (8.00e-2)"	"unprognostic (2.96e-2)"	"unprognostic (2.32e-1)"	"unprognostic (1.44e-2)"	"unprognostic (1.52e-1)"	"unprognostic (9.22e-2)"	"unprognostic (8.20e-2)"	2.8	2.6	1.2	3.1	2.2	1.9	2.2	6.1	2.0	4.2	4.0	2.5	4.1	1.7	6.0	2.9	3.8	8.1	2.0	1.8	1.5	1.7	3.2	1.4	2.1	3.0	2.4	0.7	6.6	2.5	2.7	6.8	0.5	2.0	3.4	4.9	16.4	2.8	6.5	1.5	2.1	5.3	6.7	2.4	4.3	4.1	1.3	3.0	5.5	2.4	1.6	6.1	4.9	3.1	3.2	0.2	0.7	1.4	0.8	4.0	1.6	0.0	1.4	2.4	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	1.1	1.4	6.8	1.0	0.0	0.0	0.0	3.9	0.8	1.7	0.0	1.6	2.2	0.3	0.0	0.0	4.7	3.0	0.0	1.0	0.1	0.3	0.0	0.0	7.0	4.9	5.0	0.0	0.3	2.5	0.8	6.4	1.9	0.6	3.8	0.0	1.7	0.4	1.1	0.0	0.7	0.0	0.1	0.0	1.3	1.3	2.4	0.0	0.0	1.6	5.6	0.0	0.0	0.5	4.3	0.0	0.0	0.0	0.4	0.4	0.1	3.2	1.2	3.1	3.0	3.3	2.0	0.2	3.2	4.0	3.5	0.7	0.8	1.4	0.2	1.7	1.6	1.2	2.2	6.1	2.0	1.5	1.7	2.4	0.7	2.0	3.0	0.0	0.0	0.5	0.8	0.3	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.6	0.0	0.4	0.3	0.0	0.2	0.2	0.2	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.3	0.0	0.6	0.0	0.0	0.0	0.1	0.0	0.3	0.9	0.7	0.3	0.0	0.0	0.1	0.0	0.3	0.1	0.2	0.0	0.4	1.0
NT5C	"cdN, DNT-1, DNT1, PN-I, UMPH2"	ENSG00000125458	"5', 3'-nucleotidase, cytosolic"	Q8TCD5	17	75130225-75131795	"Predicted intracellular proteins"	"Nucleotide metabolism"	Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA021581, HPA023632"	Approved		Supported	Cytosol		NA	NA		600000	Cytosol		"HPA021581: AB_1854663, HPA023632: AB_1854662"	"unprognostic (3.83e-2)"	"unprognostic (4.45e-2)"	"unprognostic (2.39e-1)"	"unprognostic (3.61e-2)"	"unprognostic (1.26e-1)"	"unprognostic (9.21e-2)"	"prognostic unfavorable (3.05e-4)"	"unprognostic (1.26e-1)"	"unprognostic (7.25e-2)"	"unprognostic (8.26e-3)"	"unprognostic (7.15e-2)"	"unprognostic (2.22e-1)"	"unprognostic (6.57e-2)"	"unprognostic (1.58e-1)"	"unprognostic (1.10e-1)"	"unprognostic (2.13e-1)"	"prognostic favorable (7.66e-4)"	14.5	16.7	10.7	32.5	10.5	14.4	15.2	16.0	13.8	16.3	27.3	18.5	16.2	25.1	18.0	18.7	21.6	15.9	21.0	16.7	9.6	11.0	21.0	13.5	19.9	30.1	12.3	11.0	19.7	28.0	10.4	9.7	11.6	10.9	17.5	14.2	18.0	17.9	17.7	27.1	16.0	30.1	16.7	13.7	20.5	24.5	11.4	12.0	17.2	22.0	30.4	24.5	20.5	17.1	30.7	16.8	46.7	15.8	22.7	14.3	9.7	21.0	33.1	10.9	11.4	3.3	6.9	15.0	12.6	11.0	12.7	8.1	12.3	24.9	14.7	9.2	8.8	2.3	14.8	7.6	15.7	7.3	6.9	23.9	16.1	25.7	20.6	16.5	15.6	7.4	10.0	7.5	9.1	25.5	5.2	14.1	11.7	15.7	7.2	13.0	21.2	11.4	15.9	11.2	18.3	22.0	10.4	14.3	20.4	16.5	11.4	12.9	26.5	12.1	15.0	17.4	6.5	21.0	11.5	8.1	11.1	27.5	4.2	16.6	14.3	2.1	16.3	10.3	9.6	17.2	46.7	10.2	15.2	13.8	15.8	9.7	30.7	9.0	11.6	12.7	29.1	7.9	11.9	4.6	22.7	15.5	16.8	14.3	9.7	10.7	10.5	16.0	13.8	9.6	11.0	12.3	11.0	10.9	12.0	29.8	21.6	121.5	83.2	42.1	67.1	15.5	94.3	9.4	11.4	55.8	19.6	58.2	66.3	80.9	1.6	21.2	215.1	0.0	106.1	86.7	57.7	61.8	46.1	34.2	66.0	39.7	61.5	16.5	50.0	3.3	55.0	59.6	55.6	144.3	82.5	46.3	97.1	133.3	44.6	119.5	63.7	32.3	67.0	20.7	54.1	38.8	26.1	67.1	96.4	63.4
NT5DC3	"FLJ11266, TU12B1-TY"	ENSG00000111696	"5'-nucleotidase domain containing 3"	Q86UY8	12	103770453-103841197	"Predicted secreted proteins"		Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 52.0"	"Cell type enhanced"	"Detected in many"	9	"Intestinal endocrine cells: 39.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"hTERT-HME1: 22.0"					"Low region specificity"	"Detected in all"			HPA041634			Approved	Mitochondria,Cytosol	"Secreted - unknown location"	NA	NA			Mitochondria	Cytosol	"HPA041634: AB_10795597"	"unprognostic (2.61e-2)"	"unprognostic (1.16e-1)"	"unprognostic (7.30e-2)"	"unprognostic (2.72e-1)"	"unprognostic (8.45e-2)"	"unprognostic (1.04e-1)"	"prognostic unfavorable (4.31e-4)"	"unprognostic (1.57e-1)"	"unprognostic (2.19e-1)"	"unprognostic (2.45e-2)"	"unprognostic (5.43e-2)"	"unprognostic (2.95e-1)"	"prognostic unfavorable (5.72e-6)"	"unprognostic (8.60e-3)"	"unprognostic (7.42e-2)"	"unprognostic (2.14e-1)"	"prognostic unfavorable (8.11e-4)"	4.2	5.4	14.8	3.2	10.5	23.9	5.4	2.7	16.2	12.2	52.0	2.9	9.4	2.0	17.9	8.4	8.9	3.5	2.6	2.2	13.3	5.7	2.2	4.0	2.8	2.3	2.8	11.7	3.8	3.5	1.8	4.2	4.5	10.4	9.8	12.5	3.7	3.9	9.1	7.0	2.8	4.2	32.9	2.1	1.9	6.6	3.5	2.7	0.0	2.9	0.9	2.4	22.4	5.2	4.1	4.9	2.4	1.6	1.5	3.3	0.8	3.3	6.0	3.5	4.0	4.9	3.9	6.5	5.5	3.3	3.9	2.5	4.1	0.9	5.6	1.1	6.5	4.3	3.8	4.9	10.9	5.7	4.1	4.0	7.0	2.2	4.7	2.8	3.7	1.9	3.4	2.4	5.0	22.0	8.0	2.3	2.9	11.0	2.9	8.7	3.0	3.2	6.0	4.3	4.8	6.5	4.5	6.1	2.1	6.2	2.3	4.7	1.9	4.6	5.2	6.5	3.3	2.9	3.5	3.0	3.9	4.7	5.3	11.0	2.6	3.1	4.2	3.7	5.7	5.6	0.8	1.5	0.1	1.7	1.6	3.3	3.5	2.4	1.4	3.8	4.1	2.1	1.8	2.4	1.5	1.0	4.9	0.6	0.8	14.8	10.5	2.7	16.2	13.3	5.7	2.8	11.7	10.4	2.7	0.0	2.9	0.8	17.0	3.9	1.5	2.8	2.5	9.4	2.3	1.8	0.0	4.2	0.0	1.8	8.8	1.6	1.6	0.0	1.8	4.4	3.9	10.0	0.0	4.3	1.7	9.5	39.5	1.3	3.5	7.4	4.6	2.5	0.0	2.8	9.1	0.8	2.3	0.0	7.8	1.5	4.9	0.0	8.0	0.5	3.1	3.9	3.4	0.9	9.0	8.6
NT5M	"dNT-2, dNT2, mdN"	ENSG00000205309	"5',3'-nucleotidase, mitochondrial"	Q9NPB1	17	17303335-17347663	"Predicted intracellular proteins"	"Nucleotide metabolism"	Hydrolase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 27.1"	"Cell type enhanced"	"Detected in many"	10	"Distal tubular cells: 14.9;Erythroid cells: 23.3;Horizontal cells: 15.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"eosinophil: 3.6"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"JURKAT: 10.1;U-266/70: 11.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA043777	Uncertain					NA	NA					"HPA043777: AB_10962842"	"unprognostic (5.70e-2)"	"unprognostic (3.20e-2)"	"unprognostic (1.06e-2)"	"unprognostic (2.59e-2)"	"unprognostic (8.61e-3)"	"unprognostic (1.24e-1)"	"unprognostic (1.60e-1)"	"unprognostic (1.61e-1)"	"unprognostic (2.48e-1)"	"prognostic favorable (8.42e-5)"	"unprognostic (4.28e-5)"	"unprognostic (2.27e-1)"	"unprognostic (4.93e-2)"	"unprognostic (3.89e-2)"	"unprognostic (1.05e-1)"	"unprognostic (7.93e-2)"	"unprognostic (1.05e-2)"	2.6	1.8	7.2	2.0	7.4	9.4	2.1	8.8	11.8	3.3	2.8	3.7	3.1	2.1	2.8	1.9	2.7	3.0	1.9	6.6	5.8	5.3	3.3	5.5	1.7	1.7	5.5	3.9	3.8	1.9	2.9	5.0	1.5	5.7	3.3	1.4	3.5	2.7	2.7	27.1	2.1	2.2	2.0	4.1	1.7	1.3	7.0	2.0	4.2	1.7	2.4	1.6	2.6	1.7	0.2	0.6	3.6	0.0	0.0	1.5	3.1	0.4	0.9	0.4	3.5	2.2	2.4	1.6	0.7	0.2	0.3	0.5	0.0	0.2	4.0	2.1	0.0	0.7	0.0	0.2	0.1	0.0	3.4	2.2	2.6	0.0	0.3	2.1	0.7	5.2	1.7	1.8	0.3	1.4	0.7	0.1	10.1	2.2	0.0	0.0	1.0	3.3	2.9	2.2	1.1	3.1	2.5	0.3	7.1	1.2	0.0	4.4	6.8	1.2	0.2	3.1	2.7	1.2	1.0	0.0	1.1	1.3	0.3	0.9	11.1	1.4	0.6	0.6	0.5	2.8	0.0	0.0	3.6	0.1	0.0	1.4	0.0	0.1	1.5	0.6	0.2	0.0	0.1	0.2	0.0	0.0	0.0	0.0	3.1	7.2	7.4	8.8	11.8	5.8	5.3	5.5	3.9	5.7	2.0	0.0	0.3	0.0	1.7	1.4	5.8	7.2	0.0	0.0	1.2	8.7	2.0	0.5	14.9	0.2	0.8	0.8	0.0	23.3	0.5	0.9	1.0	1.2	0.0	1.0	1.2	15.9	1.2	0.6	0.3	3.6	0.6	0.5	0.0	0.0	0.6	3.5	0.0	0.0	1.1	1.7	1.5	0.0	0.9	0.9	4.1	0.4	0.5	0.9	0.2	0.4
NUDT10	"DIPP3a, hDIPP3alpha"	ENSG00000122824	"Nudix hydrolase 10"	Q8NFP7	X	51332231-51337525	"Enzymes, Predicted intracellular proteins"		Hydrolase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in many"		"ductus deferens: 28.8;seminal vesicle: 36.3;testis: 27.2"	"Group enriched"	"Detected in some"	5	"Ito cells: 54.6;Peritubular cells: 27.3"	"Group enriched"	"Detected in many"	6	"glioma: 5.0;prostate cancer: 5.4;testis cancer: 7.7"	"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"NK-cell: 2.1"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"AF22: 6.2;HAP1: 11.6;HEK 293: 8.6;NTERA-2: 21.3;SH-SY5Y: 4.6;SuSa: 4.4;U-2 OS: 10.7"									"HPA047027, HPA057684"	Approved		Approved	Cytosol		NA	NA			Cytosol		"HPA047027: AB_2679907, HPA057684: AB_2683501"	"unprognostic (2.61e-2)"	"unprognostic (1.12e-2)"	"unprognostic (7.40e-3)"	"unprognostic (7.84e-2)"	"unprognostic (1.82e-1)"	"unprognostic (2.51e-2)"	"unprognostic (1.16e-1)"	"unprognostic (2.06e-1)"	"unprognostic (2.54e-2)"	"unprognostic (1.11e-1)"	"unprognostic (2.49e-2)"	"unprognostic (1.27e-1)"	"unprognostic (1.51e-3)"	"unprognostic (1.80e-3)"	"unprognostic (1.04e-2)"	"unprognostic (1.12e-2)"	"unprognostic (5.04e-5)"	1.0	2.3	9.3	1.4	10.7	1.8	1.4	6.0	13.1	4.4	2.0	0.9	28.8	1.1	5.5	18.3	1.7	3.4	2.0	0.9	4.9	13.6	3.1	1.9	0.7	0.9	5.3	8.0	19.2	0.6	0.5	4.5	0.5	6.2	17.9	1.3	0.8	1.0	36.3	0.5	1.0	1.2	4.9	1.9	3.1	1.1	27.2	1.2	0.0	0.8	0.0	0.9	2.8	2.9	0.8	0.1	0.0	0.7	2.1	1.0	0.3	0.0	0.0	6.2	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.3	1.0	0.0	11.6	0.5	0.0	0.0	8.6	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	21.3	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	4.6	0.0	0.0	0.0	4.4	0.0	0.0	0.0	0.0	10.7	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.7	0.0	0.1	0.1	0.0	0.8	1.0	0.0	0.1	0.3	0.0	0.6	0.0	2.1	0.5	0.0	0.0	0.3	9.3	10.7	6.0	11.7	4.9	13.6	5.3	8.0	6.2	1.2	0.0	2.2	0.0	4.6	0.9	0.0	0.2	0.0	0.0	1.2	0.0	0.0	0.1	0.0	0.0	1.2	0.6	0.0	0.0	0.0	0.4	0.4	2.1	0.0	0.0	0.2	0.0	0.0	54.6	3.4	4.0	5.5	0.0	1.7	0.0	0.0	1.8	0.0	0.0	27.3	0.0	0.4	0.0	1.9	2.4	7.9	0.1	0.3	0.0	0.0	0.0
NUDT11	"DIPP3b, FLJ10628, hDIPP3beta"	ENSG00000196368	"Nudix hydrolase 11"	Q96G61	X	51490011-51496596	"Enzymes, Predicted intracellular proteins"		Hydrolase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 26.1;testis: 35.5"	"Cell type enhanced"	"Detected in many"	7	"Basal keratinocytes: 13.6;Peritubular cells: 19.4;Smooth muscle cells: 12.7;Spermatocytes: 13.4;Spermatogonia: 11.9"	"Cancer enhanced"	"Detected in many"		"testis cancer: 17.4"	"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	4	"gdT-cell: 3.7;MAIT T-cell: 1.4;memory CD4 T-cell: 1.2;memory CD8 T-cell: 1.9;naive CD8 T-cell: 3.1;NK-cell: 1.9"	"Group enriched"	"Detected in many"	5	"NK-cells: 1.9;T-cells: 3.7"	"Cell line enhanced"	"Detected in many"		"HAP1: 33.6;NTERA-2: 21.0"									"HPA047027, HPA057684"	Approved		Approved	Cytosol		NA	NA			Cytosol		"HPA047027: AB_2679907, HPA057684: AB_2683501"	"unprognostic (2.01e-1)"	"unprognostic (2.57e-1)"	"unprognostic (8.21e-2)"	"unprognostic (1.93e-3)"	"unprognostic (6.61e-2)"	"unprognostic (1.13e-3)"	"unprognostic (5.52e-3)"	"unprognostic (1.25e-1)"	"unprognostic (2.25e-2)"	"unprognostic (2.18e-1)"	"unprognostic (8.41e-2)"	"unprognostic (1.33e-1)"	"unprognostic (7.80e-12)"	"unprognostic (4.34e-4)"	"unprognostic (1.17e-2)"	"unprognostic (2.78e-1)"	"unprognostic (3.94e-4)"	1.2	5.4	11.2	1.4	21.9	1.6	2.8	7.4	26.1	3.8	2.6	0.8	4.4	1.7	5.9	4.3	1.9	1.6	2.2	0.8	7.0	17.9	0.9	0.6	0.8	1.1	5.3	12.7	10.0	3.8	0.5	2.8	0.6	5.3	10.1	1.4	0.5	1.3	11.9	0.6	1.7	1.5	5.0	1.8	0.9	0.9	35.5	1.1	3.6	1.0	0.2	1.1	1.7	1.6	0.5	0.4	0.0	0.2	1.9	3.7	1.0	0.0	0.5	10.1	0.0	8.8	11.2	0.0	4.7	1.3	0.2	0.2	0.0	0.0	0.0	0.2	5.7	5.6	0.7	33.6	11.5	0.1	0.0	2.2	0.0	0.0	0.0	4.1	0.0	2.2	6.8	4.6	3.0	11.1	1.9	7.9	10.4	0.0	0.0	9.5	0.2	12.7	0.0	21.0	0.0	8.5	0.0	7.1	0.0	2.1	0.0	0.0	6.6	2.0	0.0	1.8	5.2	0.0	0.0	4.6	2.4	11.1	0.7	0.0	4.4	2.0	7.2	1.5	0.0	0.9	0.0	0.0	0.0	3.7	0.0	1.4	0.5	1.2	1.9	0.4	0.3	0.2	3.1	0.0	1.9	0.2	0.2	0.0	1.0	11.2	21.9	7.4	14.9	7.0	17.9	5.3	12.7	5.3	1.1	0.0	0.0	0.0	4.8	13.6	1.5	0.4	0.0	0.0	1.2	0.0	0.0	0.2	0.0	0.2	9.4	0.0	0.0	0.0	1.3	0.9	4.1	9.3	0.0	0.0	0.1	0.0	0.0	0.0	0.8	10.2	8.1	0.6	5.0	0.0	0.0	0.9	2.2	0.0	19.4	0.0	0.1	0.0	12.7	13.4	11.9	8.0	0.2	0.0	0.0	1.1
NUDT3	DIPP	ENSG00000272325	"Nudix hydrolase 3"	O95989	6	34279679-34392674	"Enzymes, Predicted intracellular proteins"		Hydrolase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA047027, HPA055953"	Uncertain		Approved	Cytosol		NA	NA		110000	Cytosol		"HPA047027: AB_2679907, HPA055953: AB_2682984"	"unprognostic (2.42e-1)"	"prognostic favorable (5.29e-4)"	"unprognostic (9.63e-3)"	"unprognostic (4.74e-3)"	"unprognostic (3.60e-2)"	"unprognostic (1.84e-1)"	"unprognostic (1.41e-3)"	"unprognostic (4.21e-2)"	"unprognostic (4.93e-3)"	"unprognostic (1.08e-1)"	"unprognostic (3.16e-1)"	"unprognostic (4.63e-1)"	"unprognostic (1.24e-2)"	"unprognostic (3.28e-2)"	"unprognostic (1.09e-1)"	"unprognostic (1.54e-1)"	"unprognostic (6.24e-2)"	10.5	11.4	38.8	9.3	28.6	8.8	12.6	33.4	40.0	15.4	11.4	16.8	10.3	7.7	11.4	25.9	10.8	15.2	8.5	16.9	33.8	30.0	15.3	10.1	11.2	10.5	29.4	25.6	17.4	9.1	27.9	9.3	8.9	26.1	11.4	9.7	11.2	9.4	15.6	50.7	11.2	8.0	11.2	20.3	13.0	8.4	7.3	21.3	5.4	21.3	8.7	12.1	8.6	9.9	4.5	6.4	12.4	5.9	2.1	3.9	2.6	5.4	4.0	10.8	21.1	7.2	12.2	4.7	4.0	6.7	4.1	3.0	4.8	3.8	19.6	5.4	7.1	2.7	4.6	6.1	10.8	7.7	7.3	7.8	21.6	5.6	10.4	7.2	20.3	11.3	11.0	10.0	5.0	9.4	5.3	11.8	10.2	21.4	7.1	6.6	5.7	14.0	23.8	6.9	16.1	4.0	12.3	8.9	20.4	9.4	11.4	15.2	17.0	8.8	12.5	15.9	3.4	12.5	14.6	12.9	8.3	3.0	7.2	8.6	6.1	14.1	14.4	5.0	20.8	12.9	1.9	5.8	12.4	3.4	5.9	3.9	3.4	3.4	3.2	6.4	4.5	3.2	3.7	4.1	2.1	5.8	3.2	2.4	2.6	38.8	28.6	33.4	40.0	33.8	30.0	29.4	25.6	26.1	21.3	14.9	22.4	43.5	59.4	53.1	115.6	43.3	63.7	46.8	14.8	40.1	111.9	28.0	11.6	15.4	3.0	55.9	18.4	0.0	24.5	26.3	42.3	39.4	12.8	52.1	67.2	160.5	47.2	84.7	91.0	4.0	34.8	58.5	50.6	22.6	24.7	115.6	20.8	19.8	59.4	19.2	125.0	58.2	46.4	44.7	78.0	52.7	16.4	20.1	25.2	59.3
NUDT4	"DIPP2, DIPP2alpha, DIPP2beta, HDCMB47P, KIAA0487"	ENSG00000173598	"Nudix hydrolase 4"	Q9NZJ9	12	93377883-93408146	"Enzymes, Predicted intracellular proteins"		"Hydrolase, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"heart muscle: 140.7"	"Cell type enhanced"	"Detected in all"	5	"Muller glia cells: 411.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											"HPA017593, HPA047027, HPA057684"	Approved		Approved	Cytosol		NA	NA			Cytosol		"HPA017593: AB_1854703, HPA047027: AB_2679907, HPA057684: AB_2683501"	"unprognostic (1.44e-2)"	"unprognostic (2.15e-1)"	"unprognostic (4.40e-3)"	"unprognostic (4.25e-1)"	"unprognostic (3.08e-3)"	"unprognostic (1.42e-1)"	"unprognostic (8.12e-2)"	"unprognostic (9.09e-3)"	"unprognostic (1.88e-1)"	"unprognostic (1.51e-1)"	"unprognostic (2.60e-2)"	"unprognostic (1.96e-1)"	"prognostic favorable (1.27e-4)"	"unprognostic (1.75e-1)"	"unprognostic (2.87e-1)"	"unprognostic (5.01e-1)"	"unprognostic (8.32e-3)"	17.2	29.7	14.1	14.7	9.5	37.4	20.4	7.0	29.0	15.2	14.7	6.7	17.5	6.5	13.6	24.8	13.7	12.8	40.0	140.7	12.4	12.4	47.9	11.2	11.3	10.9	9.4	13.7	41.9	21.1	16.1	11.9	19.2	13.9	27.1	16.9	25.1	65.2	14.8	40.3	8.1	12.7	13.8	12.6	9.2	13.1	10.6	6.3	14.6	25.5	22.4	8.9	19.6	32.9	6.0	4.1	13.6	3.6	7.6	6.6	2.5	5.8	5.0	9.1	10.2	34.0	14.1	11.5	16.3	13.0	9.4	6.9	46.9	14.6	8.2	3.6	13.0	6.1	7.4	25.5	8.2	14.4	12.5	5.4	30.7	4.4	23.9	32.7	15.9	7.4	30.5	27.5	9.6	21.6	47.1	53.1	14.8	31.1	11.5	10.7	6.0	14.8	15.2	14.4	14.4	12.0	12.4	8.2	8.8	11.2	42.3	7.4	9.5	13.2	25.9	36.5	15.3	18.8	20.8	20.1	8.0	4.7	12.0	10.3	6.5	8.1	12.1	4.2	12.6	24.4	8.2	2.8	13.6	3.9	3.6	6.6	6.0	5.8	3.9	2.6	4.7	6.2	5.8	2.4	7.6	2.9	4.1	5.2	2.5	14.1	9.5	7.0	29.0	12.4	12.4	9.4	13.7	13.9	6.3	17.9	42.6	40.8	110.6	103.7	39.3	226.3	94.3	91.0	31.8	59.3	58.9	156.3	306.7	20.9	78.9	50.0	102.5	327.1	14.7	23.0	86.0	142.6	25.3	48.9	37.7	39.7	146.0	28.8	34.5	17.0	36.2	31.8	101.3	12.6	83.5	411.5	37.2	85.6	43.9	43.1	40.3	71.1	166.9	28.7	7.7	84.6	137.0	29.9	64.3	133.5
OCRL	OCRL1	ENSG00000122126	"OCRL, inositol polyphosphate-5-phosphatase"	Q01968	X	129539849-129592561	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Cilium biogenesis/degradation"	Hydrolase	"Cataract, Ciliopathy, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	4	"Peritubular cells: 32.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"non-classical monocyte: 6.6"	"Group enriched"	"Detected in many"	6	"dendritic cells: 2.4;monocytes: 6.6"	"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA012495	Approved		Approved	"Microtubules,Centriolar satellite,Cytosol"		NA	NA			Cytosol	"Microtubules, Centriolar satellite"	"HPA012495: AB_1851804"	"prognostic unfavorable (2.93e-5)"	"unprognostic (3.17e-2)"	"unprognostic (2.30e-1)"	"unprognostic (6.34e-3)"	"unprognostic (9.88e-2)"	"unprognostic (1.35e-1)"	"unprognostic (2.82e-2)"	"unprognostic (2.68e-1)"	"unprognostic (3.08e-3)"	"unprognostic (2.56e-2)"	"unprognostic (6.30e-3)"	"unprognostic (1.74e-1)"	"unprognostic (4.61e-3)"	"unprognostic (4.10e-1)"	"unprognostic (5.83e-2)"	"unprognostic (1.59e-1)"	"unprognostic (1.17e-1)"	12.1	20.5	10.7	6.0	18.2	5.3	10.8	13.4	23.1	12.7	13.4	10.1	28.8	9.1	15.8	19.7	13.3	12.8	13.8	8.6	13.0	20.5	10.9	11.3	8.6	6.0	12.9	15.1	33.0	12.4	37.3	20.3	13.2	17.8	21.7	14.1	15.3	8.5	27.7	11.4	9.6	9.8	21.5	8.0	6.3	11.4	23.2	6.4	4.3	19.0	5.6	4.1	18.0	9.2	0.4	2.4	0.3	6.6	0.0	0.7	0.7	9.7	11.2	9.3	10.5	16.4	13.7	9.1	14.9	11.9	15.5	14.4	7.5	7.1	0.8	25.7	12.6	18.2	6.1	17.1	11.4	16.1	0.0	11.5	3.0	10.1	7.5	12.2	3.0	0.3	11.4	15.0	15.2	15.1	15.4	11.5	4.5	4.0	7.4	16.0	12.7	2.2	4.2	3.3	12.9	16.7	2.2	9.6	5.8	8.8	10.1	11.3	14.3	7.1	10.1	7.8	12.4	7.2	5.3	9.6	12.6	5.8	13.1	14.8	2.1	1.6	2.0	8.9	11.1	9.9	0.0	2.1	0.0	0.2	2.4	0.7	0.3	0.1	0.1	2.4	0.4	0.6	0.2	0.3	0.0	6.6	0.9	0.1	0.7	10.7	18.2	13.4	23.1	13.0	20.5	12.9	15.1	17.8	6.4	3.0	8.5	0.8	3.1	4.1	9.9	7.9	5.1	4.0	10.3	17.4	5.9	5.1	3.3	4.9	19.5	5.3	13.7	0.0	3.1	4.7	5.1	5.7	0.0	10.9	4.3	12.7	16.8	7.4	10.4	5.9	21.3	4.4	8.5	2.8	11.7	8.6	6.7	10.7	32.2	3.9	6.0	0.0	5.7	6.4	14.0	6.5	4.8	0.0	9.7	6.0
PHPT1	"bA216L13.10, CGI-202, DKFZp564M173, HSPC141, PHP14"	ENSG00000054148	"Phosphohistidine phosphatase 1"	Q9NRX4	9	136848724-136851027	"Enzymes, Predicted intracellular proteins"		"Hydrolase, Protein phosphatase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB013584, HPA020952"	Approved		Approved	"Nucleoplasm,Nuclear bodies,Plasma membrane,Cytosol"		NA	NA		430000	Cytosol	"Nucleoplasm, Nuclear bodies, Plasma membrane"	"CAB013584: , HPA020952: AB_1855331"	"unprognostic (7.34e-2)"	"unprognostic (9.21e-2)"	"unprognostic (7.90e-2)"	"unprognostic (1.57e-2)"	"unprognostic (3.76e-2)"	"unprognostic (2.30e-1)"	"unprognostic (4.64e-2)"	"unprognostic (1.69e-2)"	"unprognostic (3.23e-2)"	"unprognostic (1.82e-1)"	"unprognostic (1.26e-3)"	"unprognostic (5.85e-2)"	"unprognostic (9.66e-3)"	"unprognostic (1.11e-2)"	"unprognostic (2.01e-1)"	"unprognostic (3.95e-2)"	"unprognostic (8.49e-2)"	15.8	26.4	31.5	12.1	28.0	11.7	15.3	14.7	27.2	19.2	15.7	18.5	13.7	14.7	11.2	21.7	13.7	21.1	14.2	59.1	22.7	19.3	18.4	12.6	12.1	12.7	27.0	21.0	13.7	46.5	15.6	21.2	14.7	20.8	20.2	11.6	14.1	30.5	22.6	86.0	9.2	16.3	16.9	24.3	10.3	13.4	13.8	18.6	7.5	20.7	19.8	10.4	12.0	9.8	24.9	48.8	3.3	35.4	20.0	24.3	32.1	7.1	52.0	29.7	18.9	19.2	34.9	43.7	16.6	21.2	20.3	18.1	18.9	16.3	15.2	20.2	20.5	24.3	18.9	6.4	37.5	6.4	13.6	13.2	4.8	34.2	41.5	23.9	9.5	19.5	43.5	30.9	11.6	14.0	18.4	26.6	11.9	11.5	14.1	31.4	40.6	13.8	20.0	23.5	47.6	22.4	11.5	13.0	25.1	32.1	11.9	14.6	13.8	17.9	21.0	8.6	14.8	15.9	26.4	21.6	42.5	13.2	11.7	15.3	9.4	9.1	9.3	24.0	6.9	25.4	2.9	35.4	3.3	24.3	34.2	20.9	24.9	21.1	21.9	37.5	16.5	15.0	21.3	1.7	20.0	24.0	48.8	22.9	32.1	31.5	28.0	14.7	27.2	22.7	19.3	27.0	21.0	20.8	18.6	89.3	132.7	80.4	156.2	133.5	37.9	336.8	191.1	136.5	125.1	205.9	21.6	300.5	633.3	164.3	214.6	110.1	411.5	70.0	220.3	372.9	227.8	244.3	120.2	179.9	249.5	63.5	254.7	94.5	103.8	640.4	189.8	148.3	317.2	367.9	241.4	126.9	202.0	354.2	210.0	509.4	53.8	84.1	248.0	93.6	149.9	141.4	220.8	93.5	262.8	160.3
PI4K2A	"DKFZP761G1923, PI4KII, PIK42A"	ENSG00000155252	"Phosphatidylinositol 4-kinase type 2 alpha"	Q9BTU6	10	97640686-97676434	"Enzymes, Predicted intracellular proteins"		"Kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	4	"Hofbauer cells: 32.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB030649, HPA076857"	Approved		Approved	"Plasma membrane"		NA	NA			"Plasma membrane"		"CAB030649: , HPA076857: AB_2686817"	"unprognostic (1.34e-1)"	"unprognostic (3.50e-2)"	"prognostic unfavorable (4.21e-5)"	"unprognostic (1.80e-2)"	"unprognostic (2.12e-1)"	"unprognostic (1.75e-2)"	"unprognostic (2.84e-3)"	"unprognostic (1.60e-2)"	"unprognostic (1.39e-3)"	"unprognostic (1.38e-2)"	"unprognostic (1.02e-2)"	"unprognostic (1.65e-1)"	"unprognostic (9.92e-2)"	"unprognostic (1.27e-1)"	"unprognostic (1.80e-1)"	"unprognostic (1.45e-1)"	"unprognostic (2.90e-1)"	17.2	23.0	13.8	10.7	21.2	22.8	9.5	16.8	33.8	12.0	9.1	16.8	9.5	10.9	12.8	15.5	18.3	8.9	16.1	15.2	14.5	17.9	14.7	17.1	15.0	11.0	15.9	15.7	10.6	9.5	23.2	15.5	19.9	30.7	10.3	10.2	23.8	10.1	12.7	11.3	15.3	9.9	15.0	9.9	14.4	8.8	14.9	7.5	8.2	12.0	8.8	11.8	13.6	11.2	4.1	3.7	1.1	3.4	1.9	4.0	1.6	12.1	9.2	7.6	13.5	16.3	11.8	6.1	12.2	27.0	19.3	20.5	8.3	12.1	4.4	7.2	15.4	14.2	11.8	8.4	24.3	16.1	5.3	7.2	3.9	6.5	7.5	15.7	3.5	5.6	12.4	20.8	20.2	36.0	21.2	9.8	8.7	6.1	7.3	13.3	6.2	7.7	2.7	4.9	6.3	8.7	3.6	7.9	4.3	13.2	11.4	2.6	8.4	10.3	2.6	15.2	11.2	7.2	5.6	10.8	9.2	6.9	10.9	9.4	6.5	7.6	7.2	17.1	2.1	3.0	0.0	3.4	0.0	4.0	2.3	2.8	4.1	1.7	3.4	3.7	1.9	1.4	2.6	1.1	1.9	1.6	1.7	3.1	1.6	13.8	21.2	16.8	33.8	14.5	17.9	15.9	15.7	30.7	7.5	3.0	4.8	4.7	4.1	11.8	12.9	9.8	10.2	1.4	2.3	5.2	11.8	11.6	3.3	4.0	1.9	5.0	8.3	0.0	4.2	5.3	9.4	4.3	1.1	9.3	32.1	11.1	2.9	3.1	11.0	1.7	4.0	17.5	10.1	22.6	2.5	6.9	5.7	0.0	8.5	6.2	14.2	6.5	5.9	9.1	5.6	12.5	22.7	7.0	2.5	7.1
PI4K2B	"FLJ11105, PI4KIIB, PIK42B"	ENSG00000038210	"Phosphatidylinositol 4-kinase type 2 beta"	Q8TCG2	4	25233975-25279092	"Enzymes, Predicted intracellular proteins"		"Kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"intestine: 49.3"	"Cell type enhanced"	"Detected in many"	4	"Hepatocytes: 36.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"											HPA004099	Approved		Supported	Cytosol		NA	NA			Cytosol		"HPA004099: AB_1855353"	"unprognostic (1.02e-1)"	"unprognostic (6.34e-3)"	"prognostic favorable (9.64e-5)"	"unprognostic (2.75e-2)"	"unprognostic (1.98e-2)"	"unprognostic (2.68e-2)"	"unprognostic (7.54e-2)"	"unprognostic (7.75e-2)"	"unprognostic (5.06e-1)"	"unprognostic (6.39e-3)"	"unprognostic (1.71e-1)"	"unprognostic (1.32e-1)"	"unprognostic (9.07e-2)"	"unprognostic (9.61e-2)"	"unprognostic (2.39e-2)"	"unprognostic (2.02e-2)"	"unprognostic (4.47e-2)"	9.2	7.1	3.4	13.6	2.9	3.9	8.0	3.2	2.3	8.7	48.4	4.1	11.3	19.4	7.4	8.0	13.5	4.9	9.5	4.2	3.1	2.7	12.9	38.6	14.3	9.4	3.5	2.3	6.9	10.5	4.2	5.7	7.7	2.9	6.4	9.8	3.3	22.6	12.0	4.4	8.6	49.3	6.9	4.5	13.8	11.3	8.0	2.7	18.6	16.2	12.9	14.1	7.8	10.3	1.4	1.8	1.5	1.0	0.4	4.1	0.4	11.5	2.1	4.9	5.2	6.6	12.3	11.9	17.4	16.4	15.2	19.5	3.7	12.4	29.9	4.0	13.1	10.6	4.8	11.1	8.7	15.1	9.1	3.9	9.5	5.2	9.2	6.3	19.2	7.5	8.2	7.9	5.7	6.0	4.6	10.3	8.5	6.3	25.1	14.8	4.4	18.5	17.2	8.5	13.8	4.7	11.2	19.2	17.4	13.4	8.2	10.2	2.2	8.8	7.0	3.6	5.5	9.9	11.1	10.5	10.8	2.8	6.6	11.2	28.8	13.8	22.8	12.7	16.3	11.0	1.5	0.4	0.0	1.3	1.0	0.9	1.4	1.5	1.2	0.3	1.0	1.4	1.3	0.2	0.4	0.9	1.8	4.1	0.4	3.4	2.9	3.2	2.3	3.1	2.7	3.5	2.3	2.9	2.7	6.0	14.4	14.1	11.2	13.4	1.9	0.0	7.6	2.7	12.5	8.7	0.0	18.1	5.0	5.1	0.6	6.4	14.2	23.3	6.2	10.1	8.3	11.3	0.0	36.0	9.1	1.6	8.1	6.7	12.4	0.9	4.0	7.0	5.0	12.6	12.8	1.1	5.0	8.6	4.2	15.6	3.0	0.0	7.2	8.0	12.7	13.7	11.3	5.0	12.7	11.9
PI4KA	"PI4K-ALPHA, pi4K230, PIK4CA"	ENSG00000241973	"Phosphatidylinositol 4-kinase alpha"	P42356	22	20707691-20859417	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"		"Kinase, Transferase"	"Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 48.0"	"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"K-562: 52.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB009092, HPA075515"	Approved		Approved	"Nucleoplasm,Plasma membrane"		NA	NA		18000	Nucleoplasm	"Plasma membrane"	"CAB009092: AB_2164033, HPA075515: AB_2686753"	"unprognostic (8.06e-2)"	"unprognostic (1.53e-1)"	"unprognostic (1.20e-2)"	"unprognostic (4.45e-2)"	"unprognostic (1.21e-1)"	"unprognostic (5.01e-3)"	"unprognostic (3.19e-2)"	"prognostic favorable (5.24e-4)"	"unprognostic (2.08e-1)"	"unprognostic (4.21e-2)"	"unprognostic (1.88e-2)"	"unprognostic (1.29e-1)"	"prognostic favorable (7.22e-5)"	"unprognostic (1.37e-1)"	"unprognostic (1.33e-1)"	"unprognostic (2.35e-1)"	"unprognostic (1.50e-1)"	7.7	9.2	28.8	10.5	34.2	12.5	6.5	14.1	48.0	9.7	8.8	10.1	4.9	9.1	9.7	6.1	8.3	8.4	8.0	8.5	30.4	19.2	9.0	12.6	9.0	11.2	19.0	25.9	10.2	8.6	25.6	12.5	10.4	19.3	9.8	8.9	10.8	6.8	10.6	7.1	6.6	10.0	13.2	6.8	10.2	9.9	13.1	8.2	17.9	9.9	2.9	10.2	8.4	4.8	5.0	12.5	7.6	5.5	9.1	7.7	2.9	9.9	8.4	7.4	11.1	21.2	12.8	10.6	9.0	13.7	13.3	13.1	6.5	4.2	18.7	5.4	18.1	13.1	8.8	14.0	8.7	8.2	15.9	21.5	19.2	11.3	7.4	10.6	19.0	15.4	11.4	5.5	11.3	6.3	8.7	10.8	5.7	52.4	15.9	10.3	13.7	16.6	6.5	5.8	17.8	8.7	16.7	16.2	3.4	7.4	15.9	18.2	13.3	11.8	13.8	9.4	10.8	11.6	8.7	10.9	24.3	12.6	8.9	7.6	12.2	12.4	14.9	16.0	13.7	10.1	3.1	5.5	7.3	5.1	5.4	4.9	4.6	5.6	6.1	3.6	5.0	5.7	7.7	7.6	9.1	4.6	12.5	5.8	2.9	28.8	34.2	14.1	48.0	30.4	19.2	19.0	25.9	19.3	8.2	11.9	25.4	14.0	5.7	9.0	32.8	25.7	25.5	6.7	9.1	7.0	45.2	15.6	1.7	8.5	30.2	12.8	18.2	0.0	5.5	16.0	10.8	10.3	11.5	15.5	17.4	35.0	18.4	14.7	15.5	19.2	18.4	16.5	10.1	6.4	16.8	22.8	7.1	10.5	22.6	9.1	23.8	25.8	10.5	32.1	28.9	8.5	16.7	13.3	12.7	7.0
PI4KB	"PI4K-BETA, pi4K92, PIK4CB"	ENSG00000143393	"Phosphatidylinositol 4-kinase beta"	Q9UBF8	1	151291797-151327715	"Enzymes, Predicted intracellular proteins"	"Host-virus interaction"	"Kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA006280, HPA006281, CAB022071"	Approved		Supported	"Golgi apparatus"		NA	NA			"Golgi apparatus"		"CAB022071: , HPA006280: AB_1079613, HPA006281: AB_1079614"	"unprognostic (1.17e-1)"	"unprognostic (1.57e-1)"	"unprognostic (5.42e-3)"	"unprognostic (5.23e-3)"	"unprognostic (7.32e-2)"	"unprognostic (1.36e-2)"	"prognostic unfavorable (2.97e-4)"	"unprognostic (1.87e-1)"	"unprognostic (3.94e-1)"	"unprognostic (1.58e-1)"	"prognostic favorable (1.25e-5)"	"unprognostic (8.51e-2)"	"prognostic unfavorable (3.23e-4)"	"unprognostic (2.53e-1)"	"unprognostic (2.16e-1)"	"prognostic unfavorable (6.78e-4)"	"unprognostic (7.08e-2)"	25.5	22.2	29.8	21.6	32.3	41.6	27.3	42.6	47.2	30.8	27.1	44.8	26.6	21.8	38.6	35.8	25.6	33.0	25.1	23.8	26.3	22.5	25.6	19.3	27.2	26.2	38.7	28.8	38.6	22.6	41.8	35.5	24.2	29.6	32.2	28.1	28.8	27.1	29.9	36.2	36.9	25.3	39.8	22.7	34.7	23.7	33.1	34.0	26.2	41.2	24.6	28.7	27.1	30.1	17.1	19.7	27.9	20.4	14.7	20.3	17.1	19.7	16.5	14.4	22.5	40.0	29.6	12.2	21.0	36.7	27.5	22.9	21.0	18.0	18.7	24.2	32.1	17.4	18.6	23.8	21.6	21.3	25.3	21.1	13.3	19.6	10.8	28.0	15.3	25.8	30.9	26.3	30.4	21.8	23.9	26.5	19.2	22.8	28.4	23.3	36.7	16.2	12.4	11.5	28.2	25.1	14.6	12.1	21.9	19.0	25.1	17.4	15.0	14.6	29.8	18.8	23.8	25.1	29.2	20.6	19.8	15.6	15.7	22.3	30.2	19.6	36.4	22.5	16.1	34.2	25.2	17.5	27.9	15.6	20.4	17.4	17.1	16.1	20.3	19.7	15.1	13.6	12.5	17.2	14.7	19.6	11.4	15.9	17.1	29.8	32.3	42.6	47.2	26.3	22.5	38.7	28.8	29.6	34.0	14.9	25.3	16.7	17.9	19.8	30.2	6.7	20.4	9.4	14.8	12.2	19.6	22.5	16.6	17.6	8.9	15.8	24.9	0.0	21.6	16.5	23.4	16.5	18.5	10.9	24.5	33.4	17.7	9.8	15.9	11.5	21.6	17.4	13.5	31.5	17.8	18.9	18.2	17.5	23.3	12.4	26.6	12.9	23.7	24.7	23.0	27.1	40.7	21.0	18.0	26.9
PIK3C2A	PI3K-C2alpha	ENSG00000011405	"Phosphatidylinositol-4-phosphate 3-kinase catalytic subunit type 2 alpha"	O00443	11	17077730-17207983	"Enzymes, Predicted intracellular proteins"	"Endocytosis, Exocytosis"	"Kinase, Transferase"	"Cataract, Disease mutation, Dwarfism"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA037641, HPA037642"	Uncertain		Supported	Nucleoplasm,Vesicles,Cytosol		NA	NA			Nucleoplasm	"Vesicles, Cytosol"	"HPA037641: AB_10671878, HPA037642: AB_10697081"	"unprognostic (2.35e-1)"	"unprognostic (2.16e-2)"	"unprognostic (3.71e-2)"	"unprognostic (1.06e-1)"	"unprognostic (1.63e-1)"	"unprognostic (6.63e-2)"	"unprognostic (2.47e-2)"	"unprognostic (1.39e-1)"	"unprognostic (2.29e-2)"	"unprognostic (1.86e-2)"	"unprognostic (4.74e-2)"	"unprognostic (1.84e-1)"	"prognostic favorable (1.66e-4)"	"unprognostic (3.20e-2)"	"unprognostic (1.51e-1)"	"unprognostic (1.18e-1)"	"unprognostic (1.37e-1)"	22.3	16.8	17.6	17.2	26.3	9.2	20.0	22.6	17.2	22.1	17.2	13.9	22.2	15.6	20.3	19.2	16.8	18.2	20.2	16.3	14.5	11.6	25.7	16.3	22.2	11.3	17.6	16.1	17.6	14.2	62.9	23.0	23.5	28.5	18.7	14.3	15.2	15.6	27.5	15.4	13.1	17.9	19.5	31.8	17.5	18.3	19.4	18.0	11.4	32.2	9.3	11.5	23.1	20.5	4.4	5.2	6.0	7.2	4.2	4.8	1.6	23.1	10.6	17.8	11.1	12.9	13.2	16.0	14.7	15.9	10.8	15.1	25.8	2.6	6.8	7.3	12.6	17.7	15.4	14.2	11.2	19.2	5.8	12.3	4.2	12.9	10.1	14.1	5.2	6.7	10.2	7.9	10.6	20.9	10.1	25.6	4.3	9.9	6.6	8.3	7.1	2.8	3.3	10.1	13.0	8.2	2.9	18.5	4.7	13.4	20.6	10.5	9.3	22.3	9.6	10.3	15.6	5.7	5.3	31.9	8.7	12.6	22.5	8.9	2.7	5.9	5.6	10.4	4.9	10.0	4.1	4.1	2.9	4.6	2.5	3.0	3.6	3.7	3.6	5.2	4.4	4.8	2.8	6.0	4.2	7.2	3.7	2.3	1.6	17.6	26.3	22.6	17.2	14.5	11.6	17.6	16.1	28.5	18.0	71.5	56.0	17.6	19.9	31.4	47.8	22.4	22.9	29.4	39.8	34.9	66.8	25.6	16.6	15.8	21.3	80.2	17.1	0.0	21.6	14.0	19.7	34.1	30.2	28.6	16.4	33.4	27.5	108.1	38.5	12.0	23.9	23.8	18.6	11.8	20.1	82.7	22.6	11.5	29.4	17.0	41.1	38.8	29.8	36.4	15.5	29.6	120.0	19.2	17.2	27.3
PIK3C2B	"C2-PI3K, PI3K-C2beta"	ENSG00000133056	"Phosphatidylinositol-4-phosphate 3-kinase catalytic subunit type 2 beta"	O00750	1	204422628-204494724	"Enzymes, Plasma proteins, Predicted intracellular proteins"		"Kinase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"granulocytes: 32.3;Ito cells: 27.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"naive B-cell: 7.4"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"BEWO: 32.3;RT4: 33.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA030515, HPA050360"	Approved		Approved	Nucleoplasm,Cytosol		NA	NA			Nucleoplasm	Cytosol	"HPA030515: AB_10670043, HPA050360: AB_2681104"	"unprognostic (5.77e-2)"	"unprognostic (1.36e-1)"	"unprognostic (1.36e-1)"	"unprognostic (2.18e-2)"	"unprognostic (3.45e-1)"	"unprognostic (2.19e-3)"	"prognostic unfavorable (5.42e-4)"	"unprognostic (3.35e-3)"	"unprognostic (3.57e-3)"	"unprognostic (2.72e-2)"	"unprognostic (8.54e-2)"	"unprognostic (1.10e-1)"	"unprognostic (2.54e-1)"	"unprognostic (5.36e-2)"	"unprognostic (1.26e-1)"	"unprognostic (1.75e-1)"	"prognostic favorable (1.16e-4)"	12.9	4.5	11.0	16.0	19.3	5.3	11.0	9.1	17.5	7.4	17.0	36.0	9.6	15.5	10.5	5.8	14.6	7.7	14.7	10.7	14.4	9.1	7.6	5.8	18.0	23.9	24.2	11.2	3.9	6.1	4.7	4.3	20.4	14.5	7.3	14.5	6.3	8.0	14.1	20.0	22.6	15.7	11.2	16.2	14.2	20.7	2.4	23.0	31.8	9.8	8.1	23.1	13.1	11.8	7.4	0.3	0.5	0.2	1.6	2.0	0.4	3.2	6.6	5.9	5.4	3.5	0.3	32.3	0.4	1.3	1.3	0.9	3.9	8.7	5.6	1.2	0.7	1.1	8.2	3.5	2.3	0.5	3.4	0.9	0.1	13.1	1.4	0.2	1.9	4.3	0.4	2.5	0.3	0.2	0.5	8.6	5.7	2.0	3.8	0.1	7.3	6.7	5.6	5.4	12.9	4.2	7.3	1.5	1.0	1.6	33.8	6.5	3.6	11.7	16.4	3.8	2.2	7.3	1.0	0.3	0.2	2.1	0.6	0.1	4.1	1.1	7.3	0.2	3.0	0.8	0.1	0.2	0.0	1.2	0.0	1.0	2.9	1.3	0.8	0.3	7.4	0.7	0.6	0.5	1.6	0.0	0.1	2.0	0.4	11.0	19.3	9.1	17.5	14.4	9.1	24.2	11.2	14.5	23.0	0.0	12.6	11.1	1.9	3.4	16.6	6.4	0.0	2.7	4.5	3.5	0.0	3.8	0.0	1.1	0.6	20.0	14.8	0.0	3.0	3.4	4.1	2.2	32.3	3.9	3.3	14.3	9.2	27.0	2.2	0.0	1.1	2.3	3.3	2.8	23.7	2.5	3.3	10.5	7.1	1.9	1.0	0.0	3.1	0.0	1.5	6.9	1.8	2.5	13.2	6.3
PIK3C2G		ENSG00000139144	"Phosphatidylinositol-4-phosphate 3-kinase catalytic subunit type 2 gamma"	O75747	12	18247614-18648416	"Enzymes, Plasma proteins, Predicted intracellular proteins"	Chemotaxis	"Kinase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"ductus deferens: 54.2;epididymis: 30.7;seminal vesicle: 46.0"	"Cell type enhanced"	"Detected in many"	12	"Basal keratinocytes: 15.5;Cholangiocytes: 33.1;Collecting duct cells: 38.4;Hepatocytes: 21.5;Suprabasal keratinocytes: 18.7"	"Cancer enhanced"	"Detected in some"		"stomach cancer: 2.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	4	"BEWO: 2.9;HaCaT: 4.7;hTERT-HME1: 8.7"	"Low region specificity"	"Detected in some"			"Not detected"	"Not detected"									NA	NA						"unprognostic (1.29e-1)"	"unprognostic (1.61e-1)"		"unprognostic (6.21e-2)"	"unprognostic (1.47e-2)"	"unprognostic (9.46e-2)"	"unprognostic (8.27e-2)"	"unprognostic (2.85e-1)"	"unprognostic (6.52e-2)"	"unprognostic (1.81e-3)"	"prognostic unfavorable (3.50e-4)"	"unprognostic (6.05e-2)"	"unprognostic (1.81e-1)"	"unprognostic (2.74e-1)"	"unprognostic (1.98e-1)"		"unprognostic (2.37e-2)"	0.3	0.6	0.2	0.1	0.2	0.0	6.7	0.2	0.3	0.6	0.3	0.1	54.2	0.0	0.3	30.7	4.2	0.6	6.0	0.2	0.3	0.2	9.6	8.8	0.3	0.1	0.3	0.1	0.3	1.2	8.1	0.4	1.2	0.1	2.4	0.0	0.1	13.1	46.0	0.2	7.0	2.2	0.2	0.3	0.2	15.1	2.1	0.1	0.1	0.5	1.6	0.5	0.9	0.9	0.1	0.1	0.4	0.0	0.3	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.9	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	1.3	4.7	0.0	0.3	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	1.1	0.1	8.7	0.0	0.0	0.0	0.0	0.4	0.0	0.3	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.2	0.0	0.0	0.2	0.0	0.1	0.3	0.0	0.2	0.1	0.1	0.0	0.0	0.0	0.1	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.4	0.0	0.4	0.3	0.0	0.4	0.0	0.1	0.1	0.0	0.1	0.1	0.2	0.0	0.3	0.0	0.1	0.0	0.0	0.2	0.2	0.2	0.3	0.3	0.2	0.3	0.1	0.1	0.1	0.0	0.0	0.0	6.7	15.5	0.0	0.3	33.1	0.0	1.2	38.4	0.0	1.0	1.7	1.3	3.5	0.1	0.7	0.0	0.0	4.1	0.2	0.5	0.0	21.5	0.2	0.0	0.0	0.0	1.0	1.8	0.0	0.0	1.7	0.0	0.1	0.0	0.6	0.3	0.0	1.1	0.0	0.0	0.0	2.4	2.1	18.7	0.7	0.0	0.2	0.7
PIK3C3	Vps34	ENSG00000078142	"Phosphatidylinositol 3-kinase catalytic subunit type 3"	Q8NEB9	18	41955206-42087830	"Enzymes, Predicted intracellular proteins"	"Autophagy, Cell cycle, Cell division"	"Kinase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA040718	Approved					NA	NA					"HPA040718: AB_10793862"	"unprognostic (1.26e-1)"	"unprognostic (1.24e-1)"	"unprognostic (1.40e-2)"	"unprognostic (3.55e-3)"	"unprognostic (6.15e-2)"	"unprognostic (3.61e-2)"	"unprognostic (6.00e-3)"	"unprognostic (1.91e-1)"	"unprognostic (2.11e-1)"	"unprognostic (1.71e-2)"	"unprognostic (3.86e-2)"	"unprognostic (6.41e-2)"	"prognostic favorable (4.97e-4)"	"unprognostic (1.09e-1)"	"unprognostic (1.35e-2)"	"unprognostic (1.76e-1)"	"unprognostic (6.85e-3)"	19.3	24.1	24.0	14.8	28.3	18.5	21.8	48.2	29.6	18.9	15.3	18.2	17.9	11.4	21.1	23.1	18.8	16.8	16.2	17.0	22.9	12.8	21.9	18.2	16.7	16.7	22.6	22.1	23.9	15.1	23.1	33.7	22.2	30.7	17.7	18.3	12.3	21.2	17.7	21.2	20.7	14.6	18.4	27.4	18.5	16.2	22.2	28.0	24.0	20.3	13.0	20.0	18.0	17.8	10.8	9.4	19.2	10.7	11.1	15.7	7.4	7.5	5.3	13.5	10.3	15.8	17.1	8.3	15.0	19.2	12.1	16.4	2.5	3.8	4.7	8.6	15.1	9.5	12.5	10.5	8.3	16.8	7.6	7.4	9.7	8.2	10.3	13.2	14.2	10.6	18.6	12.7	11.3	14.8	18.6	12.4	9.5	9.4	6.0	16.7	2.4	6.3	9.3	9.9	2.8	3.9	38.3	10.0	12.1	14.0	8.2	11.9	13.8	4.7	3.6	10.5	15.8	5.2	11.9	16.0	16.4	4.8	3.6	6.8	16.2	19.0	5.3	13.6	19.5	8.7	14.5	9.4	19.2	9.3	10.3	10.3	10.8	9.4	11.4	9.4	9.2	12.3	9.1	18.3	11.1	10.7	5.6	15.7	7.4	24.0	28.3	48.2	29.6	22.9	12.8	22.6	22.1	30.7	28.0	20.8	37.5	14.2	10.2	10.2	25.0	20.7	2.5	24.1	34.2	14.0	19.6	17.3	6.6	11.9	13.3	18.0	9.9	0.0	9.0	11.2	12.7	12.5	16.2	11.5	13.4	52.4	4.7	16.0	17.6	8.7	13.6	13.4	6.8	13.6	12.5	24.3	12.6	10.1	22.6	10.0	21.5	19.4	13.4	20.9	17.9	9.9	22.9	18.3	9.3	14.4
PIK3CA	PI3K	ENSG00000121879	"Phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit alpha"	P42336	3	179148114-179240093	"Cancer-related genes, Disease related genes, Enzymes, FDA approved drug targets, Predicted intracellular proteins, RAS pathway related proteins"	"Angiogenesis, Phagocytosis"	"Kinase, Serine/threonine-protein kinase, Transferase"	"Cancer-related genes, Disease mutation, FDA approved drug targets, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA009985, CAB017804"	Approved		Supported	Mitochondria,Cytosol		NA	NA			Cytosol	Mitochondria	"CAB017804: , HPA009985: AB_1079610"	"unprognostic (1.81e-1)"	"unprognostic (2.77e-1)"	"unprognostic (2.18e-1)"	"unprognostic (2.69e-3)"	"unprognostic (6.49e-3)"	"unprognostic (1.43e-1)"	"unprognostic (2.65e-2)"	"unprognostic (1.00e-2)"	"unprognostic (1.03e-1)"	"unprognostic (2.37e-1)"	"unprognostic (2.57e-3)"	"unprognostic (5.21e-2)"	"unprognostic (4.50e-2)"	"unprognostic (1.16e-2)"	"unprognostic (2.48e-1)"	"unprognostic (9.74e-2)"	"unprognostic (3.82e-2)"	20.1	12.3	13.7	11.5	13.4	25.7	22.4	17.1	24.5	12.9	14.0	5.2	5.7	6.5	15.3	7.9	11.6	11.1	13.2	14.2	18.4	9.7	11.7	10.8	13.2	13.8	9.8	15.7	15.4	9.2	24.7	11.6	16.5	16.3	10.7	8.9	7.2	10.9	10.9	15.2	12.0	10.5	12.8	14.4	16.2	10.6	9.3	9.8	29.6	11.0	7.3	13.9	15.1	15.7	6.2	2.6	7.8	3.8	2.4	5.0	1.1	14.6	5.0	8.0	7.4	19.0	22.2	5.9	9.4	12.7	9.3	14.7	4.3	10.9	13.4	16.1	11.2	13.2	6.0	6.6	8.1	13.5	22.4	5.8	18.4	5.5	3.8	9.1	10.3	10.5	14.0	8.6	10.2	11.7	10.4	13.3	9.7	9.1	15.0	13.3	5.8	7.9	9.3	6.4	7.3	6.8	12.0	8.1	16.1	7.3	9.0	4.5	7.7	10.2	9.1	12.2	7.3	15.2	8.9	14.0	8.7	5.7	13.7	9.3	7.3	10.3	24.1	7.9	7.8	5.1	2.1	3.8	1.6	5.0	2.9	3.9	5.8	4.2	2.8	2.2	6.2	4.6	3.8	7.8	2.4	3.0	2.6	4.1	1.1	13.7	13.4	17.1	24.5	18.4	9.7	9.8	15.7	16.3	9.8	29.8	23.2	13.7	15.2	13.1	26.3	15.4	7.6	18.7	17.0	7.0	29.5	8.1	1.7	9.8	1.7	21.4	4.9	0.0	11.9	5.0	18.3	27.3	30.1	17.4	9.5	36.5	2.4	29.4	21.2	1.6	30.2	16.4	13.5	16.2	9.6	15.6	13.1	12.7	37.1	11.2	26.2	25.8	22.1	9.6	7.6	13.0	7.3	14.0	9.2	27.6
PIK3CB	PIK3C1	ENSG00000051382	"Phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit beta"	P42338	3	138652699-138834938	"Cancer-related genes, Enzymes, Plasma proteins, Predicted intracellular proteins, RAS pathway related proteins"	"Autophagy, Cell adhesion, Endocytosis"	"Kinase, Transferase"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"HEL: 42.0;HMC-1: 66.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB031938, HPA042288, HPA064207"	Approved		Supported	Nucleoplasm,Nucleoli,Vesicles,Midbody		Yes	No			Nucleoplasm	"Nucleoli, Vesicles, Midbody"	"CAB031938: AB_2165408, HPA042288: , HPA064207: AB_2685212"	"unprognostic (4.89e-2)"	"unprognostic (1.42e-2)"	"unprognostic (5.97e-2)"	"unprognostic (7.85e-2)"	"unprognostic (4.89e-2)"	"unprognostic (6.01e-2)"	"prognostic unfavorable (6.42e-4)"	"unprognostic (3.98e-2)"	"unprognostic (1.35e-1)"	"unprognostic (2.28e-1)"	"prognostic unfavorable (3.99e-5)"	"unprognostic (2.15e-1)"	"unprognostic (6.18e-3)"	"unprognostic (9.33e-2)"	"unprognostic (7.82e-2)"	"unprognostic (2.79e-1)"	"unprognostic (4.59e-2)"	12.5	9.9	10.6	9.7	20.6	17.4	11.5	29.9	25.0	12.4	14.6	11.9	11.7	13.7	9.6	6.9	15.2	10.9	8.7	12.7	12.2	14.2	22.6	9.3	9.5	9.1	11.9	15.2	8.8	20.3	20.2	10.9	18.1	24.1	13.4	15.7	12.2	14.9	15.9	33.4	19.6	16.4	8.3	12.5	9.9	11.0	6.4	10.7	14.4	37.4	7.1	11.9	13.4	11.0	4.6	9.1	11.3	7.8	1.3	6.5	2.6	23.0	10.0	4.3	3.6	3.9	5.3	29.3	5.4	5.2	5.5	5.9	10.7	8.8	9.3	14.8	5.3	10.6	9.9	5.6	8.6	9.9	11.8	6.3	42.0	6.8	6.4	4.0	10.2	66.6	4.5	6.6	3.8	7.8	9.8	8.3	4.5	16.0	6.9	6.9	10.6	5.9	7.2	6.2	17.0	9.4	4.3	4.5	6.6	8.5	12.8	3.7	2.7	15.0	6.5	19.3	13.2	16.3	24.4	8.7	3.5	4.5	7.7	7.6	11.7	7.6	8.5	8.6	9.9	4.9	7.0	7.8	11.3	4.0	4.5	2.7	4.6	5.2	3.0	9.1	4.1	6.5	4.4	10.0	1.3	4.3	1.4	2.2	2.6	10.6	20.6	29.9	25.0	12.2	14.2	11.9	15.2	24.1	10.7	8.9	14.7	4.7	12.9	16.9	15.4	30.2	12.7	14.7	21.6	17.4	23.6	29.1	5.0	9.4	0.9	8.5	21.3	0.0	16.5	46.3	6.5	23.0	13.9	15.8	13.4	20.6	15.6	11.6	28.8	1.1	3.4	19.7	6.8	14.4	14.9	8.2	15.2	21.8	6.3	18.9	17.9	6.5	6.1	10.7	14.9	20.5	40.0	6.1	12.7	15.3
PIK3CD	p110D	ENSG00000171608	"Phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit delta"	O00329	1	9651732-9729114	"Disease related genes, Enzymes, FDA approved drug targets, Predicted intracellular proteins, RAS pathway related proteins"	"Adaptive immunity, Chemotaxis, Differentiation, Immunity, Inflammatory response, Innate immunity"	"Kinase, Transferase"	"Disease mutation, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 35.0;bone marrow: 32.8;lymphoid tissue: 40.3"	"Cell type enhanced"	"Detected in many"	7	"Alveolar cells type 2: 20.7;granulocytes: 24.3;Kupffer cells: 28.8;T-cells: 30.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HDLM-2: 51.7;NB-4: 22.4;REH: 23.3;THP-1: 22.5;U-937: 26.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB015420, HPA044953"	Enhanced		Approved	"Vesicles,Cytokinetic bridge"		Yes	No			Vesicles	"Cytokinetic bridge"	"CAB015420: AB_831654, HPA044953: AB_2679153"	"unprognostic (5.73e-3)"	"unprognostic (2.75e-3)"	"unprognostic (8.93e-2)"	"unprognostic (4.05e-2)"	"unprognostic (4.71e-2)"	"unprognostic (1.40e-2)"	"unprognostic (2.13e-1)"	"unprognostic (7.42e-2)"	"unprognostic (2.78e-2)"	"unprognostic (1.54e-2)"	"unprognostic (3.46e-2)"	"unprognostic (6.75e-2)"	"unprognostic (8.65e-3)"	"unprognostic (2.09e-1)"	"unprognostic (1.34e-1)"	"unprognostic (2.04e-1)"	"unprognostic (6.78e-2)"	4.5	2.1	3.4	34.8	7.1	32.8	2.9	3.3	4.3	3.2	3.3	5.5	0.7	3.1	3.7	3.4	3.5	4.0	6.5	2.9	4.2	3.1	4.6	3.3	8.2	40.3	7.4	1.8	5.3	2.2	2.3	2.2	3.3	4.6	3.2	2.1	3.1	11.2	1.8	0.9	2.0	11.4	2.9	5.3	35.5	3.3	3.0	5.7	23.5	4.1	2.3	36.0	5.8	3.6	8.4	14.5	35.0	15.0	14.5	13.7	16.6	2.7	1.8	0.1	0.5	0.4	0.4	0.2	4.2	8.6	9.2	7.6	0.1	1.1	7.3	1.7	3.3	4.4	0.8	0.7	3.8	5.8	51.7	0.1	0.8	0.4	3.0	1.8	18.8	6.6	1.5	1.6	10.3	3.5	4.0	1.3	5.2	2.6	0.0	5.2	0.2	1.8	22.4	0.8	0.1	0.5	23.3	4.6	0.2	3.9	0.0	0.6	0.5	0.9	1.7	4.1	2.5	0.3	22.5	3.4	2.7	2.8	0.0	3.9	1.7	1.6	10.2	5.9	26.9	1.5	9.6	11.8	21.1	12.9	13.1	13.7	7.8	9.8	11.8	12.5	8.4	12.9	13.4	35.0	14.5	15.0	14.5	7.4	16.6	3.4	7.1	3.3	4.3	4.2	3.1	7.4	1.8	4.6	5.7	8.9	20.7	7.8	1.8	1.3	0.4	2.7	0.0	1.4	1.2	0.0	2.0	0.1	1.7	3.1	2.0	1.6	0.0	0.0	1.8	0.3	1.4	2.5	24.3	0.0	12.5	0.0	0.0	3.7	28.8	1.7	1.1	13.4	3.3	1.0	0.0	2.5	7.7	0.0	1.4	2.9	1.6	6.5	3.8	1.1	2.1	1.0	0.2	30.5	0.1	2.0
PIK3CG		ENSG00000105851	"Phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit gamma"	P48736	7	106865278-106907145	"Cancer-related genes, Enzymes, Predicted intracellular proteins"	"Angiogenesis, Chemotaxis, Endocytosis, Immunity, Inflammatory response"	"Kinase, Serine/threonine-protein kinase, Transferase"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"blood: 24.5;bone marrow: 27.8;lymphoid tissue: 40.8"	"Cell type enhanced"	"Detected in some"	8	"B-cells: 17.3;Early spermatids: 26.6;granulocytes: 19.7;monocytes: 24.4;T-cells: 17.5"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in some"		"Daudi: 12.4;HL-60: 12.1;HMC-1: 15.5;Karpas-707: 12.9;MOLT-4: 23.5;U-266/70: 31.5;U-937: 22.2"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA069976	Enhanced		Supported	"Plasma membrane,Cytosol"		NA	NA			"Plasma membrane"	Cytosol	"HPA069976: AB_2686224"	"unprognostic (8.34e-2)"	"unprognostic (2.01e-2)"	"unprognostic (1.44e-2)"	"unprognostic (1.71e-2)"	"unprognostic (3.20e-2)"	"unprognostic (3.82e-3)"	"unprognostic (3.02e-1)"	"unprognostic (6.77e-2)"	"unprognostic (1.16e-1)"	"unprognostic (7.06e-3)"	"unprognostic (1.15e-1)"	"unprognostic (1.97e-1)"	"unprognostic (1.77e-2)"	"unprognostic (9.08e-2)"	"unprognostic (1.23e-1)"	"unprognostic (5.38e-1)"	"unprognostic (5.24e-2)"	5.0	1.8	2.2	16.0	3.1	27.8	2.3	0.8	1.7	1.7	4.1	2.7	0.0	2.8	1.7	2.0	2.0	1.8	3.5	1.7	1.7	1.5	1.9	1.5	4.3	13.1	3.0	1.0	1.7	1.5	0.6	1.4	2.0	2.5	2.2	2.6	1.9	3.1	0.5	1.1	1.3	6.1	1.9	6.4	17.4	2.5	7.6	3.0	40.8	2.3	0.9	21.2	4.1	1.5	6.2	5.6	14.2	24.5	5.3	5.6	3.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	12.4	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	7.6	0.0	0.0	0.0	12.1	15.5	0.0	0.0	0.0	0.0	0.0	4.8	7.4	8.6	12.9	0.0	0.0	23.5	4.6	0.0	0.0	0.0	6.2	0.0	8.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.3	1.2	0.0	0.1	0.0	0.0	31.5	0.0	11.7	0.0	22.2	2.9	4.6	3.4	14.2	5.6	10.6	5.1	4.7	2.6	4.2	5.6	6.2	2.8	3.8	13.9	5.3	24.5	4.9	2.6	3.6	2.2	3.1	0.8	1.7	1.7	1.5	3.0	1.0	2.5	3.0	0.0	2.6	17.3	0.0	0.7	0.0	0.3	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	26.6	0.9	0.0	0.0	0.0	0.0	0.1	0.0	19.7	0.5	5.9	0.0	0.0	1.8	11.0	12.8	0.6	13.3	6.8	24.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.2	3.1	0.3	0.1	17.5	0.0	0.0
PIK3R1	"GRB1, p85, p85-ALPHA"	ENSG00000145675	"Phosphoinositide-3-kinase regulatory subunit 1"	P27986	5	68215720-68301821	"Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins, RAS pathway related proteins"	"Host-virus interaction, Protein transport, Stress response, Transport"		"Cancer-related genes, Disease mutation, Dwarfism"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	6	"Cardiomyocytes: 241.2;Leydig cells: 159.3;Muller glia cells: 180.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"ASC diff: 73.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA001216, CAB004268"	Approved		Supported	Cytosol		NA	NA			Cytosol		"CAB004268: AB_628126, HPA001216: AB_1079612"	"unprognostic (5.74e-2)"	"unprognostic (6.58e-2)"	"unprognostic (2.01e-1)"	"unprognostic (1.31e-2)"	"unprognostic (1.18e-1)"	"unprognostic (1.33e-2)"	"prognostic favorable (8.09e-4)"	"unprognostic (3.78e-3)"	"unprognostic (1.78e-1)"	"unprognostic (2.71e-1)"	"unprognostic (6.10e-2)"	"unprognostic (1.32e-1)"	"unprognostic (4.59e-3)"	"unprognostic (5.66e-3)"	"unprognostic (1.27e-1)"	"unprognostic (5.92e-2)"	"unprognostic (1.54e-1)"	26.2	13.4	26.0	13.0	24.3	51.6	42.3	15.3	50.3	27.1	20.3	12.8	12.8	8.1	41.3	22.1	20.8	33.0	18.1	33.9	24.0	13.4	17.9	46.5	16.3	12.0	22.0	40.8	25.8	6.8	22.3	9.4	15.0	18.2	15.2	10.8	8.7	54.6	16.2	48.9	19.1	16.1	36.3	17.6	18.8	13.1	7.6	23.6	16.2	12.8	8.5	10.8	25.2	24.4	2.2	2.1	10.6	4.1	8.2	14.8	4.0	1.1	2.1	6.4	19.1	73.1	21.4	2.8	6.1	2.8	2.3	2.5	5.3	1.9	5.6	10.5	8.4	1.1	2.6	1.8	12.4	3.0	23.5	2.3	6.7	1.8	4.3	24.6	6.9	5.4	22.6	28.2	4.3	22.9	1.1	3.1	6.6	1.0	4.3	2.1	2.9	16.7	2.7	1.8	3.8	1.1	15.8	3.0	4.4	3.1	12.6	1.2	5.8	1.0	1.6	4.0	3.9	9.2	4.9	3.7	2.8	2.8	4.6	3.8	4.8	7.1	6.5	3.0	8.6	2.0	10.6	1.2	5.9	9.2	1.7	12.7	1.2	11.5	8.4	2.1	2.2	14.8	10.8	1.5	8.2	4.1	0.9	8.5	4.0	26.0	24.3	15.3	50.3	24.0	13.4	22.0	40.8	18.2	23.6	47.6	25.6	14.3	14.9	12.8	45.1	241.2	28.1	12.0	27.3	5.2	23.6	12.3	61.3	13.7	9.4	23.1	20.0	0.0	8.1	13.0	36.6	8.2	66.0	142.1	25.9	46.1	9.2	39.9	52.0	6.8	159.3	29.5	32.1	21.6	24.8	180.6	9.7	19.3	114.9	31.6	85.9	19.4	26.7	0.9	2.6	8.9	8.4	132.3	21.7	6.0
PIK3R2	"p85, P85B"	ENSG00000105647	"Phosphoinositide-3-kinase regulatory subunit 2"	O00459	19	18153118-18170540	"Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins, RAS pathway related proteins"	"Protein transport, Stress response, Transport"		"Cancer-related genes, Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	7	"Erythroid cells: 23.3;Undifferentiated cells: 15.3"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											HPA069291	Approved		Approved	"Golgi apparatus"		NA	NA			"Golgi apparatus"		"HPA069291: AB_2686109"	"unprognostic (2.50e-1)"	"unprognostic (1.90e-3)"	"unprognostic (1.68e-2)"	"unprognostic (1.87e-1)"	"unprognostic (2.00e-2)"	"unprognostic (9.65e-3)"	"unprognostic (1.69e-3)"	"unprognostic (2.36e-3)"	"unprognostic (9.24e-2)"	"unprognostic (4.28e-2)"	"unprognostic (1.17e-1)"	"unprognostic (3.36e-1)"	"unprognostic (1.69e-2)"	"unprognostic (2.02e-1)"	"unprognostic (6.35e-3)"	"unprognostic (8.63e-2)"	"unprognostic (2.00e-2)"	6.4	20.9	27.5	7.2	30.1	10.1	7.2	14.4	36.6	14.5	13.5	11.4	6.7	21.7	13.9	12.0	19.0	17.8	17.2	12.5	33.2	11.5	10.3	10.3	8.4	6.3	10.1	18.1	20.2	13.0	24.3	16.7	10.2	7.9	11.6	10.1	11.4	14.5	11.9	10.9	26.2	16.5	11.1	7.4	7.1	15.9	9.8	11.0	11.3	9.0	9.4	10.4	13.9	11.6	2.5	1.9	3.1	1.8	1.9	3.2	0.8	19.0	9.8	13.4	17.9	17.9	18.0	20.2	15.2	19.2	11.5	8.5	10.0	9.3	15.1	24.2	21.2	8.0	14.3	8.0	16.6	6.4	12.3	29.4	5.7	13.3	23.8	14.3	13.0	7.0	22.5	16.4	7.7	11.8	17.3	2.8	5.5	16.3	5.5	14.1	29.7	8.9	11.1	15.6	15.2	21.9	9.4	18.7	11.5	16.4	14.1	30.1	34.2	14.4	13.9	13.2	8.1	8.9	7.2	5.7	20.5	10.6	25.3	13.5	10.3	13.1	6.8	16.3	19.0	12.9	0.7	1.7	3.1	3.2	1.8	2.0	2.5	1.7	1.5	1.9	2.3	1.6	1.8	1.0	1.9	1.0	1.4	0.3	0.8	27.5	30.1	14.4	36.6	33.2	11.5	10.1	18.1	7.9	11.0	6.0	1.4	0.0	1.2	1.6	5.3	1.1	2.5	0.0	1.2	3.5	3.9	1.4	0.0	5.0	0.2	0.2	8.0	23.3	5.4	2.3	2.2	0.3	2.3	1.0	1.8	9.5	5.8	1.3	6.4	0.0	1.7	1.2	0.0	1.8	11.5	4.5	5.5	2.9	1.8	0.6	3.9	0.0	1.9	0.5	1.5	1.9	1.0	0.0	15.3	0.4
PIK3R3	p55	ENSG00000117461	"Phosphoinositide-3-kinase regulatory subunit 3"	Q92569	1	46040140-46133036	"Cancer-related genes, Predicted intracellular proteins, RAS pathway related proteins"			"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	5	"Bipolar cells: 44.0;Cone photoreceptor cells: 43.2;Endothelial cells: 43.8;Rod photoreceptor cells: 44.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"eosinophil: 8.6"	"Group enriched"	"Detected in many"	8	"granulocytes: 8.6;monocytes: 3.1;T-cells: 3.5"	"Cell line enhanced"	"Detected in many"		"RT4: 33.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA005751, HPA071988"	Approved		Approved	Nucleoplasm,Vesicles		NA	NA			Vesicles	Nucleoplasm	"HPA005751: AB_1855350, HPA071988: AB_2686479"	"unprognostic (1.98e-1)"	"unprognostic (3.75e-3)"	"unprognostic (8.04e-2)"	"prognostic favorable (1.93e-4)"	"unprognostic (6.32e-2)"	"prognostic favorable (3.62e-4)"	"unprognostic (4.88e-2)"	"unprognostic (3.33e-3)"	"unprognostic (4.16e-2)"	"unprognostic (4.63e-2)"	"unprognostic (1.05e-2)"	"unprognostic (1.45e-1)"	"unprognostic (9.99e-3)"	"unprognostic (2.87e-2)"	"unprognostic (9.74e-2)"	"unprognostic (6.71e-2)"	"unprognostic (8.22e-3)"	33.7	10.9	7.4	7.0	8.2	0.8	24.7	36.4	11.0	16.9	6.3	3.5	9.1	3.3	15.8	11.0	8.4	7.6	10.9	28.7	6.8	8.5	10.4	4.1	20.0	6.0	8.7	3.1	4.6	4.0	18.7	10.2	13.4	10.4	9.0	5.3	13.6	9.4	8.0	14.8	4.6	6.0	12.3	7.1	10.9	7.4	24.0	4.5	5.9	12.7	6.2	5.3	12.3	8.7	0.5	0.6	8.6	3.1	0.1	3.5	0.9	4.7	1.6	21.6	10.9	2.1	0.9	6.9	2.8	2.0	3.7	4.6	0.9	1.4	6.2	8.6	1.1	4.5	2.8	7.5	2.6	2.4	4.8	6.7	3.9	19.4	0.7	0.7	3.5	5.4	2.7	1.5	3.9	1.4	3.6	7.7	14.5	1.4	4.5	5.2	7.2	14.1	2.2	7.6	1.3	4.3	18.2	5.7	7.4	9.3	33.6	15.6	11.3	9.1	24.1	2.6	13.5	6.7	3.2	14.3	4.0	3.7	0.6	2.7	6.4	6.6	3.8	3.1	4.7	2.0	0.0	0.3	8.6	3.3	0.5	3.0	0.5	0.8	2.9	0.0	0.0	0.3	1.9	0.1	0.1	3.1	0.6	3.5	0.9	7.4	8.2	36.4	8.9	6.8	8.5	8.7	3.1	10.4	4.5	0.0	9.6	0.0	3.0	2.3	44.0	17.3	0.0	17.4	5.7	17.4	43.2	4.0	0.0	0.4	8.7	43.8	5.1	0.0	1.0	1.0	4.5	7.4	9.2	0.0	1.4	3.2	7.5	0.0	0.0	12.1	1.1	1.8	5.0	1.0	1.5	30.4	1.3	1.1	7.4	3.4	44.4	0.0	12.5	29.2	28.5	1.6	1.1	1.5	1.7	3.3
PIK3R5	"p101, P101-PI3K"	ENSG00000141506	"Phosphoinositide-3-kinase regulatory subunit 5"	Q8WYR1	17	8878911-8965712	"Disease related genes, Predicted intracellular proteins"			"Disease mutation, Neurodegeneration"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 51.0"	"Cell type enhanced"	"Detected in some"	9	"B-cells: 14.4;Hofbauer cells: 16.8;Kupffer cells: 22.6;Macrophages: 26.2;monocytes: 12.6;T-cells: 17.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in some"		"HDLM-2: 28.0;HMC-1: 4.2;JURKAT: 10.1;U-937: 8.1"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA044505, HPA052247, HPA052412"	Uncertain		Supported	"Centriolar satellite,Cytosol"		No	NA			Cytosol	"Centriolar satellite"	"HPA044505: AB_2678964, HPA052247: AB_2681772, HPA052412: AB_2681823"	"unprognostic (2.81e-1)"	"unprognostic (1.31e-2)"	"unprognostic (3.10e-2)"	"unprognostic (2.37e-2)"	"unprognostic (3.44e-2)"	"unprognostic (9.89e-3)"	"unprognostic (1.42e-1)"	"unprognostic (5.70e-2)"	"unprognostic (1.38e-1)"	"unprognostic (7.95e-2)"	"unprognostic (1.33e-2)"	"unprognostic (2.66e-1)"	"unprognostic (7.59e-3)"	"unprognostic (6.89e-2)"	"unprognostic (1.09e-1)"	"unprognostic (1.94e-1)"	"unprognostic (1.24e-1)"	13.8	4.1	2.0	13.0	3.4	51.0	7.2	0.6	1.8	2.1	5.6	3.6	0.0	2.5	1.9	3.1	3.1	3.8	5.7	3.1	3.4	1.6	2.7	2.4	16.4	22.9	5.0	0.6	2.5	1.8	0.7	1.3	2.3	3.0	2.7	2.1	2.4	3.1	1.0	1.0	1.8	10.4	2.9	5.3	23.8	2.6	4.0	2.5	17.6	2.2	1.9	12.4	4.5	2.8	3.6	8.0	23.8	12.1	5.7	13.6	9.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	28.0	0.3	1.0	0.0	0.0	0.0	0.4	4.2	0.0	0.0	0.0	0.0	0.0	0.0	10.1	0.0	0.0	0.0	0.2	1.0	1.8	0.4	0.0	0.0	3.4	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	3.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.1	0.0	4.9	10.6	3.7	13.6	10.0	8.8	3.2	7.5	11.4	8.0	3.6	5.8	8.9	23.8	5.7	12.1	6.4	9.2	9.5	2.0	3.4	0.6	1.8	3.4	1.6	5.0	0.6	3.0	2.5	0.0	9.6	14.4	0.0	0.9	0.0	2.0	2.5	0.0	0.0	0.0	0.0	0.1	0.0	0.1	3.9	0.0	0.0	0.0	0.0	0.2	1.1	0.1	4.7	0.2	16.8	0.0	0.0	1.8	22.6	6.3	0.3	26.2	1.7	12.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.3	0.4	0.6	0.3	17.9	0.0	0.0
PIK3R6	"C17orf38, FLJ34500, HsT41028, p87PIKAP"	ENSG00000276231	"Phosphoinositide-3-kinase regulatory subunit 6"	Q5UE93	17	8802723-8867677	"Predicted intracellular proteins"	Angiogenesis			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 32.1;lymphoid tissue: 12.2"	"Cell type enhanced"	"Detected in some"	26	"Early spermatids: 8.7;granulocytes: 45.2;Late spermatids: 13.8"	"Low cancer specificity"	"Detected in many"							"Cell type enriched"	"Detected in many"	4	"eosinophil: 32.1"	"Lineage enriched"	"Detected in many"	7	"granulocytes: 32.1"	"Cell line enriched"	"Detected in some"	8	"HMC-1: 58.9"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA023077	Approved		Approved	"Nucleoplasm,Golgi apparatus,Plasma membrane,Cytosol"		NA	NA			"Nucleoplasm, Golgi apparatus"	"Plasma membrane, Cytosol"	"HPA023077: AB_1854909"	"unprognostic (4.29e-2)"	"unprognostic (8.56e-3)"	"unprognostic (9.39e-2)"	"unprognostic (5.96e-3)"	"unprognostic (2.46e-1)"	"unprognostic (5.25e-3)"	"unprognostic (4.50e-3)"	"unprognostic (2.29e-2)"	"unprognostic (3.12e-2)"	"unprognostic (3.14e-1)"	"unprognostic (2.20e-2)"	"unprognostic (1.38e-1)"	"prognostic unfavorable (1.50e-6)"	"unprognostic (3.45e-1)"	"unprognostic (3.91e-2)"	"unprognostic (2.68e-1)"	"unprognostic (8.98e-2)"	2.2	0.0	2.1	12.2	5.4	5.3	1.0	0.0	3.7	1.5	1.9	2.5	1.4	3.5	2.6	2.3	1.2	0.4	6.6	2.6	3.1		0.0	0.6	3.4	4.4	2.5	0.0	0.3	0.8	0.3	0.0	1.4	3.2	2.4	1.5	1.4	0.9	0.7	1.0	1.8	5.2	2.2	3.1	6.3	2.3	1.1	2.7	6.9	0.0	0.8	6.4	3.0	3.3	1.3	4.9	32.1	4.3	0.5	0.2	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.5	0.0	7.5	0.0	0.0	0.0	0.0	58.9	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	7.7	3.4	32.1	0.2	4.3	0.2	1.3	0.0	0.1	4.9	0.1	0.0	0.1	0.5	0.5	3.3	0.0	0.0	1.4											0.0	2.2	0.0	0.0	0.5	0.0	0.4	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	8.7	0.0	0.0	0.0	0.0	0.1	0.2	0.0	45.2	0.0	6.3	0.0	0.0	0.0	2.6	13.8	0.0	3.2	1.7	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.3	0.0	0.0	0.1	0.0	1.5	0.0	0.0
PIKFYVE	"FAB1, KIAA0981, MGC40423, p235, PIKfyve, PIP5K, PIP5K3, ZFYVE29"	ENSG00000115020	"Phosphoinositide kinase, FYVE-type zinc finger containing"	Q9Y2I7	2	208266267-208358751	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"		"Kinase, Transferase"	"Corneal dystrophy, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA042558, HPA042604"	Uncertain		Supported	Vesicles		NA	NA			Vesicles		"HPA042558: , HPA042604: AB_10796580"	"unprognostic (1.00e-1)"	"unprognostic (1.67e-1)"	"unprognostic (1.88e-1)"	"unprognostic (3.03e-1)"	"unprognostic (2.04e-2)"	"prognostic favorable (6.81e-4)"	"unprognostic (6.82e-3)"	"unprognostic (6.45e-2)"	"unprognostic (1.85e-2)"	"unprognostic (3.81e-2)"	"unprognostic (1.77e-1)"	"unprognostic (2.10e-2)"	"unprognostic (1.32e-1)"	"unprognostic (2.14e-1)"	"unprognostic (3.29e-1)"	"unprognostic (1.06e-1)"	"unprognostic (7.05e-2)"	15.9	13.5	17.7	21.1	21.9	36.1	24.9	25.6	23.1	14.8	12.1	14.0	16.6	9.1	14.7	18.3	11.2	12.6	11.1	12.5	19.4	14.3	16.2	15.2	16.5	23.1	14.4	15.3	15.6	31.5	21.5	17.0	14.1	20.6	17.7	11.5	13.8	13.7	19.7	13.6	12.9	15.3	13.5	24.4	21.7	12.1	19.3	15.8	23.5	18.2	7.8	22.6	12.4	14.0	7.5	2.1	1.4	1.2	5.6	2.6	0.5	4.9	5.0	12.0	9.3	12.1	14.5	5.6	6.2	12.6	7.3	10.0	7.2	4.2	5.8	6.5	10.5	14.3	5.2	10.4	6.9	12.4	4.9	6.6	20.7	9.8	6.4	9.2	18.3	18.7	10.7	7.6	8.5	15.9	12.2	11.8	15.5	14.0	10.5	9.1	2.1	16.5	13.8	9.9	3.8	3.8	6.2	9.3	7.9	9.3	7.3	3.8	9.1	6.8	4.4	12.3	14.7	2.8	19.8	13.5	9.2	6.1	6.1	5.7	7.3	8.7	12.4	7.3	16.0	9.0	1.4	1.0	0.7	1.7	0.8	1.1	7.5	2.3	2.6	0.9	5.4	1.8	2.1	1.4	5.6	1.2	2.1	1.5	0.5	17.7	21.9	25.6	23.1	19.4	14.3	14.4	15.3	20.6	15.8	23.8	14.4	13.7	6.0	13.6	20.7	14.4	12.7	8.1	10.3	10.4	15.7	6.1	5.0	4.6	5.2	14.8	9.3	0.0	3.7	4.4	12.2	15.4	34.7	16.6	12.2	9.5	17.9	18.4	27.6	5.9	17.3	20.4	10.1	2.8	8.9	14.8	7.1	6.2	12.7	8.1	19.0	12.9	12.2	27.2	22.8	13.4	6.1	10.2	7.8	7.0
PIP4K2A	"PIP5K2A, PIP5KIIA, PIP5KIIalpha"	ENSG00000150867	"Phosphatidylinositol-5-phosphate 4-kinase type 2 alpha"	P48426	10	22534849-22714555	"Enzymes, Plasma proteins, Predicted intracellular proteins"		"Kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 92.0"	"Cell type enhanced"	"Detected in all"	7	"Erythroid cells: 93.5;Melanocytes: 99.5;T-cells: 152.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA065440, HPA068771"	Supported		Approved	"Golgi apparatus,Plasma membrane,Cytosol"		NA	NA		8800000	"Golgi apparatus"	"Plasma membrane, Cytosol"	"HPA065440: AB_2685490, HPA068771: AB_2686030"	"unprognostic (1.11e-1)"	"unprognostic (2.71e-3)"	"unprognostic (1.57e-3)"	"unprognostic (4.20e-3)"	"unprognostic (1.55e-1)"	"unprognostic (8.80e-3)"	"unprognostic (1.56e-3)"	"unprognostic (7.32e-2)"	"unprognostic (1.68e-1)"	"unprognostic (7.08e-2)"	"unprognostic (1.29e-1)"	"unprognostic (1.21e-1)"	"prognostic unfavorable (1.46e-4)"	"unprognostic (1.52e-3)"	"unprognostic (2.51e-1)"	"unprognostic (1.38e-1)"	"unprognostic (7.92e-3)"	13.0	7.3	43.8	20.3	63.8	17.3	6.9	6.6	41.4	13.2	7.8	75.5	1.0	5.9	9.9	5.6	9.2	7.2	15.1	5.9	56.0	31.7	7.6	8.3	11.5	33.4	65.7	22.9	4.3	4.9	29.5	4.2	10.5	36.5	4.4	9.0	5.7	3.9	6.3	2.6	4.0	8.1	14.4	92.0	26.6	8.4	5.4	59.8	10.1	5.9	1.0	38.5	11.5	5.8	14.7	12.0	26.3	16.6	38.4	46.7	39.3	8.9	8.8	10.3	3.3	16.5	22.5	7.8	16.6	17.7	9.0	11.1	8.2	14.3	18.7	6.0	33.3	19.8	3.1	8.9	4.6	9.1	41.4	9.3	35.2	6.4	18.1	29.3	6.7	27.6	11.2	4.2	12.2	11.9	13.9	13.3	25.3	19.5	36.6	16.6	3.7	26.9	6.0	4.2	4.3	6.3	10.9	14.7	25.4	13.3	1.7	1.8	4.3	5.3	2.7	26.4	12.2	2.3	11.7	16.0	7.0	10.2	12.8	10.1	23.3	13.1	13.6	18.9	20.5	5.3	16.1	8.8	26.3	34.5	15.6	46.7	14.7	27.5	40.0	11.6	8.6	18.6	34.9	10.9	38.4	16.6	12.0	19.6	39.3	43.8	63.8	6.6	30.3	56.0	31.7	65.7	22.9	36.5	59.8	3.0	7.9	43.2	3.6	15.7	4.1	6.8	15.3	1.4	7.9	17.4	2.0	6.7	10.0	8.7	15.7	24.8	2.6	93.5	9.3	4.0	17.1	5.4	22.0	6.4	27.8	12.7	4.7	68.2	77.2	23.8	15.5	49.0	99.5	85.6	2.8	4.0	16.5	3.5	9.6	9.8	8.1	19.4	21.1	4.1	2.3	14.8	10.4	152.2	2.3	5.5
PIP4K2B	"PIP5K2B, PIP5KIIB, PIP5KIIbeta"	ENSG00000276293	"Phosphatidylinositol-5-phosphate 4-kinase type 2 beta"	P78356	17	38765689-38800126	"Cancer-related genes, Enzymes, Predicted intracellular proteins"		"Kinase, Transferase"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 23.6"	"Cell type enhanced"	"Detected in many"	5	"Horizontal cells: 41.3"	"Low cancer specificity"	"Detected in all"							"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA062220			Supported	Nucleoplasm		NA	NA			Nucleoplasm		"HPA062220: AB_2684715"	"unprognostic (7.77e-2)"	"unprognostic (8.37e-2)"	"unprognostic (3.74e-2)"	"unprognostic (1.13e-1)"	"unprognostic (2.67e-1)"	"unprognostic (1.91e-1)"	"prognostic unfavorable (4.54e-4)"	"unprognostic (2.64e-1)"	"unprognostic (2.33e-1)"	"unprognostic (1.50e-2)"	"unprognostic (6.10e-3)"	"unprognostic (3.79e-1)"	"unprognostic (4.82e-3)"	"unprognostic (3.38e-2)"	"unprognostic (3.22e-1)"	"prognostic favorable (1.36e-4)"	"unprognostic (2.48e-1)"	5.1	6.5	12.4	3.3	12.9	1.1	5.0	8.8	17.4	6.8	2.7	7.0	4.2	2.2	7.2	5.9	3.5	7.4	3.6	7.1	9.6		4.1	2.2	5.0	4.2	5.4	13.3	13.3	3.0	5.1	2.7	5.4	7.5	5.1	3.2	4.1	3.8	6.5	23.6	5.8	2.3	7.3	4.7	5.1	2.5	2.8	6.5	2.0	4.7	2.2	4.5	3.7	5.9	3.3	3.1	2.4	2.4	3.4	5.0	3.7	5.7	12.7	21.2	22.0	18.5	14.7	4.3	10.8	12.0	13.6	11.2	8.6	5.7	14.8	6.8	18.4	11.9	12.4	14.0	8.9	13.1	10.2	9.0	12.8	8.2	12.6	8.4	14.6	7.9	12.9	10.9	10.6	7.9	19.2	11.3	15.4	11.2	7.0	14.6	4.3	13.4	10.7	11.8	6.4	5.9	14.6	20.9	8.1	10.0	7.2	11.8	17.1	10.9	4.4	11.0	23.1	14.0	13.8	11.9	11.5	7.6	9.9	9.3	9.2	11.5	6.7	13.7	11.6	10.4	1.6	2.4	0.8	4.8	2.2	5.0	3.1	4.1	4.6	3.1	3.3	4.7	4.2	2.4	3.4	1.8	3.0	3.9	3.7											17.9	10.7	3.7	3.7	5.5	33.8	18.9	7.6	4.0	9.1	5.2	9.8	6.3	1.7	4.7	8.7	14.6	3.9	0.0	4.2	4.1	8.5	4.5	1.1	9.8	7.5	41.3	11.1	20.3	8.3	13.7	14.1	5.7	1.7	1.8	6.9	12.9	5.4	3.5	15.6	6.7	13.4	6.5	7.2	4.6	8.1	3.9	2.1	7.2	7.3	1.8
PIP4K2C	"FLJ22055, PIP5K2C"	ENSG00000166908	"Phosphatidylinositol-5-phosphate 4-kinase type 2 gamma"	Q8TBX8	12	57591174-57603418	"Enzymes, Predicted intracellular proteins"		"Kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	8	"Cardiomyocytes: 112.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"RH-30: 49.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA028658	Approved		Supported	"Nucleoplasm,Plasma membrane,Cytosol"		NA	NA			Cytosol	"Nucleoplasm, Plasma membrane"	"HPA028658: AB_10601245"	"unprognostic (7.84e-3)"	"unprognostic (1.51e-1)"	"unprognostic (2.42e-1)"	"unprognostic (2.77e-2)"	"unprognostic (2.49e-2)"	"unprognostic (3.37e-2)"	"prognostic unfavorable (7.98e-4)"	"unprognostic (3.17e-2)"	"unprognostic (6.00e-2)"	"unprognostic (5.51e-2)"	"unprognostic (1.75e-1)"	"unprognostic (1.88e-1)"	"prognostic favorable (2.06e-6)"	"unprognostic (1.87e-1)"	"unprognostic (2.16e-1)"	"unprognostic (3.27e-1)"	"unprognostic (3.42e-1)"	9.3	13.3	13.9	9.2	25.9	16.7	15.0	18.9	45.5	12.5	17.5	14.6	15.8	11.6	14.2	62.0	20.0	20.0	12.1	10.8	15.4	10.9	26.9	14.4	14.4	9.2	14.3	21.2	12.3	14.9	29.6	13.7	11.1	18.8	16.7	19.4	17.4	18.6	14.6	9.4	18.4	13.3	11.9	12.7	10.7	27.6	25.6	12.1	5.9	17.9	8.5	13.1	14.6	14.1	6.8	5.4	29.7	8.4	9.4	16.1	6.5	19.1	13.5	5.5	6.6	0.0	0.0	17.8	8.0	15.0	14.5	13.5	17.2	27.7	4.1	17.6	9.3	17.9	17.5	9.0	15.7	11.7	6.2	10.1	7.5	6.5	12.1	12.8	6.9	13.5	5.0	26.7	5.5	10.3	17.8	7.3	4.6	9.6	12.6	7.5	18.9	6.2	6.0	10.5	11.7	11.8	0.1	49.9	6.2	15.2	32.8	9.3	11.5	17.2	11.5	10.9	19.4	31.6	6.4	1.6	7.3	10.1	10.7	8.4	9.7	11.3	9.3	14.4	5.9	12.1	29.7	5.2	15.3	16.1	6.2	10.7	5.9	9.9	12.0	5.4	6.8	9.6	11.5	10.2	9.4	8.4	2.3	12.1	6.5	13.9	25.9	18.9	45.5	15.4	10.9	14.3	21.2	18.8	12.1	8.9	7.5	3.0	5.7	11.0	13.1	112.2	15.3	13.4	9.1	33.2	17.7	9.3	18.3	16.2	23.8	3.5	18.0	0.0	17.1	13.6	4.9	9.9	3.5	11.6	7.9	7.9	21.4	9.8	2.9	35.3	6.4	4.1	11.8	8.2	16.1	6.5	28.1	13.6	4.9	10.1	8.3	19.4	6.4	11.9	7.1	11.2	14.5	8.7	8.6	7.1
PIP4P1	"C14orf9, MGC26684, TMEM55B"	ENSG00000165782	"Phosphatidylinositol-4,5-bisphosphate 4-phosphatase 1"	Q86T03	14	20457719-20461612	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins"		Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	14	"Cytotrophoblasts: 66.6;Hofbauer cells: 47.2;Syncytiotrophoblasts: 139.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA048528	Approved					NA	NA					"HPA048528: AB_2680427"	"unprognostic (1.84e-1)"	"unprognostic (6.23e-2)"	"unprognostic (1.81e-1)"	"unprognostic (7.07e-2)"	"unprognostic (2.04e-1)"	"unprognostic (8.51e-2)"	"unprognostic (1.71e-2)"	"unprognostic (3.37e-3)"	"unprognostic (4.94e-2)"	"unprognostic (1.33e-1)"	"unprognostic (7.78e-3)"	"unprognostic (1.85e-1)"	"prognostic favorable (1.01e-4)"	"unprognostic (4.80e-2)"	"unprognostic (1.47e-1)"	"unprognostic (7.53e-2)"	"unprognostic (1.96e-1)"	15.9	16.8	19.7	15.1	24.7	42.2	15.6	23.8	41.0	14.4	19.2	22.9	12.6	17.9	15.6	29.3	16.5	16.4	18.0	15.9	20.2	23.5	18.7	17.7	17.3	16.8	18.9	22.2	15.3	21.1	28.4	20.0	22.6	28.5	16.1	16.5	20.3	16.1	17.2	22.2	22.1	22.1	16.7	17.0	22.0	18.0	13.3	18.5	14.2	17.7	12.8	20.8	17.5	14.0	13.3	10.6	6.9	3.3	4.6	6.6	2.4	10.3	16.3	11.0	12.8	17.3	10.7	20.3	9.8	19.4	13.5	16.5	9.6	16.9	9.3	8.5	12.4	39.5	10.9	13.4	10.9	12.0	12.3	9.9	6.7	7.8	14.1	23.6	12.3	13.8	13.9	14.9	15.6	16.0	12.4	12.5	14.5	5.6	19.1	11.2	11.8	16.7	10.9	7.3	16.4	22.5	12.4	10.6	6.1	12.7	23.4	15.9	11.8	10.1	16.7	12.6	9.9	8.4	11.7	8.6	12.4	15.8	18.6	8.8	21.5	27.5	13.3	8.6	9.5	13.5	1.3	3.3	6.9	4.7	2.4	4.0	13.3	5.6	5.1	4.1	11.3	6.4	6.6	4.2	4.6	2.0	10.6	4.2	2.4	19.7	24.7	23.8	41.0	20.2	23.5	18.9	22.2	28.5	18.5	8.9	8.1	0.0	0.0	0.0	0.0	0.0	0.0	9.4	5.7	21.0	0.0	66.6	16.6	31.2	0.0	0.0	0.0	0.0	35.5	31.3	0.0	0.0	3.5	0.0	47.2	0.0	0.0	0.0	0.0	0.0	0.0	6.3	0.0	22.6	0.0	0.0	27.8	0.0	0.0	15.1	0.0	0.0	0.0	0.0	0.0	0.0	139.8	0.0	0.0	0.0
PIP4P2	"DKFZp762O076, TMEM55A"	ENSG00000155099	"Phosphatidylinositol-4,5-bisphosphate 4-phosphatase 2"	Q8N4L2	8	90993796-91041064	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins"		Hydrolase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	9	"Cytotrophoblasts: 27.7;Distal tubular cells: 41.4;Extravillous trophoblasts: 27.3;Hofbauer cells: 39.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in many"	6	"neutrophil: 36.2"	"Lineage enriched"	"Detected in all"	6	"granulocytes: 36.2"	"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA014591	Approved					NA	NA		57000			"HPA014591: AB_1858124"	"unprognostic (6.09e-2)"	"prognostic unfavorable (1.01e-4)"	"unprognostic (8.45e-2)"	"unprognostic (1.23e-3)"	"unprognostic (1.19e-1)"	"prognostic unfavorable (1.54e-4)"	"prognostic unfavorable (3.76e-5)"	"unprognostic (3.76e-2)"	"unprognostic (1.08e-1)"	"unprognostic (7.58e-2)"	"unprognostic (4.42e-1)"	"unprognostic (6.95e-2)"	"unprognostic (7.25e-2)"	"prognostic unfavorable (8.01e-4)"	"unprognostic (1.59e-1)"	"unprognostic (9.05e-2)"	"unprognostic (7.99e-2)"	15.8	18.6	18.7	9.1	19.5	35.2	11.7	21.4	31.7	14.2	16.5	11.1	7.3	4.4	15.0	7.1	8.5	8.6	15.5	26.0	18.2	23.5	13.7	5.7	8.1	11.8	22.8	20.0	16.1	4.8	14.6	13.4	12.2	25.5	12.3	7.2	17.4	10.1	18.6	16.7	8.0	6.6	18.6	25.4	11.2	9.6	9.7	21.1	7.1	9.4	6.9	7.7	13.3	10.5	1.5	5.3	36.2	5.6	1.2	2.4	2.9	2.6	1.6	9.4	5.9	15.3	18.1	1.9	11.4	13.5	5.8	8.6	1.0	4.4	5.1	1.5	10.9	5.8	0.6	2.2	3.7	7.6	4.7	4.6	8.1	1.7	0.8	13.8	1.9	7.3	10.0	2.4	7.3	5.4	15.5	5.5	1.5	4.0	17.0	20.1	1.8	5.4	4.8	4.9	0.0	5.9	2.2	3.8	6.1	8.1	1.6	1.0	5.3	0.7	3.6	13.9	6.6	0.1	3.3	8.3	10.4	4.3	6.0	4.8	6.8	4.1	3.1	18.0	3.4	13.9	0.3	5.6	5.3	0.8	2.6	1.3	1.5	1.8	0.9	5.3	1.1	2.4	1.0	36.2	1.2	1.0	3.1	1.5	2.9	18.7	19.5	21.4	31.7	18.2	23.5	22.8	20.0	25.5	21.1	0.0	3.2	0.0	0.0	0.0	0.0	0.0	0.0	2.7	5.7	8.7	0.0	27.7	41.4	15.5	0.0	0.0	0.0	0.0	7.7	27.3	0.0	0.0	8.1	0.0	39.4	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	6.4	0.0	0.0	11.2	0.0	0.0	10.3	0.0	0.0	0.0	0.0	0.0	0.0	9.2	0.0	0.0	0.0
PIP5K1A		ENSG00000143398	"Phosphatidylinositol-4-phosphate 5-kinase type 1 alpha"	Q99755	1	151197949-151249536	"Cancer-related genes, Enzymes, Predicted intracellular proteins"		"Kinase, Transferase"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Cone photoreceptor cells: 92.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA029366	Approved		Supported	"Nucleoplasm,Plasma membrane,Cytosol"		NA	NA			"Plasma membrane, Cytosol"	Nucleoplasm	"HPA029366: AB_10602116"	"unprognostic (1.05e-1)"	"unprognostic (2.36e-2)"	"unprognostic (8.64e-2)"	"unprognostic (7.94e-3)"	"unprognostic (1.17e-1)"	"unprognostic (3.28e-2)"	"unprognostic (1.26e-2)"	"unprognostic (3.01e-1)"	"unprognostic (8.79e-2)"	"unprognostic (1.15e-1)"	"unprognostic (1.37e-1)"	"unprognostic (1.04e-1)"	"prognostic unfavorable (4.16e-7)"	"unprognostic (1.44e-1)"	"unprognostic (8.14e-2)"	"unprognostic (2.93e-1)"	"unprognostic (1.59e-1)"	18.1	19.5	15.7	15.4	21.0	9.6	20.2	22.6	27.6	19.8	18.0	20.3	14.7	16.4	24.8	22.6	20.7	19.4	20.7	18.9	17.3	13.4	17.8	18.3	21.7	17.1	12.7	17.5	20.4	16.6	21.8	25.3	44.6	14.6	17.3	15.6	29.5	17.8	15.2	26.1	20.4	20.4	27.2	16.1	20.1	16.8	42.1	14.0	19.3	20.1	13.9	22.3	16.2	17.7	9.1	8.7	11.7	6.2	4.7	5.9	6.3	17.7	13.8	21.4	24.7	14.1	15.0	21.1	23.5	33.0	43.9	39.4	25.1	17.2	16.2	25.0	25.0	19.8	15.1	27.7	16.1	38.5	24.3	19.8	12.8	18.3	12.0	26.7	22.9	16.2	19.9	15.0	27.3	34.6	19.4	17.8	25.8	12.5	13.8	22.0	24.9	22.8	11.4	31.7	13.6	21.5	22.1	18.7	12.0	22.5	10.3	14.4	19.0	31.7	24.4	20.6	37.4	25.6	21.7	17.1	17.5	24.4	16.1	28.2	19.3	32.1	36.5	17.0	6.7	20.8	0.1	5.5	7.3	5.3	6.2	4.1	9.1	5.0	5.9	8.4	4.6	5.4	4.2	11.7	4.7	4.8	8.7	3.9	6.3	15.7	21.0	22.6	27.6	17.3	13.4	12.7	17.5	14.6	14.0	29.8	13.5	19.0	21.3	58.7	33.2	17.3	12.7	12.0	11.4	29.6	92.3	21.0	8.3	11.8	2.8	13.2	15.9	0.0	7.5	24.0	19.1	15.9	11.5	11.6	11.1	25.4	5.8	17.8	10.1	3.6	12.4	11.5	11.8	10.0	8.4	13.8	13.3	8.4	10.3	7.9	43.5	12.9	19.6	46.5	22.4	43.7	53.1	8.7	9.5	32.5
PIP5K1B	"MSS4, STM7"	ENSG00000107242	"Phosphatidylinositol-4-phosphate 5-kinase type 1 beta"	O14986	9	68705414-69009176	"Enzymes, Predicted intracellular proteins"		"Kinase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	7	"Muller glia cells: 103.2"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in many"	6	"eosinophil: 22.1"	"Lineage enriched"	"Detected in many"	6	"granulocytes: 22.1"	"Cell line enhanced"	"Detected in some"		"AF22: 23.8;HEL: 8.9;Hep G2: 7.3;OE19: 39.1;U-266/70: 9.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA009687	Uncertain		Approved	Nucleoplasm,Vesicles		NA	NA			Nucleoplasm	Vesicles	"HPA009687: AB_1855391"	"unprognostic (2.02e-3)"	"unprognostic (1.84e-2)"	"unprognostic (3.77e-2)"	"unprognostic (2.72e-1)"	"unprognostic (1.56e-1)"	"unprognostic (1.62e-1)"	"unprognostic (5.85e-3)"	"unprognostic (1.80e-2)"	"unprognostic (1.38e-2)"	"unprognostic (1.17e-1)"	"unprognostic (2.98e-2)"	"unprognostic (2.92e-2)"	"prognostic favorable (1.03e-9)"	"unprognostic (2.10e-2)"	"unprognostic (1.71e-1)"	"unprognostic (1.19e-1)"	"unprognostic (3.34e-1)"	4.0	9.5	9.4	8.4	6.5	10.2	4.2	33.4	14.6	5.6	26.9	4.1	10.8	26.1	6.1	2.0	1.2	5.0	7.6	24.6	8.1	11.7	6.1	0.8	12.6	2.1	10.4	6.4	1.4	6.7	21.3	8.5	16.8	32.8	3.3	23.1	28.7	11.6	13.6	3.0	2.4	39.7	2.6	3.7	3.1	19.9	17.6	1.5	0.0	1.6	1.9	3.3	3.5	2.9	3.9	0.9	22.1	0.3	0.0	1.0	0.2	0.0	0.0	23.8	0.0	0.0	0.0	4.6	0.0	0.0	0.0	0.0	2.5	0.0	1.7	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.4	8.9	0.2	7.3	0.0	0.5	2.2	0.0	1.0	0.0	0.0	0.0	0.0	0.2	0.4	5.1	0.1	0.6	0.0	0.1	1.2	39.1	0.7	0.7	0.0	0.1	0.1	1.8	0.4	0.0	0.0	0.0	0.3	0.6	0.1	0.0	0.0	0.0	0.2	0.0	0.0	9.2	1.7	1.1	0.0	1.6	0.0	3.1	0.3	22.1	0.0	0.0	0.0	3.3	0.2	0.0	0.1	3.9	0.5	0.0	1.2	0.0	0.1	0.9	1.0	0.2	9.4	6.5	33.4	14.6	8.1	11.7	10.4	6.4	32.8	1.5	32.8	27.2	5.2	3.0	0.6	4.6	51.2	5.1	4.0	2.3	5.2	2.0	16.1	23.2	1.3	54.3	3.0	49.9	46.7	12.3	0.7	1.0	2.3	5.7	0.0	3.2	0.0	35.5	1.8	1.3	32.7	2.3	2.2	5.0	0.0	26.7	103.2	5.6	33.1	1.4	0.7	3.1	25.8	46.7	1.2	1.7	0.3	7.3	1.3	23.7	4.3
PIP5K1C	"KIAA0589, LCCS3, PIP5Kgamma"	ENSG00000186111	"Phosphatidylinositol-4-phosphate 5-kinase type 1 gamma"	O60331	19	3630183-3700479	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Cell adhesion, Chemotaxis, Endocytosis, Exocytosis, Phagocytosis"	"Kinase, Transferase"	"Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"U-2197: 38.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA017168	Approved		Approved	Nucleoplasm,Cytosol		No	No			"Nucleoplasm, Cytosol"		"HPA017168: AB_1855395"	"unprognostic (1.20e-1)"	"prognostic favorable (1.79e-4)"	"unprognostic (1.36e-3)"	"prognostic favorable (7.28e-5)"	"unprognostic (7.03e-2)"	"unprognostic (4.02e-3)"	"unprognostic (5.80e-3)"	"unprognostic (8.50e-2)"	"unprognostic (1.31e-1)"	"unprognostic (2.57e-3)"	"prognostic favorable (2.32e-4)"	"unprognostic (1.51e-1)"	"prognostic favorable (3.00e-4)"	"unprognostic (2.25e-1)"	"unprognostic (1.84e-1)"	"unprognostic (2.30e-1)"	"unprognostic (2.70e-1)"	16.1	10.2	20.5	12.8	25.8	4.5	8.0	58.6	46.3	10.7	23.5	8.5	14.8	10.9	19.8	10.0	12.3	12.8	12.7	13.8	22.8	10.7	7.5	3.8	11.5	7.5	11.3	17.1	11.5	17.2	10.0	9.2	13.7	19.0	16.7	6.4	16.9	20.0	33.4	13.5	10.2	11.5	19.2	6.3	15.8	13.6	23.9	8.7	5.3	9.3	3.9	6.0	17.3	19.0	2.5	3.2	3.6	3.0	1.7	2.8	2.0	9.2	8.8	6.9	8.9	13.5	11.0	10.4	17.9	11.3	7.7	6.2	7.8	2.6	3.9	6.9	19.1	8.5	8.2	3.2	5.8	3.2	13.8	5.8	4.4	7.3	6.3	11.3	4.5	13.8	12.2	5.5	6.3	2.4	5.5	13.0	5.9	6.7	7.2	7.2	7.7	5.4	3.3	7.2	3.4	12.2	10.2	5.3	5.3	5.7	8.0	7.0	6.0	9.2	5.0	5.4	9.0	4.0	6.8	28.6	10.8	6.2	38.1	8.3	8.3	6.6	1.7	14.5	9.5	7.7	3.6	2.8	0.0	2.8	2.6	1.2	2.5	2.1	2.0	3.2	1.3	1.0	1.6	2.2	1.7	3.0	2.2	1.4	2.0	20.5	25.8	58.6	46.3	22.8	10.7	11.3	17.1	19.0	8.7	6.0	5.3	5.4	2.8	4.7	40.8	5.5	7.6	2.7	0.0	15.7	35.3	6.2	1.7	6.9	8.4	12.0	7.0	0.0	6.2	6.0	8.5	4.9	1.1	3.6	13.3	28.6	8.1	16.0	11.0	17.7	13.8	10.8	5.0	13.6	9.2	10.5	9.9	7.0	22.6	5.7	26.6	12.9	10.7	19.0	10.4	5.9	13.7	6.4	5.7	3.8
PIP5KL1	"bA203J24.5, MGC46424"	ENSG00000167103	"Phosphatidylinositol-4-phosphate 5-kinase like 1"	Q5T9C9	9	127920879-127930797	"Enzymes, Predicted intracellular proteins"		"Kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	10	"Alveolar cells type 2: 9.4;Ciliated cells: 9.4;Early spermatids: 20.0;Late spermatids: 14.7"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	6	"intermediate monocyte: 1.2;MAIT T-cell: 1.0;memory B-cell: 1.0;myeloid DC: 1.0;naive B-cell: 2.4;plasmacytoid DC: 1.3"	"Low lineage specificity"	"Detected in many"			"Group enriched"	"Detected in many"	5	"Karpas-707: 29.6;RPMI-8226: 19.3"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA056240	Uncertain		Supported	Cytosol		NA	NA			Cytosol		"HPA056240: AB_2683075"	"unprognostic (2.15e-2)"	"unprognostic (3.06e-1)"	"unprognostic (1.23e-3)"	"unprognostic (8.51e-5)"	"unprognostic (1.44e-2)"	"unprognostic (4.62e-2)"	"unprognostic (1.19e-1)"	"unprognostic (6.29e-2)"	"unprognostic (5.20e-2)"	"unprognostic (5.50e-2)"	"unprognostic (2.49e-2)"	"unprognostic (1.57e-3)"	"unprognostic (9.95e-8)"	"unprognostic (1.87e-1)"	"unprognostic (7.21e-2)"	"unprognostic (6.05e-2)"	"unprognostic (1.59e-1)"	0.6	0.7	3.1	0.6	1.0	1.4	2.5	2.4	5.3	2.1	0.6	1.9	0.6	0.5	1.3	0.6	3.7	1.8	1.2	0.6	2.1	2.9	1.3	0.6	2.9	0.6	1.4	2.6	0.7	1.3	6.5	4.8	1.6	8.3	3.3	0.2	1.0	8.7	4.1	0.6	4.7	0.6	1.0	1.5	0.6	2.4	2.5	1.2	0.6	2.9	0.6	0.6	1.2	4.0	2.4	1.3	0.0	1.2	0.0	1.0	0.3	0.0	0.5	0.4	0.5	0.5	1.3	2.8	0.6	0.5	0.1	0.1	0.2	3.6	0.3	1.1	2.4	1.1	1.1	0.0	2.6	0.1	0.3	1.7	0.0	0.8	0.0	0.9	0.0	0.1	1.4	1.7	0.3	0.0	0.9	0.0	2.4	0.0	29.6	0.0	2.5	0.0	1.0	0.2	1.1	0.4	0.2	0.0	19.3	0.0	0.0	1.0	1.8	0.1	0.7	0.0	0.3	1.1	1.4	0.3	0.3	1.0	0.6	0.1	2.6	1.7	0.7	5.3	0.4	0.3	0.0	0.0	0.0	0.0	1.2	1.0	1.0	0.1	0.0	1.0	2.4	0.2	0.1	0.0	0.0	0.1	1.3	0.0	0.3	3.1	1.0	2.4	5.3	2.1	2.9	1.4	2.6	8.3	1.2	0.0	9.4	0.5	3.7	1.9	0.2	0.5	0.0	9.4	1.2	5.2	0.0	0.7	1.7	1.2	20.0	0.6	0.0	0.0	1.3	3.8	0.8	1.9	0.0	0.0	0.3	4.8	0.0	0.6	0.3	14.7	0.9	0.0	0.0	0.0	0.2	1.7	1.2	0.0	0.4	0.0	0.7	0.0	0.8	1.1	0.9	1.0	2.6	0.0	0.2	1.8
PLCB1	"KIAA0581, PLC-I, PLC154"	ENSG00000182621	"Phospholipase C beta 1"	Q9NQ66	20	8077251-8968360	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Lipid degradation, Lipid metabolism"	"Hydrolase, Transducer"	Epilepsy	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"parathyroid gland: 56.7"	"Cell type enhanced"	"Detected in many"	5	"Cardiomyocytes: 29.3;Distal tubular cells: 28.2;Endothelial cells: 30.5"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"CACO-2: 22.0;Hep G2: 33.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB004275, CAB005334, HPA034743, HPA057910"	Enhanced		Approved	"Plasma membrane"		NA	NA		5400	"Plasma membrane"		"CAB004275: AB_628118, CAB005334: AB_632196, HPA034743: AB_2674311, HPA057910: AB_2683552"	"unprognostic (2.32e-1)"	"unprognostic (1.02e-1)"	"unprognostic (6.63e-2)"	"unprognostic (9.77e-2)"	"unprognostic (9.87e-2)"	"unprognostic (2.37e-1)"	"unprognostic (1.27e-4)"	"unprognostic (1.13e-1)"	"unprognostic (3.16e-2)"	"unprognostic (1.91e-1)"	"unprognostic (7.12e-3)"	"unprognostic (6.57e-2)"	"unprognostic (2.87e-3)"	"unprognostic (3.20e-2)"	"unprognostic (4.41e-2)"	"unprognostic (1.71e-2)"	"unprognostic (2.12e-1)"	5.6	7.0	13.8	4.4	27.7	3.4	5.9	7.5	31.1	6.5	9.9	2.1	20.6	5.5	8.0	10.3	4.5	7.4	6.6	8.6	15.7	9.1	10.0	3.1	4.0	1.6	9.3	14.5	3.2	10.8	56.7	4.6	14.2	5.5	10.4	3.6	1.3	19.7	22.2	9.8	2.3	4.5	12.3	4.0	2.9	5.5	2.6	8.0	4.1	3.1	1.9	1.1	8.6	6.3	0.5	0.8	2.8	3.3	2.4	5.2	0.4	0.0	0.6	2.3	0.1	4.3	8.3	3.2	9.8	6.5	2.6	1.6	22.0	2.4	1.0	4.1	1.9	0.1	0.0	1.8	0.0	1.9	0.0	2.1	0.4	1.6	33.1	1.1	0.5	0.3	0.5	0.4	3.5	0.0	3.3	5.2	6.3	3.3	12.9	0.0	2.9	0.5	1.6	7.4	5.1	3.6	7.0	0.0	5.8	2.0	8.1	8.5	3.6	0.0	2.0	0.4	8.9	9.8	3.2	0.9	8.5	3.8	0.6	6.1	9.7	11.2	16.6	4.3	6.1	14.5	0.8	3.3	2.8	3.6	0.7	5.2	0.2	1.0	1.3	0.4	0.5	0.5	1.1	2.1	2.4	0.4	0.8	0.2	0.4	13.8	27.7	7.5	30.8	15.7	9.1	9.3	14.5	5.5	8.0	0.0	4.3	0.8	17.4	1.6	0.8	29.3	5.1	16.0	3.4	15.7	0.0	1.9	28.2	0.9	7.6	30.5	0.3	0.0	11.3	1.9	7.9	21.8	1.1	2.1	0.7	1.6	0.0	21.5	4.6	3.1	3.1	2.5	6.8	1.0	1.9	16.3	2.4	0.0	3.5	7.9	3.7	0.0	13.0	3.1	4.3	1.5	1.5	5.1	1.2	16.2
PLCB2	FLJ38135	ENSG00000137841	"Phospholipase C beta 2"	Q00722	15	40278176-40307935	"Enzymes, Predicted intracellular proteins"	"Lipid degradation, Lipid metabolism"	"Hydrolase, Transducer"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 30.5;lymphoid tissue: 36.3"	"Group enriched"	"Detected in many"	4	"Alveolar cells type 2: 25.1;granulocytes: 25.5;Hofbauer cells: 26.0;Kupffer cells: 49.0;Macrophages: 28.1;T-cells: 15.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in some"		"HEL: 31.5;HMC-1: 39.3;THP-1: 11.4;U-937: 21.6"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"CAB009443, HPA041298, HPA068595, HPA069308"	Enhanced		Approved	"Plasma membrane,Cytosol"		NA	NA			"Plasma membrane, Cytosol"		"CAB009443: AB_632197, HPA041298: AB_2677395, HPA068595: , HPA069308: "	"unprognostic (5.52e-2)"	"unprognostic (4.96e-3)"	"unprognostic (6.09e-3)"	"unprognostic (1.88e-2)"	"unprognostic (1.31e-1)"	"prognostic favorable (3.00e-4)"	"unprognostic (1.66e-1)"	"unprognostic (3.08e-2)"	"unprognostic (1.28e-1)"	"unprognostic (2.34e-1)"	"unprognostic (1.42e-1)"	"unprognostic (2.75e-1)"	"prognostic unfavorable (7.20e-5)"	"unprognostic (9.89e-2)"	"unprognostic (2.06e-3)"	"unprognostic (5.81e-2)"	"unprognostic (1.13e-1)"	6.3	3.6	8.1	17.6	11.6	30.5	2.9	1.1	7.5	2.9	3.3	16.2	1.7	4.0	2.8	3.2	2.4	4.6	6.5	3.3	6.9	5.1	3.3	4.2	12.5	17.2	12.7	2.4	1.6	2.0	1.3	2.9	4.6	9.3	3.2	5.5	4.1	5.2	2.9	1.3	1.5	10.2	4.8	17.9	36.3	3.6	1.4	10.9	12.2	2.8	1.8	17.6	6.9	2.5	1.0	4.5	8.5	4.3	1.8	3.1	2.0	0.1	0.0	0.2	0.0	0.0	0.0	4.4	0.0	0.0	0.0	0.0	0.0	7.8	0.6	7.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	31.5	0.0	0.0	0.0	6.7	39.3	0.0	0.0	0.0	0.0	0.0	0.0	4.1	0.3	1.7	0.0	0.0	1.8	3.6	0.4	0.0	0.1	5.5	0.8	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	2.3	0.0	11.4	4.1	0.0	3.8	0.0	0.0	0.0	0.0	1.5	0.0	21.6	0.0	2.7	4.2	8.5	3.1	4.3	2.0	0.7	1.6	1.6	4.5	1.0	1.6	1.8	6.9	1.8	4.2	1.6	2.9	2.0	8.1	11.6	1.1	7.5	6.9	5.1	12.7	2.4	9.3	10.9	6.0	25.1	3.4	0.1	0.8	0.0	2.8	2.5	6.7	5.7	1.8	0.0	0.4	0.0	0.1	1.0	0.4	0.0	0.0	0.0	0.4	1.0	0.0	25.5	0.2	26.0	0.0	0.0	1.8	49.0	0.4	0.3	28.1	3.3	0.0	0.8	0.0	0.2	0.0	0.0	0.7	0.2	0.0	0.3	0.2	2.1	0.5	0.3	15.9	1.2	0.0
PLCB3		ENSG00000149782	"Phospholipase C beta 3"	Q01970	11	64251523-64269150	"Enzymes, Predicted intracellular proteins"	"Lipid degradation, Lipid metabolism"	"Hydrolase, Transducer"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	5	"intestine: 77.5"	"Cell type enhanced"	"Detected in many"	6	"Enterocytes: 54.0;Mucus-secreting cells: 41.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"plasmacytoid DC: 4.4"	"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB009257, HPA039279, HPA043907"	Enhanced		Approved	"Nucleoplasm,Golgi apparatus"		NA	NA		94000	"Nucleoplasm, Golgi apparatus"		"CAB009257: AB_654079, HPA039279: AB_2676425, HPA043907: AB_2678726"	"unprognostic (1.30e-1)"	"unprognostic (1.21e-2)"	"unprognostic (2.86e-1)"	"unprognostic (2.35e-1)"	"unprognostic (9.35e-2)"	"unprognostic (6.23e-3)"	"prognostic unfavorable (1.39e-4)"	"unprognostic (2.44e-2)"	"unprognostic (6.61e-2)"	"unprognostic (1.26e-1)"	"unprognostic (8.07e-3)"	"unprognostic (1.00e-2)"	"prognostic unfavorable (4.31e-5)"	"unprognostic (5.04e-3)"	"unprognostic (1.52e-1)"	"unprognostic (1.20e-1)"	"unprognostic (3.88e-2)"	5.8	9.7	6.1	7.0	5.4	3.7	10.9	6.3	5.8	8.6	40.6	3.1	8.8	59.3	9.1	5.9	16.8	7.7	11.8	4.8	5.4	2.6	5.5	3.2	9.1	4.8	3.5	2.2	11.0	4.0	7.6	2.9	11.1	4.8	6.4	7.0	5.0	6.5	6.3	3.8	10.7	77.5	7.0	4.5	7.2	8.0	4.6	5.4	4.2	5.0	8.2	9.3	6.3	8.8	0.3	4.4	0.9	1.4	0.3	0.8	0.4	17.8	10.0	9.9	14.7	10.4	8.0	9.9	14.2	10.8	12.2	7.4	8.8	13.6	1.2	8.6	17.8	10.5	30.8	11.1	13.3	4.2	8.5	6.1	13.9	20.6	6.6	7.2	3.3	9.2	6.7	8.9	13.2	9.8	13.4	17.7	5.4	6.8	1.5	15.4	21.5	4.2	7.0	16.0	22.7	11.0	9.3	22.3	5.2	7.5	18.9	2.6	10.9	21.0	26.5	10.1	6.4	13.9	6.5	30.7	11.3	13.5	25.8	9.1	1.9	0.9	1.4	18.7	8.0	10.4	0.0	1.4	0.2	0.7	1.4	0.8	0.1	0.8	0.7	1.3	0.3	0.4	0.4	0.9	0.3	1.4	4.4	0.2	0.4	6.1	5.4	6.3	5.8	5.4	2.6	3.5	2.2	4.8	5.4	3.0	9.3	0.0	5.1	11.6	1.0	2.6	10.2	0.0	3.4	15.7	0.0	7.8	1.7	6.2	0.9	7.3	54.0	0.0	6.7	14.6	9.3	5.1	5.7	2.6	9.0	3.2	2.4	19.6	12.7	1.1	9.2	11.0	8.5	29.7	41.8	4.3	12.8	23.0	11.7	3.3	0.7	25.8	7.2	2.6	8.7	10.3	12.2	1.3	31.0	7.2
PLCB4		ENSG00000101333	"Phospholipase C beta 4"	Q15147	20	9068763-9481242	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Lipid degradation, Lipid metabolism"	"Hydrolase, Transducer"	"Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 44.9;retina: 40.2;salivary gland: 39.8"	"Cell type enhanced"	"Detected in many"	13	"Bipolar cells: 79.8;Cardiomyocytes: 57.6;Ciliated cells: 56.2;Horizontal cells: 155.7"	"Cancer enhanced"	"Detected in many"		"colorectal cancer: 23.5"	"Group enriched"	"Detected in all"	4	"cerebellum: 44.9;pons and medulla: 11.9"	"Cell type enriched"	"Detected in single"	20	"plasmacytoid DC: 6.6"	"Lineage enriched"	"Detected in single"	20	"dendritic cells: 6.6"	"Cell line enhanced"	"Detected in many"		"fHDF/TERT166: 38.2;hTERT-HME1: 18.7;LHCN-M2: 30.8;OE19: 17.8;RPTEC TERT1: 39.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA007951	Approved		Approved	Nucleoplasm,Microtubules		NA	NA			Microtubules	Nucleoplasm	"HPA007951: AB_2667944"	"unprognostic (3.88e-2)"	"unprognostic (3.62e-1)"	"unprognostic (1.19e-2)"	"prognostic favorable (2.11e-4)"	"unprognostic (1.44e-2)"	"unprognostic (9.72e-3)"	"unprognostic (3.32e-3)"	"unprognostic (2.57e-2)"	"unprognostic (7.75e-2)"	"unprognostic (4.23e-2)"	"unprognostic (5.21e-3)"	"unprognostic (1.35e-1)"	"unprognostic (4.64e-3)"	"unprognostic (7.12e-2)"	"unprognostic (1.37e-1)"	"unprognostic (2.22e-1)"	"unprognostic (4.45e-2)"	5.5	5.0	2.1	4.5	4.6	0.2	5.6	44.9	5.2	6.0	13.1	2.7	2.4	1.6	12.3	16.2	6.9	10.9	6.2	12.4	2.3	6.6	2.3	0.9	4.4	1.0	4.0	3.3	2.9	1.3	0.5	15.1	4.4	11.9	6.9	12.6	40.2	39.8	7.1	2.5	4.3	3.1	12.3	3.1	1.1	9.7	2.1	2.4	4.3	21.9	4.4	2.0	7.1	8.8	0.0	6.6	0.0	0.0	0.3	0.0	0.0	0.0	6.1	3.1	0.0	0.0	0.1	0.0	13.4	3.8	4.0	2.5	1.2	0.9	0.0	0.2	38.2	14.5	0.0	0.9	2.9	6.0	0.0	1.8	1.6	2.2	0.0	0.6	0.0	0.0	0.9	1.2	5.2	18.7	7.3	0.0	0.0	1.5	0.1	30.8	2.0	0.0	0.0	3.3	17.8	3.9	0.0	0.0	0.2	39.4	2.8	10.2	7.1	0.0	9.2	5.6	4.3	7.8	0.0	0.1	4.3	0.3	0.4	5.2	0.0	0.0	0.0	0.6	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	6.6	0.0	0.0	2.1	4.6	44.9	5.2	2.3	6.6	4.0	3.3	11.9	2.4	6.0	0.3	0.0	3.6	2.2	79.8	57.6	0.0	56.2	11.4	5.2	0.0	0.0	0.0	0.5	1.0	35.4	2.3	0.0	0.2	0.0	4.8	10.1	0.0	0.0	0.1	155.7	40.4	1.3	0.0	0.4	1.4	0.3	6.8	1.0	35.3	1.9	5.0	7.0	19.4	0.6	5.4	12.9	23.6	1.4	1.3	0.9	0.1	0.0	34.0	1.8
PLCD1		ENSG00000187091	"Phospholipase C delta 1"	P51178	3	38007496-38029762	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Lipid degradation, Lipid metabolism"	"Hydrolase, Transducer"	"Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	7	"Enterocytes: 48.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"ASC diff: 16.0;ASC TERT1: 14.3;fHDF/TERT166: 15.8;hTCEpi: 19.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"CAB009913, HPA020107, HPA021677"	Approved		Approved	Microtubules		NA	NA			Microtubules		"CAB009913: AB_2163388, HPA020107: AB_1855318, HPA021677: AB_1855319"	"unprognostic (1.75e-3)"	"unprognostic (1.01e-2)"	"unprognostic (4.29e-2)"	"unprognostic (1.45e-2)"	"unprognostic (3.44e-1)"	"unprognostic (9.67e-3)"	"unprognostic (1.55e-1)"	"unprognostic (7.25e-3)"	"unprognostic (3.95e-1)"	"unprognostic (1.45e-1)"	"unprognostic (2.80e-1)"	"unprognostic (2.24e-1)"	"prognostic favorable (9.25e-11)"	"unprognostic (1.50e-1)"	"unprognostic (7.71e-2)"	"unprognostic (2.93e-1)"	"unprognostic (7.88e-2)"	10.9	11.3	11.2	5.6	12.1	5.1	8.0	6.0	11.2	11.6	19.3	15.2	7.3	6.6	9.1	7.6	21.9	8.6	8.5	8.0	13.0	6.9	7.8	5.8	9.4	9.3	10.5	11.4	12.8	6.2	4.7	7.3	6.9	15.9	10.6	12.7	8.3	10.9	12.6	4.5	17.0	6.5	12.3	15.5	6.3	6.5	37.3	8.7	7.7	6.6	21.2	12.2	14.6	23.1	1.0	2.6	8.6	2.4	3.7	13.2	5.4	0.6	1.7	5.7	1.6	16.0	14.3	1.8	1.7	6.9	2.7	4.1	0.6	1.4	0.4	0.9	15.8	1.7	9.1	3.0	1.8	0.8	2.5	0.7	0.2	0.9	2.9	9.4	0.0	1.0	11.6	19.6	7.9	1.1	5.9	5.0	1.4	9.6	0.8	5.9	0.7	1.3	0.6	1.5	3.3	1.7	0.5	0.8	2.2	3.1	3.1	0.0	1.6	0.5	7.7	1.9	1.9	1.6	0.7	2.9	1.6	4.1	4.2	0.0	3.5	1.4	0.3	4.1	0.0	0.9	8.6	1.9	0.1	10.2	2.4	11.6	1.0	13.2	9.8	2.6	0.5	7.8	6.1	6.9	3.7	1.4	1.5	11.8	5.4	11.2	12.1	6.0	10.7	13.0	6.9	10.5	11.4	15.9	8.7	3.0	6.9	1.4	11.2	2.5	1.0	3.8	10.2	0.0	4.5	8.7	2.0	1.5	3.3	9.2	1.4	7.4	48.4	0.0	2.6	3.8	6.6	12.4	4.6	3.8	3.5	3.2	4.7	19.6	3.5	2.5	11.8	5.1	1.7	3.6	23.8	14.2	3.3	15.9	13.4	5.0	1.4	6.5	9.1	2.6	3.2	5.1	0.7	8.2	9.4	15.0
PLCD3		ENSG00000161714	"Phospholipase C delta 3"	Q8N3E9	17	45108967-45133354	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"Lipid degradation, Lipid metabolism"	"Hydrolase, Transducer"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 63.6"	"Cell type enhanced"	"Detected in many"	11	"Enterocytes: 138.0;Paneth cells: 62.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"OE19: 40.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA025711, HPA053665"	Approved		Approved	"Plasma membrane"		NA	NA			"Plasma membrane"		"HPA025711: AB_1855320, HPA053665: AB_2732580"	"unprognostic (3.58e-2)"	"unprognostic (1.66e-1)"	"unprognostic (2.77e-2)"	"unprognostic (1.27e-2)"	"unprognostic (2.66e-1)"	"unprognostic (4.14e-3)"	"unprognostic (8.13e-3)"	"prognostic unfavorable (2.89e-6)"	"unprognostic (2.96e-1)"	"unprognostic (9.53e-2)"	"unprognostic (1.34e-3)"	"unprognostic (6.21e-2)"	"unprognostic (3.18e-2)"	"unprognostic (2.07e-1)"	"unprognostic (1.62e-1)"	"prognostic favorable (4.28e-4)"	"unprognostic (3.34e-3)"	5.7	12.0	10.1	4.8	16.5	2.4	6.6	12.2	12.9	5.0	24.9	14.0	2.8	2.9	6.3	6.4	8.9	5.8	9.4	13.1	11.6	6.6	3.6	1.2	4.5	1.7	13.9	11.4	9.9	2.7	1.5	3.0	5.7	19.5	5.8	13.7	10.3	4.7	5.7	63.6	9.9	2.8	12.9	15.0	2.0	17.9	5.4	14.6	0.0	2.3	20.1	2.8	17.5	10.5	1.3	0.9	2.9	1.5	1.3	0.9	0.5	8.4	21.1	1.5	3.1	2.3	5.0	10.7	4.6	10.4	4.3	4.1	5.1	15.5	0.3	16.7	10.8	3.5	19.3	2.4	19.9	1.7	4.2	7.9	0.3	22.2	6.6	11.9	0.4	1.2	5.4	8.0	3.9	5.3	11.0	2.6	0.9	1.8	0.6	4.6	13.2	1.3	1.9	1.8	40.6	20.8	3.0	3.5	0.5	13.6	16.9	0.4	2.7	5.0	8.4	4.5	3.4	17.9	0.9	5.3	2.7	14.8	3.5	5.4	0.8	0.9	0.6	4.4	0.5	2.1	2.3	1.5	2.4	0.9	1.5	0.6	1.0	0.7	0.6	0.5	1.3	0.9	0.8	2.9	1.3	0.3	0.9	0.6	0.5	10.1	16.5	12.2	11.5	11.6	6.6	13.9	11.4	19.5	14.6	11.9	2.2	0.0	10.9	6.8	27.2	23.8	12.7	1.4	2.3	7.0	23.6	2.5	1.7	7.0	12.5	9.2	138.0	0.0	2.9	7.2	8.2	9.8	1.1	0.4	1.5	6.4	4.7	8.6	0.3	3.6	18.4	0.3	3.3	1.0	13.0	6.8	18.3	62.6	31.1	1.7	37.9	6.5	4.2	1.9	6.6	5.0	6.1	0.0	26.3	40.1
PLCD4		ENSG00000115556	"Phospholipase C delta 4"	Q9BRC7	2	218607765-218637184	"Enzymes, Predicted intracellular proteins"	"Lipid degradation, Lipid metabolism"	"Guanine-nucleotide releasing factor, Hydrolase, Transducer"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"retina: 23.0;skeletal muscle: 62.5;smooth muscle: 33.1"	"Group enriched"	"Detected in some"	8	"Bipolar cells: 81.4;Cone photoreceptor cells: 231.7;Rod photoreceptor cells: 181.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in single"			"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in many"		"SH-SY5Y: 21.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB009914, HPA038139, HPA038140"	Enhanced		Supported	"Endoplasmic reticulum,Plasma membrane,Cytosol"		NA	NA			Cytosol	"Endoplasmic reticulum, Plasma membrane"	"CAB009914: AB_2252306, HPA038139: AB_2675855, HPA038140: AB_2675856"	"unprognostic (2.11e-1)"	"unprognostic (1.72e-1)"	"unprognostic (1.76e-2)"	"unprognostic (5.65e-5)"	"unprognostic (7.77e-2)"	"unprognostic (1.45e-2)"	"unprognostic (7.06e-3)"	"unprognostic (2.86e-2)"	"unprognostic (3.15e-1)"	"unprognostic (8.87e-3)"	"unprognostic (7.54e-5)"	"unprognostic (3.28e-2)"	"unprognostic (2.49e-1)"	"unprognostic (1.86e-1)"	"unprognostic (6.32e-2)"	"unprognostic (8.46e-3)"	"unprognostic (3.09e-1)"	1.1	2.5	1.5	1.0	1.6	0.5	1.0	0.9	2.4	0.6	6.4	0.3	3.8	0.9	0.8	1.1	3.7	0.6	0.9	0.9	1.0	1.5	3.9	0.5	0.7	0.7	1.6	1.0	0.7	0.4	1.4	4.7	0.6	2.6	6.4	1.5	23.0	1.4	0.6	62.5	0.8	1.4	33.1	1.1	0.5	3.5	3.9	0.5	0.0	1.4	6.8	0.5	9.6	5.3	0.9	1.2	0.3	0.4	0.9	0.9	1.0	0.6	1.6	2.2	0.4	0.2	1.4	1.2	1.2	2.6	0.4	1.4	2.4	0.3	1.4	1.8	0.4	1.0	1.0	0.0	1.5	0.3	0.5	1.8	1.2	3.6	1.9	0.2	1.2	0.6	3.0	0.1	2.0	0.5	4.8	2.8	0.8	1.0	1.1	2.3	1.8	0.4	1.2	0.7	0.2	3.4	0.9	0.8	0.5	4.4	3.0	2.3	21.5	1.0	0.8	0.3	1.3	2.6	0.5	6.1	1.6	1.2	0.7	0.7	0.5	0.8	0.9	4.7	0.3	1.6	0.0	0.4	0.0	0.5	0.0	0.1	0.0	0.3	0.9	0.3	0.9	0.7	0.8	0.3	0.9	0.0	1.2	0.7	1.0	1.5	1.6	0.9	2.4	1.0	1.5	1.6	1.0	2.6	0.5	0.0	1.4	0.0	0.2	0.5	81.4	0.8	0.0	0.0	0.0	0.0	231.7	0.1	0.0	0.2	14.2	1.1	0.0	0.0	0.0	12.6	0.6	0.0	0.0	0.0	0.5	7.9	0.0	0.0	0.0	22.0	0.3	0.0	0.0	0.0	0.0	8.8	0.4	0.0	0.0	1.4	181.4	0.0	1.4	2.2	0.8	0.1	0.7	0.0	0.0	0.1
PLCE1	"KIAA1516, NPHS3, PLCE"	ENSG00000138193	"Phospholipase C epsilon 1"	Q9P212	10	94030812-94332823	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, RAS pathway related proteins"	"Lipid degradation, Lipid metabolism"	"Guanine-nucleotide releasing factor, Hydrolase, Transducer"	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"retina: 44.6"	"Cell type enhanced"	"Detected in many"	9	"Alveolar cells type 1: 65.5;Enterocytes: 45.9;Muller glia cells: 98.6;Paneth cells: 46.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"RT4: 18.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"HPA015597, HPA015598"	Enhanced		Supported	Cytosol		NA	NA			Cytosol		"HPA015597: AB_1855321, HPA015598: AB_1855322"	"unprognostic (4.73e-2)"	"unprognostic (1.16e-1)"	"unprognostic (4.03e-2)"	"unprognostic (3.59e-3)"	"unprognostic (3.01e-1)"	"unprognostic (2.96e-1)"	"unprognostic (1.73e-2)"	"unprognostic (4.76e-3)"	"unprognostic (1.58e-1)"	"unprognostic (1.75e-1)"	"unprognostic (1.14e-1)"	"unprognostic (1.23e-1)"	"unprognostic (3.26e-3)"	"unprognostic (3.56e-1)"	"unprognostic (3.92e-2)"	"unprognostic (3.54e-2)"	"unprognostic (4.30e-2)"	3.2	2.4	4.1	9.1	5.5	0.0	2.2	1.8	7.9	9.2	13.8	3.1	1.6	5.0	11.4	4.6	4.5	4.2	3.8	12.8	4.1	2.6	6.3	0.7	7.2	0.4	2.4	6.8	3.2	12.8	0.1	5.2	3.1	6.4	3.3	12.6	44.6	2.1	7.7	4.3	0.7	4.6	5.8	2.4	5.8	8.7	1.7	2.3	0.0	15.1	7.3	1.1	7.9	5.4	3.2	1.2	0.8	0.9	1.1	2.3	0.5	5.8	8.1	1.7	0.9	0.9	5.7	2.3	3.6	1.0	0.8	1.1	5.2	1.4	0.6	1.8	2.9	2.9	2.5	4.1	1.0	1.3	0.3	2.0	0.4	4.4	0.4	0.1	0.7	0.3	2.3	0.0	2.2	0.0	9.7	0.0	0.3	0.4	0.3	7.0	0.2	0.6	0.8	0.6	11.0	8.4	0.1	5.5	0.2	0.2	18.2	0.8	1.4	4.2	5.8	0.5	7.9	4.9	0.5	0.5	3.7	10.9	2.3	4.7	0.5	0.2	0.3	3.0	1.0	3.3	0.4	0.5	0.1	1.5	0.9	1.3	2.6	1.6	1.1	0.6	3.2	2.3	1.8	0.8	1.1	0.8	1.2	0.6	0.5	4.1	5.5	1.8	7.9	4.1	2.6	2.4	6.8	6.4	2.3	65.5	4.8	9.3	7.4	7.2	11.5	32.3	0.0	10.7	13.6	0.0	0.0	3.2	1.7	1.3	15.0	7.4	45.9	0.0	5.7	2.0	7.3	2.9	0.0	1.1	0.6	6.4	1.7	6.2	0.6	3.4	11.2	1.4	6.8	1.0	6.4	98.6	3.2	46.7	21.9	2.1	19.4	6.5	19.4	3.5	7.8	6.5	1.6	4.3	28.0	6.0
PLCG1	"NCKAP3, PLC-II, PLC1, PLC148, PLCgamma1"	ENSG00000124181	"Phospholipase C gamma 1"	P19174	20	41136960-41196801	"Cancer-related genes, Enzymes, Plasma proteins, Predicted intracellular proteins, RAS pathway related proteins"	"Host-virus interaction, Lipid degradation, Lipid metabolism"	"Hydrolase, Transducer"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	7	"gdT-cell: 5.9;MAIT T-cell: 8.0;memory CD4 T-cell: 5.2;memory CD8 T-cell: 4.9;naive CD4 T-cell: 5.7;naive CD8 T-cell: 5.4;NK-cell: 4.0;T-reg: 4.4"	"Group enriched"	"Detected in many"	8	"NK-cells: 4.0;T-cells: 8.0"	"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB004277, HPA036681, HPA036682"	Approved		Enhanced	Cytosol		NA	NA			Cytosol		"CAB004277: AB_628119, HPA036681: AB_2675245, HPA036682: AB_2675246"	"unprognostic (2.77e-1)"	"unprognostic (1.35e-1)"	"unprognostic (1.65e-1)"	"unprognostic (4.31e-2)"	"unprognostic (5.82e-2)"	"unprognostic (2.09e-2)"	"unprognostic (4.45e-3)"	"unprognostic (1.25e-2)"	"unprognostic (2.29e-2)"	"unprognostic (1.16e-1)"	"prognostic favorable (4.72e-4)"	"unprognostic (3.32e-1)"	"unprognostic (2.73e-3)"	"unprognostic (1.82e-1)"	"unprognostic (2.65e-1)"	"unprognostic (9.27e-2)"	"unprognostic (2.79e-2)"	20.2	15.1	25.1	20.9	22.1	8.3	34.9	52.6	26.8	19.9	13.9	23.4	12.5	16.5	27.6	13.9	13.5	17.0	18.7	20.9	25.4	13.6	15.3	6.8	19.3	30.7	18.5	20.5	28.7	9.1	16.9	14.2	22.2	18.7	18.4	13.2	20.0	13.2	20.6	13.4	22.3	17.1	22.2	15.4	20.1	12.4	19.9	23.9	48.1	28.5	11.9	21.9	17.1	21.1	0.7	0.0	0.0	0.0	4.0	8.0	3.3	5.4	6.9	33.2	24.3	13.3	9.3	10.6	8.9	11.5	18.0	15.3	16.6	1.8	12.1	11.0	9.7	18.9	10.1	14.4	16.0	10.5	3.4	7.7	0.8	11.5	19.5	10.1	4.7	3.3	11.9	9.0	13.3	10.4	16.3	20.0	26.0	9.0	8.0	16.2	40.4	29.2	3.7	12.3	7.0	12.7	23.3	24.2	5.9	9.9	10.0	11.8	22.5	16.0	7.5	16.0	19.4	8.7	5.6	21.6	43.1	14.0	13.7	10.8	8.9	3.9	10.0	10.2	5.2	17.8	0.0	0.0	0.0	5.9	0.0	8.0	0.3	5.2	4.9	0.0	0.7	5.7	5.4	0.0	4.0	0.0	0.0	4.4	3.3	25.1	22.1	52.6	26.8	25.4	13.6	18.5	20.5	18.7	23.9	14.9	6.5	0.8	1.8	4.9	3.7	9.2	0.0	1.4	3.4	3.5	9.8	1.3	0.0	2.7	5.1	15.8	6.4	0.0	1.4	1.6	6.1	1.9	1.1	2.5	3.2	3.2	1.7	13.5	2.2	5.3	14.1	1.7	3.3	1.0	9.8	7.2	2.8	3.7	17.3	2.4	4.6	12.9	5.1	11.6	11.5	6.0	0.7	6.9	5.1	0.9
PLCG2		ENSG00000197943	"Phospholipase C gamma 2"	P16885	16	81739097-81962693	"Cancer-related genes, Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, RAS pathway related proteins"	"Lipid degradation, Lipid metabolism"	"Hydrolase, Transducer"	"Cancer-related genes, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"lymphoid tissue: 55.8"	"Cell type enhanced"	"Detected in many"	7	"Bipolar cells: 211.5;Muller glia cells: 142.4;Rod photoreceptor cells: 205.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in some"		"Daudi: 40.5;HMC-1: 19.4;REH: 16.5;U-698: 90.0"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"CAB004280, HPA020099, HPA020100"	Enhanced		Approved	Nucleoplasm,Vesicles,Cytosol		NA	NA		21000	"Vesicles, Cytosol"	Nucleoplasm	"CAB004280: AB_628120, HPA020099: AB_1855324, HPA020100: AB_1855325"	"unprognostic (2.86e-2)"	"unprognostic (1.34e-1)"	"unprognostic (1.09e-3)"	"unprognostic (1.10e-1)"	"unprognostic (1.58e-1)"	"prognostic favorable (6.71e-4)"	"unprognostic (6.23e-2)"	"unprognostic (5.01e-2)"	"unprognostic (2.22e-1)"	"unprognostic (4.58e-2)"	"unprognostic (4.66e-2)"	"unprognostic (1.71e-2)"	"prognostic favorable (4.88e-4)"	"unprognostic (1.52e-2)"	"unprognostic (1.21e-1)"	"unprognostic (2.89e-1)"	"unprognostic (3.40e-3)"	8.4	3.8	3.3	55.8	4.9	14.1	10.7	1.0	2.4	5.6	10.3	5.3	3.1	8.7	11.2	12.2	6.0	4.7	10.1	4.4	3.3	2.8	20.6	8.8	10.7	35.5	5.2	1.8	2.0	3.6	1.0	1.8	4.1	4.5	4.3	3.6	4.6	8.8	2.8	2.0	4.1	17.6	4.6	8.6	33.6	4.2	2.3	4.2	6.3	5.3	2.6	44.6	7.5	7.7	18.8	3.9	26.8	12.2	14.0	1.1	2.3	0.3	0.7	0.1	0.6	0.0	0.0	0.9	0.0	0.1	0.5	0.2	0.2	1.8	40.5	6.9	0.0	1.7	0.9	0.9	0.1	0.3	0.3	0.4	4.8	0.0	0.0	0.3	4.8	19.4	0.0	0.4	0.3	0.2	0.0	0.9	1.8	0.5	3.4	0.1	1.2	0.5	12.1	0.7	0.5	0.2	16.5	0.0	5.2	0.1	0.8	0.3	0.1	1.1	0.3	0.3	0.9	0.7	15.0	0.2	0.0	0.7	0.1	0.1	8.1	13.2	90.0	0.0	6.7	0.3	2.8	4.4	26.8	0.7	5.7	0.3	18.8	0.2	1.1	3.9	17.3	0.3	0.8	24.8	14.0	12.2	2.6	0.1	2.3	3.3	4.9	1.0	2.4	3.3	2.8	5.2	1.8	4.5	4.2	11.9	81.1	49.9	1.4	2.6	211.5	5.2	40.8	10.7	21.6	15.7	98.2	11.2	11.6	2.3	17.0	11.7	1.0	70.0	0.0	1.8	5.8	2.7	38.3	37.2	23.7	95.3	20.6	36.2	45.8	26.9	10.3	15.6	8.5	7.2	0.4	142.4	0.1	5.8	4.6	4.5	205.4	6.5	2.3	4.4	2.9	1.9	9.3	26.2	1.2	4.8
PLCH1	"DKFZp434C1372, KIAA1069, MGC117152, PLCeta1, PLCL3"	ENSG00000114805	"Phospholipase C eta 1"	Q4KWH8	3	155375580-155745067	"Enzymes, Predicted intracellular proteins"	"Lipid degradation, Lipid metabolism"	"Hydrolase, Transducer"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 14.7;testis: 15.8"	"Cell type enriched"	"Detected in many"	6	"Early spermatids: 148.2"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in single"		"MAIT T-cell: 1.2"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in some"		"A549: 8.4;AF22: 27.2;NTERA-2: 14.5"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA036176, HPA057978"	Uncertain		Enhanced	Vesicles		NA	NA			Vesicles		"HPA036176: AB_10671837, HPA057978: AB_2683569"	"unprognostic (1.08e-2)"	"unprognostic (3.68e-1)"	"unprognostic (2.17e-2)"	"unprognostic (1.55e-2)"	"unprognostic (3.50e-4)"	"unprognostic (6.41e-2)"	"unprognostic (2.94e-5)"	"unprognostic (5.04e-2)"	"unprognostic (2.41e-1)"	"unprognostic (2.24e-3)"	"unprognostic (4.84e-2)"	"unprognostic (1.76e-2)"	"prognostic favorable (3.03e-5)"	"unprognostic (3.28e-2)"	"unprognostic (1.62e-1)"	"unprognostic (1.47e-1)"	"unprognostic (1.37e-2)"	0.3	0.3	3.9	0.7	14.1	0.5	3.9	7.4	14.7	2.1	3.9	5.7	4.1	3.9	1.4	12.9	0.5	12.4	2.4	2.5	4.5	3.6	2.1	0.4	6.1	0.3	3.4	7.3	0.5	2.5	0.8	3.2	0.8	6.5	0.8	3.9	5.6	2.3	3.4	0.6	0.5	3.9	0.5	1.9	0.3	5.8	15.8	2.9	0.0	8.9	0.0	0.4	1.3	0.4	0.1	0.3	0.7	0.0	0.0	1.2	0.9	0.0	8.4	27.2	1.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	1.6	6.7	0.0	0.6	0.0	0.1	0.0	4.8	0.0	0.0	0.0	2.5	6.8	0.0	0.9	0.0	4.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	2.2	0.2	0.0	0.0	2.9	1.6	6.2	14.5	0.9	1.1	0.6	0.0	0.0	1.7	0.1	2.5	0.6	0.0	6.5	0.0	4.2	2.9	0.0	0.0	0.0	0.1	0.0	1.1	0.3	0.0	0.0	0.0	0.9	0.2	0.0	0.0	0.0	0.0	0.0	1.2	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.3	0.0	0.9	3.9	14.1	7.4	14.7	4.5	3.6	3.4	7.3	6.5	2.9	3.0	12.8	0.0	0.3	0.0	10.0	0.5	7.6	25.4	3.4	1.8	3.9	0.0	0.0	1.9	148.2	0.1	2.4	0.0	2.0	0.2	0.0	0.1	0.0	0.0	0.2	23.8	2.9	0.0	0.3	10.0	1.1	0.0	0.0	0.0	4.3	19.3	1.5	2.9	0.4	1.9	3.0	0.0	0.0	2.1	1.1	0.1	0.0	0.0	4.7	0.1
PLCH2	"KIAA0450, PLC-eta2, PLCeta2, PLCL4, RP3-395M20.1"	ENSG00000149527	"Phospholipase C eta 2"	O75038	1	2425980-2505530	"Enzymes, Predicted intracellular proteins"	"Lipid degradation, Lipid metabolism"	"Hydrolase, Transducer"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 32.0;retina: 28.6;skin 1: 36.6"	"Cell type enhanced"	"Detected in many"	18	"Bipolar cells: 76.1;Cone photoreceptor cells: 70.7;Rod photoreceptor cells: 155.3"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Group enriched"	"Detected in many"	9	"NK-cells: 2.9;T-cells: 2.4"	"Group enriched"	"Detected in some"	4	"HBEC3-KT: 50.7;hTCEpi: 23.9;hTERT-HME1: 14.3"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA072705	Enhanced					NA	NA					"HPA072705: AB_2732211"	"unprognostic (2.06e-3)"	"unprognostic (1.30e-2)"	"unprognostic (1.09e-3)"	"unprognostic (3.84e-3)"	"unprognostic (1.99e-1)"	"unprognostic (1.59e-2)"	"unprognostic (7.39e-2)"	"unprognostic (7.70e-2)"	"unprognostic (7.58e-2)"	"unprognostic (9.28e-2)"	"unprognostic (2.26e-1)"	"unprognostic (5.95e-2)"	"unprognostic (6.61e-3)"	"unprognostic (8.43e-2)"	"unprognostic (1.07e-1)"	"unprognostic (8.64e-2)"	"unprognostic (5.80e-2)"	0.5	1.2	6.4	2.9	9.1	1.4	3.1	32.0	25.1	3.2	0.9	1.6	0.5	1.6	0.3	1.7	9.7	2.5	2.4	0.3	20.2	2.7	0.8	0.8	1.2	4.0	2.6	8.4	0.2	1.7	0.1	3.0	0.4	2.6	6.7	0.7	28.6	8.6	4.9	0.2	36.6	2.0	0.2	6.4	4.0	1.7	0.8	2.0	0.2	1.2	0.2	4.9	8.3	6.4	0.3	0.1	0.0	0.0	2.9	2.4	0.9	0.1	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.1	0.0	0.0	7.0	0.0	50.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	23.9	0.0	14.3	0.0	0.0	0.0	0.0	1.2	0.1	0.4	0.0	0.0	0.0	0.7	0.9	0.0	0.0	0.0	0.1	2.8	5.7	1.5	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	2.4	0.0	0.9	0.3	1.5	1.4	0.0	0.3	1.1	0.7	0.0	2.9	0.0	0.1	2.1	0.9	6.4	9.1	32.0	25.1	20.2	2.7	2.6	8.4	2.6	2.0	0.0	1.7	2.0	13.5	13.7	76.1	3.2	5.1	1.4	4.5	0.0	70.7	0.0	1.7	0.0	0.0	0.3	1.1	0.0	0.0	0.0	0.5	4.9	0.0	0.0	0.1	25.4	1.2	0.0	0.0	0.0	0.0	0.0	3.3	0.0	1.4	12.3	0.2	0.0	0.0	16.6	155.3	0.0	0.9	0.1	0.2	12.8	0.0	6.9	0.4	6.7
PLCL1	"PLC-L, PLCE, PLCL, PPP1R127, PRIP"	ENSG00000115896	"Phospholipase C like 1 (inactive)"	Q15111	2	197804702-198572581	"FDA approved drug targets, Predicted intracellular proteins"		Transducer	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 34.9"	"Cell type enhanced"	"Detected in many"	16	"Cardiomyocytes: 128.1;Distal tubular cells: 49.7;Proximal tubular cells: 34.2;Sertoli cells: 32.3"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"T-reg: 4.1"	"Lineage enriched"	"Detected in single"	6	"T-cells: 4.1"	"Cell line enhanced"	"Detected in some"		"HUVEC TERT2: 8.8;K-562: 14.7;Karpas-707: 11.1;MOLT-4: 10.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA031849	Enhanced					NA	NA					"HPA031849: AB_10602192"	"unprognostic (7.77e-3)"	"unprognostic (2.57e-1)"	"unprognostic (2.09e-1)"	"unprognostic (5.18e-3)"	"unprognostic (4.40e-2)"	"unprognostic (7.14e-2)"	"unprognostic (2.05e-1)"	"unprognostic (4.42e-3)"	"unprognostic (1.07e-1)"	"unprognostic (1.32e-1)"	"unprognostic (3.02e-2)"	"unprognostic (7.42e-2)"	"prognostic favorable (3.91e-7)"	"unprognostic (1.07e-4)"	"unprognostic (6.74e-2)"	"unprognostic (1.68e-1)"	"unprognostic (3.20e-2)"	4.4	5.2	11.1	3.3	26.0	2.2	4.4	3.4	16.3	5.3	4.5	21.2	3.4	1.3	15.4	3.9	4.3	4.1	3.7	32.8	14.9	10.9	32.8	1.3	3.9	4.4	34.9	8.8	8.1	2.2	20.7	3.0	8.4	19.9	11.8	2.1	4.8	2.9	8.2	28.4	1.8	2.5	6.7	23.0	2.5	3.1	2.3	26.9	22.1	4.0	3.2	3.2	5.3	2.9	0.0	0.1	0.6	0.1	0.0	4.1	0.2	0.0	0.0	0.1	0.0	1.7	0.4	0.0	0.4	0.2	0.1	0.1	0.0	0.1	0.0	0.1	2.0	0.0	0.0	0.0	0.0	0.0	0.3	0.8	0.0	1.5	0.0	0.2	0.2	1.9	4.3	0.0	0.0	0.0	0.0	8.8	2.9	14.7	11.1	0.1	0.4	10.3	0.0	0.1	0.0	0.0	0.0	0.0	4.5	0.3	0.0	1.7	1.0	1.8	0.0	2.6	0.8	0.3	0.0	0.7	0.2	0.0	0.0	0.1	4.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.3	0.0	2.5	0.0	1.8	0.0	0.1	0.0	1.3	0.4	0.6	0.0	0.1	0.0	4.1	0.2	11.1	26.0	3.4	16.3	14.9	10.9	34.9	8.8	19.9	26.9	17.9	4.1	0.0	0.7	1.1	18.7	128.1	0.0	4.0	3.4	14.0	0.0	0.0	49.7	0.5	10.5	1.4	0.3	0.0	0.3	0.0	3.1	1.0	5.8	0.0	2.5	14.3	1.7	0.0	4.1	3.0	1.7	2.6	0.0	2.8	0.0	2.3	0.3	0.0	7.4	34.2	1.1	32.3	13.7	0.7	1.8	1.1	0.1	3.8	0.0	0.3
PLCL2	"KIAA1092, PLCE2"	ENSG00000154822	"Phospholipase C like 2"	Q9UPR0	3	16802651-17090594	"Predicted intracellular proteins"		Transducer		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 32.0"	"Cell type enhanced"	"Detected in many"	6	"Cardiomyocytes: 32.7;Extravillous trophoblasts: 52.0;Syncytiotrophoblasts: 41.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"ASC TERT1: 15.7;Daudi: 17.1;HAP1: 17.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA047616, HPA061728"	Enhanced					NA	NA					"HPA047616: AB_2680105, HPA061728: "	"unprognostic (2.95e-2)"	"unprognostic (8.09e-2)"	"unprognostic (3.96e-2)"	"unprognostic (6.35e-2)"	"unprognostic (1.59e-1)"	"unprognostic (3.83e-3)"	"unprognostic (1.83e-1)"	"unprognostic (9.31e-2)"	"unprognostic (3.22e-2)"	"unprognostic (8.72e-2)"	"unprognostic (5.93e-3)"	"unprognostic (1.29e-2)"	"prognostic favorable (2.98e-10)"	"unprognostic (2.01e-1)"	"unprognostic (1.78e-1)"	"unprognostic (2.70e-1)"	"unprognostic (9.97e-2)"	6.7	9.2	5.6	9.0	7.9	9.6	5.3	32.0	9.2	5.1	5.1	2.0	1.7	7.0	7.3	6.9	1.5	4.8	5.2	11.3	4.9	3.4	8.1	5.8	4.3	12.3	3.0	7.4	14.1	4.7	0.5	7.8	5.5	8.0	2.7	6.2	3.1	3.6	1.5	22.7	2.1	7.6	4.5	3.8	13.0	5.6	3.2	3.4	7.3	4.0	1.0	8.0	3.4	3.1	2.4	1.6	3.0	1.8	10.0	4.9	1.7	0.0	1.3	1.8	0.0	6.8	15.7	1.4	1.3	3.6	0.6	1.5	0.0	1.3	17.1	0.0	1.1	0.7	0.0	17.6	0.7	1.3	8.1	3.7	0.0	1.9	0.0	0.2	2.6	2.0	2.5	0.1	5.0	0.0	1.1	3.1	5.7	3.9	6.7	0.0	0.0	2.9	0.3	3.6	0.0	1.8	6.5	0.0	9.2	0.0	0.2	5.8	2.6	0.7	2.2	0.5	1.3	0.0	2.8	3.1	0.9	1.2	0.8	2.9	6.4	0.0	11.1	0.9	3.6	0.6	1.2	1.4	2.8	3.6	1.5	4.5	2.2	3.4	4.9	1.6	2.4	3.3	3.7	3.0	10.0	1.8	0.9	2.4	1.7	5.6	7.9	32.0	9.2	4.9	3.4	3.0	7.4	8.0	3.4	0.0	2.1	7.1	1.0	0.9	11.0	32.7	17.8	1.4	1.2	3.5	3.9	1.6	6.6	1.7	0.6	3.3	9.0	23.3	8.3	52.0	4.5	0.4	2.3	4.2	6.5	15.9	3.5	4.9	8.8	1.1	18.1	7.8	0.0	0.0	7.6	0.8	2.1	25.9	18.0	5.0	1.8	6.5	3.8	1.4	5.8	0.5	41.6	16.6	4.7	0.4
PLCXD2	FLJ31579	ENSG00000240891	"Phosphatidylinositol specific phospholipase C X domain containing 2"	Q0VAA5	3	111674676-111846447	"Predicted intracellular proteins"	"Lipid degradation, Lipid metabolism"	"Hydrolase, Transducer"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in many"		"placenta: 16.0"	"Cell type enhanced"	"Detected in many"	10	"Collecting duct cells: 57.6;Distal tubular cells: 135.9;Hepatocytes: 132.8;Proximal tubular cells: 94.0"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"plasmacytoid DC: 7.2"	"Group enriched"	"Detected in many"	5	"dendritic cells: 7.2;NK-cells: 2.1;T-cells: 3.6"	"Cell line enhanced"	"Detected in many"		"HBF TERT88: 9.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA055947	Uncertain		Approved	Nucleoplasm		NA	NA			Nucleoplasm		"HPA055947: AB_2682981"	"unprognostic (2.68e-1)"	"unprognostic (6.43e-2)"	"unprognostic (7.26e-2)"	"unprognostic (2.42e-1)"	"unprognostic (3.09e-2)"	"unprognostic (2.76e-2)"	"unprognostic (1.36e-1)"	"unprognostic (4.64e-1)"	"unprognostic (3.47e-1)"	"unprognostic (1.99e-2)"	"unprognostic (3.38e-2)"	"unprognostic (2.04e-1)"	"prognostic favorable (1.23e-7)"	"unprognostic (7.47e-2)"	"unprognostic (1.29e-1)"	"unprognostic (1.30e-1)"	"prognostic favorable (2.99e-4)"	1.5	1.0	1.9	3.4	5.8	9.6	1.2	5.8	10.9	1.6	2.8	0.4	0.0	6.1	1.0	0.6	1.8	1.2	1.9	1.5	3.6	2.5	2.5	4.1	2.0	5.9	2.9	6.8	1.1	2.3	0.4	4.1	16.0	10.3	1.5	3.6	4.1	2.0	0.7	1.2	1.5	5.9	0.9	2.9	3.5	2.1	4.2	1.1	3.1	3.2	0.5	4.8	1.9	1.6	0.9	7.2	0.6	0.0	2.1	3.6	0.6	3.0	2.7	2.6	1.2	0.1	0.1	0.8	5.3	2.5	5.0	4.4	1.9	1.5	2.2	2.7	0.2	1.6	7.5	1.1	5.1	9.7	0.6	1.3	0.5	5.0	1.7	0.4	0.7	2.6	0.0	1.0	1.6	3.0	4.7	2.8	2.9	0.1	5.4	0.6	0.3	1.5	0.5	0.9	2.0	6.8	1.4	3.8	2.0	2.4	3.1	0.6	4.6	1.1	0.7	1.1	3.1	0.4	0.2	2.6	1.1	6.8	0.5	1.0	6.5	0.9	0.4	0.5	0.4	0.3	0.6	0.0	0.0	3.6	0.0	3.5	0.5	1.9	3.5	0.3	0.9	0.9	2.0	0.2	2.1	0.0	7.2	1.7	0.6	1.9	5.8	5.8	10.9	3.6	2.5	2.9	6.8	10.3	1.1	17.9	2.1	0.5	6.9	0.1	0.7	1.9	28.1	0.0	1.2	57.6	3.9	0.0	135.9	36.1	11.5	0.0	1.3	0.0	43.6	0.0	0.1	3.8	0.0	132.8	0.0	6.4	24.1	0.0	1.6	8.9	0.3	0.0	0.0	0.0	4.9	0.0	45.8	0.0	0.4	94.0	3.7	0.0	0.0	0.5	0.4	0.1	0.0	2.2	1.1	12.2
PLCZ1	"NYD-SP27, PLCzeta"	ENSG00000139151	"Phospholipase C zeta 1"	Q86YW0	12	18683169-18738057	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Fertilization, Lipid degradation, Lipid metabolism"	"Developmental protein, Hydrolase, Transducer"	"Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	17	"testis: 29.5"	"Group enriched"	"Detected in some"	91	"Early spermatids: 451.0;Late spermatids: 242.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"hTEC/SVTERT24-B: 3.8;hTERT-HME1: 1.4;NTERA-2: 2.1;U-2 OS: 1.2;U-251 MG: 1.4"	"Low region specificity"	"Detected in some"			"Not detected"	"Not detected"									NA	NA						"unprognostic (1.95e-1)"					"unprognostic (2.79e-1)"	"unprognostic (1.10e-1)"	"unprognostic (1.87e-2)"			"unprognostic (1.39e-2)"		"unprognostic (1.25e-2)"	"unprognostic (1.59e-1)"	"unprognostic (1.40e-1)"			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.2	0.3	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.3	29.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.3	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.5	0.1	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.8	1.4	0.4	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	2.1	0.0	0.7	0.0	0.1	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	451.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	242.6	2.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	1.4	0.0	0.0	0.0	0.0	3.8	1.3	0.0	0.0	0.0	0.0	0.0
PLPP6	"FLJ46512, FLJ90191, PDP1, PPAPDC2"	ENSG00000205808	"Phospholipid phosphatase 6"	Q8IY26	9	4662315-4665258	"Predicted membrane proteins"		Hydrolase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	12	"Early spermatids: 74.5;Late spermatids: 33.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enriched"	"Detected in many"	4	"HDLM-2: 47.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA018096	Approved		Approved	Nucleoplasm,Vesicles,Cytosol		NA	NA			"Nucleoplasm, Vesicles"	Cytosol	"HPA018096: AB_1855609"	"unprognostic (2.55e-2)"	"unprognostic (8.29e-2)"	"unprognostic (1.03e-1)"	"unprognostic (4.36e-3)"	"unprognostic (1.17e-1)"	"unprognostic (4.38e-2)"	"unprognostic (6.95e-3)"	"unprognostic (1.33e-1)"	"unprognostic (5.26e-2)"	"unprognostic (9.06e-2)"	"unprognostic (2.20e-2)"	"unprognostic (1.45e-1)"	"prognostic favorable (3.99e-4)"	"unprognostic (2.56e-1)"	"unprognostic (2.28e-2)"	"unprognostic (2.87e-2)"	"unprognostic (5.88e-2)"	4.0	8.3	4.4	7.2	6.8	1.1	7.3	11.9	9.7	5.7	9.4	6.2	4.2	10.2	4.9	13.2	9.2	4.1	9.7	3.0	4.9	4.8	6.3	20.0	4.7	8.3	8.6	6.3	4.2	19.2	8.7	5.5	13.1	9.4	16.9	10.0	4.7	10.4	8.5	2.2	8.6	15.4	3.3	4.9	7.1	10.7	8.4	3.4	16.2	7.2	6.9	9.6	7.4	5.5	4.3	5.1	8.5	5.1	4.7	13.0	5.1	3.9	4.1	4.4	5.4	3.6	4.0	4.4	2.7	3.5	2.2	2.5	1.0	2.6	3.8	1.1	2.6	5.5	4.9	3.1	3.8	2.3	47.7	2.9	7.6	3.9	5.4	3.2	2.7	5.7	4.4	3.1	1.7	3.8	2.9	3.3	4.3	1.3	4.0	2.8	4.2	2.5	7.2	4.0	4.0	1.4	2.5	0.0	2.9	3.8	4.5	11.1	5.6	3.2	2.9	1.6	5.7	4.1	6.1	3.8	2.0	1.7	2.6	1.7	0.8	3.0	1.0	3.1	1.9	1.8	8.5	5.1	4.1	4.2	4.4	4.6	3.5	7.4	6.3	5.1	4.3	13.0	9.2	2.1	4.7	4.9	3.9	10.0	5.1	4.4	6.8	11.9	9.7	4.9	4.8	8.6	6.3	9.4	3.4	6.0	2.4	3.4	2.0	0.0	6.8	0.0	5.1	0.0	2.3	1.8	2.0	14.4	1.7	10.9	74.5	1.4	8.5	0.0	12.1	2.1	0.0	7.1	0.0	13.2	5.4	3.2	10.5	4.3	5.3	33.5	2.6	2.2	0.0	1.8	8.4	3.8	8.7	7.4	4.6	2.6	4.3	0.0	0.0	0.6	1.0	0.0	8.7	1.5	6.4	2.6
PLPP7	"C9orf67, FLJ14662, MGC12921, NET39, PPAPDC3"	ENSG00000160539	"Phospholipid phosphatase 7 (inactive)"	Q8NBV4	9	131289459-131359022	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"heart muscle: 29.0;skeletal muscle: 107.3"	"Cell type enhanced"	"Detected in some"	16	"Bipolar cells: 16.8;Horizontal cells: 7.9;Leydig cells: 4.6"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"AN3-CA: 11.0;ASC diff: 11.6;ASC TERT1: 8.8;SCLC-21H: 11.3;SH-SY5Y: 8.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA070252	Uncertain		Approved	Nucleoplasm,Vesicles		No	No			Vesicles	Nucleoplasm	"HPA070252: AB_2686242"	"unprognostic (2.19e-1)"	"unprognostic (3.07e-1)"	"unprognostic (3.07e-2)"	"unprognostic (2.71e-1)"	"unprognostic (8.78e-2)"	"unprognostic (7.03e-2)"	"unprognostic (1.23e-3)"	"unprognostic (1.02e-1)"	"unprognostic (1.43e-1)"	"unprognostic (1.65e-1)"	"unprognostic (3.96e-3)"	"unprognostic (1.47e-1)"	"unprognostic (1.71e-3)"	"unprognostic (3.69e-2)"	"unprognostic (1.10e-2)"	"unprognostic (7.85e-2)"	"unprognostic (9.72e-3)"	3.6	3.7	3.3	1.7	4.6	1.2	2.8	7.7	8.2	2.3	3.2	4.6	0.0	1.5	2.5	3.1	2.5	2.0	2.3	29.0	3.6	3.9	1.9	1.1	1.5	1.3	3.7	4.2	3.9	1.8	1.1	1.7	1.4	3.7	2.6	1.3	2.0	1.6	2.6	107.3	1.3	1.6	2.9	3.2	1.7	1.4	2.2	3.2	0.0	1.2	22.6	1.2	2.1	1.6	1.3	4.6	0.0	5.2	2.3	0.5	1.9	0.0	0.0	2.2	11.0	11.6	8.8	2.3	1.7	1.2	0.3	0.0	0.0	0.0	0.0	0.3	4.4	2.5	0.0	0.2	0.0	0.1	0.0	1.9	0.0	0.1	3.5	2.9	0.0	0.0	3.0	0.0	3.2	0.0	0.0	0.0	0.0	0.2	0.0	5.2	0.1	0.0	0.1	2.6	0.0	0.0	0.0	0.0	0.0	2.5	0.0	11.3	8.7	0.0	0.1	0.0	0.3	0.3	2.7	0.1	0.1	0.8	0.5	0.0	0.0	0.4	0.0	1.9	0.0	1.7	0.0	5.2	0.0	0.0	3.3	0.0	1.0	0.0	0.0	4.6	1.3	0.4	0.5	0.0	2.3	2.8	2.0	0.0	1.9	3.3	4.6	7.7	8.2	3.6	3.9	3.7	4.2	3.7	3.2	0.0	0.0	0.0	0.0	0.0	16.8	0.0	0.0	0.0	0.0	1.8	2.0	0.0	1.7	0.0	0.9	0.0	0.0	0.0	0.6	0.6	0.0	0.0	0.0	0.0	0.5	7.9	0.0	1.8	0.8	1.3	4.6	0.4	0.0	0.0	0.0	2.3	0.4	0.0	3.5	1.9	3.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
PLPPR5	"LPPR5, PAP2, PAP2D, PRG5"	ENSG00000117598	"Phospholipid phosphatase related 5"	Q32ZL2	1	98890245-99005032	"Predicted membrane proteins"		Hydrolase		"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Group enriched"	"Detected in some"	6	"brain: 18.6;testis: 5.5"	"Group enriched"	"Detected in some"	4	"Bipolar cells: 7.2;Horizontal cells: 3.2"	"Group enriched"	"Detected in some"	13	"glioma: 2.7;renal cancer: 1.5"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	7	"PC-3: 12.3;SH-SY5Y: 22.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA018072, HPA059085"	Uncertain		Approved	"Plasma membrane,Cytosol"		NA	NA			"Plasma membrane"	Cytosol	"HPA018072: AB_1854958, HPA059085: AB_2732631"	"unprognostic (2.57e-1)"	"unprognostic (1.63e-2)"	"unprognostic (1.68e-1)"	"unprognostic (1.68e-2)"	"unprognostic (2.01e-1)"	"unprognostic (2.26e-1)"		"unprognostic (1.11e-1)"	"unprognostic (3.18e-1)"	"unprognostic (1.43e-1)"	"unprognostic (2.07e-1)"		"prognostic unfavorable (6.22e-4)"	"unprognostic (1.81e-2)"	"unprognostic (1.28e-1)"		"unprognostic (2.33e-1)"	0.5	1.8	7.8	0.7	8.7	0.5	0.5	0.8	18.6	1.4	0.6	2.1	0.0	0.7	0.7	0.5	0.6	0.5	0.6	0.5	8.0	6.6	0.7	0.5	0.7	0.5	2.5	4.5	0.6	1.6	0.5	0.3	0.5	3.6	0.6	0.8	1.8	0.5	1.0	0.9	0.6	0.7	0.6	1.0	0.5	0.7	5.5	1.8	0.0	0.5	0.0	0.5	0.6	0.1	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.7	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.4	0.0	12.3	0.0	0.0	0.0	0.5	0.1	0.4	22.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.1	0.2	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	7.8	8.7	0.8	11.6	8.0	6.6	2.5	4.5	3.6	1.8	0.0	0.0	0.0	0.0	0.0	7.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.2	0.0	0.0	0.0	0.4	0.3	0.0	0.0	0.0	0.0	0.2	0.4	0.0	0.7	0.2	1.2	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0
PMPCA	"Alpha-MPP, INPP5E, KIAA0123"	ENSG00000165688	"Peptidase, mitochondrial processing alpha subunit"	Q10713	9	136410570-136423761	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"			"Disease mutation, Mental retardation, Neurodegeneration"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA021648, HPA063735"	Supported		Enhanced	Mitochondria		NA	NA		6500	Mitochondria		"HPA021648: AB_1855491, HPA063735: AB_2685108"	"unprognostic (9.80e-2)"	"unprognostic (1.96e-2)"	"unprognostic (4.03e-1)"	"unprognostic (1.69e-2)"	"unprognostic (4.01e-2)"	"unprognostic (8.19e-2)"	"unprognostic (6.09e-2)"	"unprognostic (1.19e-2)"	"unprognostic (1.97e-1)"	"unprognostic (3.32e-2)"	"prognostic favorable (8.00e-5)"	"unprognostic (9.47e-3)"	"prognostic favorable (2.14e-6)"	"unprognostic (4.27e-3)"	"unprognostic (1.57e-2)"	"unprognostic (2.40e-1)"	"unprognostic (3.54e-2)"	15.2	27.3	19.8	14.6	23.8	20.1	13.2	20.3	24.3	12.3	15.1	13.0	10.4	18.6	14.2	14.1	16.5	13.6	14.9	37.0	15.6	14.8	17.0	48.3	12.3	18.4	15.2	21.9	15.5	18.2	14.7	19.5	15.6	16.8	15.2	11.9	12.8	20.3	17.1	56.7	17.5	17.0	13.8	14.1	18.9	16.3	23.2	12.5	14.0	15.0	19.8	15.3	13.1	13.4	25.5	30.1	17.0	25.1	32.1	30.8	28.2	14.4	27.2	13.0	26.2	9.9	14.5	20.0	15.1	12.2	21.2	15.4	31.0	17.3	20.3	15.9	15.3	11.3	33.9	24.0	22.1	9.4	29.1	29.0	16.3	35.0	37.4	17.4	21.2	14.2	21.2	15.3	16.5	8.5	12.0	17.9	18.9	41.3	13.4	13.1	40.1	20.0	27.3	26.5	25.9	25.7	24.9	18.4	44.9	14.5	10.4	26.7	17.6	20.3	29.0	17.6	9.3	39.5	28.9	14.7	15.1	16.2	12.4	19.2	8.3	10.9	21.8	19.9	18.5	13.5	15.4	25.1	17.0	27.2	24.4	26.4	25.5	25.7	29.3	30.1	23.7	30.8	26.9	5.9	32.1	23.2	15.3	24.3	28.2	19.8	23.8	20.3	24.3	15.6	14.8	15.2	21.9	16.8	12.5	14.9	25.3	23.9	29.5	24.5	22.5	31.3	10.2	13.4	18.2	21.0	21.6	90.0	41.4	28.9	19.7	20.2	19.7	0.0	26.4	41.5	17.6	17.8	24.3	54.0	33.8	17.5	20.0	20.3	17.4	12.4	17.5	14.1	15.1	21.6	22.3	19.3	25.1	17.3	21.2	37.9	25.3	38.8	16.9	32.8	39.5	23.5	86.8	23.0	30.4	23.5
PPIP5K1	"HISPPD2A, IPS1, KIAA0377, VIP1"	ENSG00000168781	"Diphosphoinositol pentakisphosphate kinase 1"	Q6PFW1	15	43533462-43590253	"Enzymes, Predicted intracellular proteins"		"Kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 28.4"	"Cell type enhanced"	"Detected in many"	9	"Cone photoreceptor cells: 39.3;Rod photoreceptor cells: 42.3"	"Low cancer specificity"	"Detected in all"							"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA039380	Approved		Supported	"Plasma membrane,Cytosol"		NA	NA			"Plasma membrane, Cytosol"		"HPA039380: AB_10673528"	"unprognostic (8.72e-2)"	"unprognostic (6.49e-2)"	"unprognostic (1.90e-2)"	"unprognostic (1.12e-1)"	"unprognostic (2.38e-1)"	"unprognostic (2.78e-1)"	"unprognostic (8.18e-2)"	"unprognostic (5.78e-2)"	"unprognostic (2.59e-3)"	"prognostic unfavorable (8.57e-4)"	"unprognostic (6.67e-2)"	"unprognostic (2.85e-3)"	"prognostic favorable (7.14e-8)"	"unprognostic (2.67e-2)"	"unprognostic (3.35e-2)"	"unprognostic (5.92e-3)"	"unprognostic (7.95e-3)"	1.7	5.2	3.4	1.8	6.4	1.1	3.4	28.4	7.0	2.8	6.1			9.1	2.2	5.6	3.7	3.1	2.5	2.1	3.6	5.0	2.5	1.4	1.4	2.0	3.3		3.0	2.9	13.4	7.6	0.9		3.4	6.5		4.7	2.7	6.3	7.2	8.8	2.3	2.8	2.3	5.3	4.5			5.0		3.0	3.3	2.7	5.3	3.2	4.3	2.8	3.5	3.8	3.0	8.4	5.6	4.9	9.1	3.0	1.9	8.4	4.2	5.4	6.1	9.0	6.4	8.1	7.9	6.4	5.8	9.1	23.1	9.5	18.4	6.2	7.8	7.5	11.9	16.9	3.4	6.8	13.6	12.4	3.4	16.2	7.4	11.4	8.3	6.4	18.6	8.6	11.8	4.5	6.6	4.5	7.7	2.4	15.9	6.0	9.7	5.0	4.0	6.6	15.3	14.8	4.6	10.9	10.4	4.1	7.3	19.2	11.4	2.8	5.3	6.4	6.7	10.2	2.6	3.2	9.8	10.0	15.6	5.1	4.3	1.4	0.0	2.7	2.8	3.8	5.3	3.3	3.6	3.2	3.6	2.7	2.5	1.0	3.5	2.1	2.4	0.8	3.0											0.0	2.1	0.0	1.5	3.5	15.3	4.0	5.1	0.0	2.3	7.0	39.3	2.7	0.0	2.1	1.7	2.4	8.8	0.0	1.3	0.8	0.8	1.3	0.0	1.1	1.6	9.5	2.4	4.3	2.7	1.6	1.7	1.6	0.0	1.0	5.0	4.3	1.8	3.5	6.7	1.4	42.3	6.5	1.0	6.6	1.3	2.9	1.8	2.1	7.6	3.2
PPIP5K2	"CFAP160, HISPPD1, KIAA0433, VIP2"	ENSG00000145725	"Diphosphoinositol pentakisphosphate kinase 2"	O43314	5	103120149-103212799	"Enzymes, Predicted intracellular proteins"	Hearing	"Kinase, Transferase"	"Deafness, Disease mutation, Non-syndromic deafness"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA037895, HPA038442"	Approved		Approved	Vesicles		NA	NA			Vesicles		"HPA037895: AB_2675724, HPA038442: AB_10673173"	"unprognostic (2.18e-1)"	"unprognostic (1.04e-1)"	"unprognostic (2.36e-2)"	"unprognostic (1.93e-1)"	"unprognostic (8.83e-2)"	"unprognostic (1.60e-3)"	"unprognostic (1.13e-1)"	"unprognostic (2.43e-1)"	"unprognostic (1.60e-2)"	"unprognostic (8.59e-3)"	"unprognostic (1.39e-1)"	"unprognostic (2.12e-1)"	"unprognostic (4.32e-2)"	"unprognostic (1.29e-1)"	"unprognostic (4.06e-1)"	"prognostic unfavorable (1.12e-4)"	"unprognostic (8.80e-2)"	21.6	20.5	12.6	18.2	18.4	37.9	22.3	30.7	24.2	26.1	23.8	9.7	16.0	14.3	22.6	20.3	17.0	18.5	17.7	16.4	13.2	17.6	21.9	22.6	14.8	20.6	19.5	18.7	26.8	25.5	22.3	40.3	21.6	37.2	18.4	22.1	10.5	17.4	21.7	5.7	16.4	20.2	16.0	19.8	27.7	18.6	13.5	16.2	38.5	20.0	12.9	20.3	16.9	18.2	12.1	15.7	24.3	18.2	10.0	11.2	6.7	9.7	9.5	18.5	21.4	15.0	19.5	16.7	20.2	14.1	12.7	17.5	8.0	16.5	22.9	19.8	20.2	17.9	6.0	16.0	12.1	20.8	18.1	8.4	29.1	17.9	12.7	11.1	25.0	26.4	13.0	9.1	17.9	16.5	11.4	14.1	15.1	30.1	21.1	18.8	8.2	21.6	17.6	20.1	4.3	22.3	20.6	16.5	31.4	13.6	11.2	10.4	13.6	13.9	14.6	13.6	13.6	11.5	17.0	14.1	18.2	8.2	20.2	15.1	13.4	30.4	31.1	10.6	39.8	17.0	23.0	13.4	24.3	8.7	13.8	10.7	12.1	8.4	9.0	15.7	11.3	11.1	11.2	13.0	10.0	18.2	9.3	7.3	6.7	12.6	18.4	30.7	24.2	13.2	17.6	19.5	18.7	37.2	16.2	44.7	17.2	18.1	11.4	12.0	34.2	42.3	20.4	29.4	37.5	15.7	43.2	10.7	5.0	9.7	3.7	21.5	17.0	0.0	14.8	16.5	16.2	12.8	41.7	17.9	26.3	15.9	15.6	14.7	40.6	4.5	27.3	34.8	11.8	16.2	21.5	15.6	13.5	21.0	22.3	17.5	25.9	6.5	14.6	28.9	11.1	13.8	21.7	17.0	25.4	11.4
PTEN	"BZS, MHAM, MMAC1, PTEN1, TEP1"	ENSG00000171862	"Phosphatase and tensin homolog"	P60484	10	87863113-87971930	"Cancer-related genes, Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted secreted proteins"	"Apoptosis, Lipid metabolism, Neurogenesis"	"Hydrolase, Protein phosphatase"	"Autism spectrum disorder, Cancer-related genes, Disease mutation, Tumor suppressor"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"neutrophil: 29.6"	"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"							"CAB004076, HPA031335"	Approved		Supported	Nucleoplasm,Cytosol	"Secreted - unknown location"	NA	NA			Nucleoplasm	Cytosol	"CAB004076: AB_390810, HPA031335: AB_2797221"	"unprognostic (8.72e-2)"	"unprognostic (2.45e-1)"	"unprognostic (5.43e-1)"	"unprognostic (1.50e-2)"	"unprognostic (3.71e-2)"	"unprognostic (1.30e-1)"	"unprognostic (2.18e-1)"	"unprognostic (2.08e-1)"	"unprognostic (2.07e-1)"	"unprognostic (6.87e-2)"	"unprognostic (9.77e-2)"	"unprognostic (2.71e-1)"	"prognostic unfavorable (7.35e-4)"	"unprognostic (1.57e-1)"	"unprognostic (2.73e-1)"	"unprognostic (6.54e-3)"	"unprognostic (2.41e-1)"	42.4	24.1	17.7	20.9	17.7	13.5	32.8	39.9	19.7	43.1	26.7	9.9	19.0	15.1	29.8	22.8	26.8	30.3	21.0	19.1	16.0	17.4	19.6	32.4	27.2	30.4	15.7	19.5	29.1	21.3	16.4	23.6	36.4	14.2	35.3	17.7	21.6	16.8	20.8	16.8	20.4	25.4	26.0	11.7	40.9	17.8	18.7	12.5	49.7	25.2	13.3	18.6	29.6	30.9	4.3	5.1	29.6	11.0	4.3	4.7	2.0	10.2	4.8	5.5	5.0	12.8	8.8	5.0	5.5	12.2	6.5	9.1	4.9	12.6	12.1	3.7	9.0	3.8	6.2	7.4	6.3	10.3	6.0	2.1	4.0	12.5	6.0	13.7	13.5	6.9	6.0	17.6	8.2	10.6	27.6	9.1	7.7	3.0	32.9	5.9	7.8	7.6	24.6	2.0	8.9	0.0	11.8	2.9	8.9	10.1	5.8	2.0	9.0	7.3	3.5	9.2	4.6	9.7	19.6	7.9	21.4	5.0	8.3	4.4	10.8	14.0	13.8	6.6	12.8	1.2	8.3	7.9	12.2	3.6	11.0	3.9	4.3	4.0	3.5	5.1	3.7	4.7	4.5	29.6	4.3	7.2	4.2	3.5	2.0	17.7	17.7	39.9	19.7	16.0	17.4	15.7	19.5	14.2	12.5	32.8	55.3	40.2	50.0	49.8	113.3	39.2	40.8	25.4	28.4	27.9	37.3	22.6	28.2	23.2	57.0	44.4	33.9	0.0	25.8	44.5	52.3	36.9	25.3	58.6	31.3	42.9	30.0	47.9	167.4	70.7	52.6	69.1	59.1	27.9	44.1	54.1	30.2	24.6	51.2	30.8	55.8	90.5	118.8	24.9	24.0	52.6	47.9	35.7	39.2	51.2
PTPDC1	"FLJ37312, PTP9Q22"	ENSG00000158079	"Protein tyrosine phosphatase domain containing 1"	A2A3K4	9	94030794-94109856	"Predicted intracellular proteins"	"Cilium biogenesis/degradation"	"Hydrolase, Protein phosphatase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 32.3"	"Cell type enhanced"	"Detected in many"	4	"Sertoli cells: 19.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"naive CD4 T-cell: 2.0"	"Group enriched"	"Detected in many"	5	"B-cells: 1.1;T-cells: 2.0"	"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA016747, HPA026832"	Uncertain		Enhanced	Nucleoplasm		NA	NA			Nucleoplasm		"HPA016747: AB_1855908, HPA026832: AB_10602917"	"unprognostic (3.99e-2)"	"unprognostic (2.54e-1)"	"unprognostic (1.74e-1)"	"unprognostic (4.91e-2)"	"unprognostic (1.94e-1)"	"unprognostic (3.64e-2)"	"unprognostic (1.90e-3)"	"unprognostic (4.71e-1)"	"unprognostic (2.43e-1)"	"unprognostic (2.56e-1)"	"unprognostic (3.49e-2)"	"unprognostic (3.55e-2)"	"unprognostic (2.48e-2)"	"unprognostic (2.45e-2)"	"unprognostic (2.17e-1)"	"unprognostic (1.28e-1)"	"unprognostic (2.61e-2)"	7.0	12.0	7.6	4.4	32.3	1.5	6.4	4.7	16.4	4.7	4.9	25.3	1.4	3.1	6.2	4.9	4.4	4.4	4.7	10.0	12.1	6.9	5.1	2.4	6.8	3.7	13.9	8.9	6.3	12.2	6.8	8.9	3.7	19.9	5.6	5.9	4.1	4.3	4.4	7.0	6.2	3.6	8.3	20.5	3.0	7.1	15.0	13.0	1.6	5.1	1.3	3.9	4.9	3.6	1.1	0.3	0.0	0.2	0.0	2.0	0.1	6.1	2.7	4.9	6.3	6.1	8.5	6.5	4.5	3.2	4.6	3.9	2.6	5.2	5.2	3.1	3.4	10.6	4.9	5.0	2.9	4.5	7.0	1.4	1.2	7.2	2.8	8.0	1.4	4.0	8.4	10.5	7.0	9.8	2.8	4.9	8.6	3.0	0.0	8.6	3.3	5.2	2.2	3.4	5.0	5.1	5.6	9.7	0.0	2.6	1.5	4.3	5.5	6.2	5.8	9.7	6.8	3.1	2.5	6.9	6.2	3.8	9.5	5.4	7.6	8.4	0.7	4.6	2.5	8.6	0.0	0.2	0.0	0.1	0.0	0.1	0.4	1.1	0.0	0.3	1.1	2.0	0.7	0.0	0.0	0.2	0.2	0.0	0.1	7.6	32.3	4.7	16.4	12.1	6.9	13.9	8.9	19.9	13.0	0.0	7.7	1.9	2.6	4.2	10.5	8.4	2.5	1.4	1.2	5.2	9.8	0.3	3.3	2.9	8.0	5.7	0.9	0.0	2.5	1.6	5.0	1.9	5.7	0.8	2.7	4.8	3.4	6.2	0.3	3.8	3.4	2.7	3.3	0.0	2.4	2.3	5.0	1.1	13.4	1.0	9.8	19.4	4.8	12.0	15.9	3.8	0.2	2.5	2.3	1.7
PTPRQ	DFNB84	ENSG00000139304	"Protein tyrosine phosphatase, receptor type Q"		12	80402178-80680271	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at transcript level"	"Evidence at transcript level"				"Tissue enhanced"	"Detected in many"		"brain: 12.6;urinary bladder: 19.2"	"Cell type enhanced"	"Detected in some"	19	"Alveolar cells type 1: 14.9;Club cells: 7.9;Early spermatids: 7.0;Late spermatids: 3.6"	"Not detected"	"Not detected"			"Region enriched"	"Detected in single"	24	"basal ganglia: 12.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"ASC TERT1: 8.4;BJ: 6.2;HBF TERT88: 4.4;RH-30: 4.9;RT4: 5.4;SiHa: 3.1;U-2197: 5.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA053245	Uncertain		Approved	Cytosol		No	NA			Cytosol		"HPA053245: AB_2682087"	"unprognostic (9.10e-2)"	"unprognostic (1.63e-1)"		"unprognostic (1.15e-1)"	"unprognostic (3.30e-2)"	"unprognostic (1.37e-1)"	"unprognostic (1.93e-2)"	"unprognostic (1.04e-2)"		"unprognostic (1.46e-1)"	"unprognostic (1.80e-2)"	"unprognostic (1.78e-1)"	"unprognostic (4.47e-11)"	"unprognostic (8.51e-3)"	"unprognostic (1.47e-1)"	"unprognostic (1.73e-2)"	"unprognostic (2.66e-2)"	4.6	0.2	0.3	1.0	12.6	0.0	5.2	0.2	0.3	1.7	1.3	0.0	1.6	0.0	0.5	4.7	1.6	4.1	0.5	1.3	0.4	0.5	6.5	0.2	5.4	2.1	0.2	0.0	0.9	0.6	0.0	1.1	6.4	0.0	6.5	0.0	0.0	0.4	0.5	0.5	0.3	0.2	4.0	0.2	0.2	0.2	5.8	0.0	0.0	3.9	0.0	0.6	19.2	3.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	8.4	0.0	6.2	1.3	1.9	1.3	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.0	4.4	0.0	0.0	0.0	0.9	0.0	0.3	0.0	0.0	0.9	0.0	0.8	0.2	0.5	0.0	0.0	0.0	0.0	2.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.9	0.0	0.0	5.4	0.0	0.0	3.1	0.1	0.0	0.3	0.3	0.0	0.0	0.5	0.1	5.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	12.6	0.2	0.3	0.4	0.5	0.2	0.0	0.0	0.0	14.9	0.6	0.0	1.5	0.0	0.0	1.7	0.0	0.0	7.9	0.0	0.0	0.0	0.0	0.0	7.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.6	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	1.6
SACM1L	"KIAA0851, SAC1"	ENSG00000211456	"SAC1 like phosphatidylinositide phosphatase"	Q9NTJ5	3	45689056-45745424	"Predicted intracellular proteins, Predicted membrane proteins"		Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA039573, HPA069869"	Approved		Approved	"Nucleoplasm,Golgi apparatus"		NA	NA		8400000	"Nucleoplasm, Golgi apparatus"		"HPA039573: AB_10674983, HPA069869: AB_2686216"	"unprognostic (2.07e-1)"	"unprognostic (4.08e-1)"	"unprognostic (1.36e-3)"	"unprognostic (1.14e-1)"	"unprognostic (2.31e-2)"	"unprognostic (4.34e-2)"	"unprognostic (2.82e-1)"	"unprognostic (1.03e-2)"	"unprognostic (8.54e-2)"	"unprognostic (1.94e-2)"	"unprognostic (1.22e-2)"	"unprognostic (6.29e-3)"	"prognostic favorable (5.47e-7)"	"unprognostic (3.50e-1)"	"unprognostic (1.62e-1)"	"unprognostic (2.50e-1)"	"unprognostic (1.33e-2)"	18.4	24.9	22.0	18.9	23.3	14.9	18.2	23.3	26.3	19.0	19.4	16.4	21.2	18.9	22.6	19.3	17.0	18.1	16.6	15.6	21.8	22.8	31.9	22.7	23.2	19.9	20.5	24.9	15.7	18.3	25.1	31.9	21.2	28.7	21.1	20.1	17.7	20.0	18.2	12.7	14.7	20.4	17.0	22.2	20.9	20.5	11.0	19.6	26.8	35.8	8.5	19.7	20.9	20.9	5.8	13.7	13.4	8.7	30.1	14.9	13.4	11.0	8.3	15.5	8.6	26.4	18.1	11.9	17.0	18.1	16.0	13.8	11.0	9.0	18.1	9.8	16.3	20.3	8.7	19.1	11.5	20.6	11.4	11.6	18.6	13.6	10.6	14.2	27.9	22.8	11.9	18.2	16.2	12.5	13.1	10.9	17.6	20.4	18.7	26.2	5.4	23.7	15.3	16.6	12.2	17.0	6.2	8.1	17.0	17.5	16.2	6.1	14.7	11.7	15.5	17.9	16.4	11.6	27.0	12.3	14.6	8.1	14.7	17.5	10.7	26.1	12.9	17.0	43.1	14.5	4.3	8.7	13.4	13.6	7.0	14.9	5.8	9.8	13.6	13.7	5.3	10.1	13.1	7.1	30.1	6.0	5.7	8.2	13.4	22.0	23.3	23.3	26.3	21.8	22.8	20.5	24.9	28.7	19.6	26.8	31.2	19.3	7.8	17.4	22.6	14.0	17.8	10.7	13.6	7.0	29.5	17.8	16.6	9.1	1.3	13.5	15.8	0.0	8.7	9.5	15.3	14.3	16.2	13.1	21.0	31.8	11.5	14.7	19.1	2.4	15.5	17.3	16.9	18.0	8.8	14.1	10.7	17.3	21.5	16.5	21.4	6.5	12.0	10.1	10.9	15.2	15.3	41.7	10.3	8.9
SGPP1		ENSG00000126821	"Sphingosine-1-phosphate phosphatase 1"	Q9BX95	14	63684214-63728039	"Predicted membrane proteins"		Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"placenta: 49.4"	"Cell type enhanced"	"Detected in many"	4	"Collecting duct cells: 48.8;Kupffer cells: 53.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"basophil: 8.8"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"Daudi: 23.9;U-698: 31.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA053149, HPA064908"	Approved		Supported	Nucleoplasm		NA	NA			Nucleoplasm		"HPA053149: AB_2682057, HPA064908: AB_2797270"	"unprognostic (1.57e-2)"	"unprognostic (1.04e-2)"	"unprognostic (5.40e-3)"	"unprognostic (7.82e-2)"	"unprognostic (9.09e-2)"	"unprognostic (4.30e-2)"	"unprognostic (6.49e-3)"	"unprognostic (1.35e-2)"	"unprognostic (1.64e-1)"	"unprognostic (7.41e-2)"	"unprognostic (1.51e-1)"	"unprognostic (3.27e-1)"	"unprognostic (8.59e-2)"	"unprognostic (1.41e-1)"	"unprognostic (1.92e-1)"	"unprognostic (1.03e-1)"	"unprognostic (1.31e-3)"	10.5	12.1	12.1	15.7	11.6	4.3	7.6	14.3	12.9	9.2	9.6	15.1	3.9	6.2	8.4	10.3	5.7	5.9	8.9	5.5	13.1	12.6	24.7	29.4	10.3	18.5	13.0	7.0	7.4	14.1	15.5	6.4	49.4	11.1	9.0	8.7	6.7	5.7	7.0	4.4	4.8	8.9	7.9	19.6	16.5	5.8	8.2	9.8	15.4	7.8	3.7	19.1	8.6	7.3	3.2	0.5	8.8	3.3	0.5	2.0	0.5	10.5	3.4	1.7	4.8	6.2	5.8	20.3	8.7	6.1	5.4	6.1	1.5	6.0	23.9	2.6	4.4	4.5	11.3	2.7	5.1	8.8	9.3	3.1	2.2	2.0	2.4	7.6	3.9	6.9	4.2	8.3	4.7	7.5	5.5	2.6	4.5	1.2	0.7	7.8	3.9	4.5	0.0	1.1	1.7	7.3	1.1	4.7	1.9	8.6	5.3	1.0	2.8	6.1	5.7	4.5	5.4	7.4	1.4	2.9	7.6	5.2	5.3	4.3	5.7	3.5	31.1	5.5	0.0	3.2	8.8	0.3	2.8	1.0	2.3	1.0	3.2	1.0	0.7	0.5	0.8	1.5	1.1	0.4	0.5	3.3	0.3	2.0	0.5	12.1	11.6	14.3	12.9	13.1	12.6	13.0	7.0	11.1	9.8	11.9	14.4	11.2	4.9	8.7	3.5	3.2	25.5	2.7	3.4	48.8	0.0	19.1	0.0	5.2	1.6	5.4	6.7	0.0	7.7	24.8	16.2	8.0	10.5	37.6	19.7	9.5	17.9	8.0	53.2	0.8	5.8	20.6	16.9	3.6	9.4	7.3	11.2	11.6	15.9	20.9	5.1	6.5	19.4	6.7	2.7	11.8	27.6	7.5	8.1	4.8
SGPP2	"FLJ39004, SPP2"	ENSG00000163082	"Sphingosine-1-phosphate phosphatase 2"	Q8IWX5	2	222424517-222560948	"Predicted membrane proteins"		Hydrolase		"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	9	"Urothelial cells: 38.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"CAPAN-2: 9.4;EFO-21: 8.2;hTCEpi: 25.9;RPTEC TERT1: 25.6;SCLC-21H: 10.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"									NA	NA						"unprognostic (1.60e-1)"	"unprognostic (1.16e-1)"	"unprognostic (2.56e-3)"	"unprognostic (1.79e-1)"	"unprognostic (8.50e-2)"	"unprognostic (2.97e-2)"	"unprognostic (1.24e-3)"	"unprognostic (5.22e-2)"	"unprognostic (9.16e-2)"	"unprognostic (2.31e-2)"	"unprognostic (3.54e-3)"	"unprognostic (6.24e-2)"	"prognostic favorable (1.28e-4)"	"unprognostic (3.25e-2)"	"unprognostic (2.19e-1)"	"unprognostic (1.74e-2)"	"unprognostic (2.69e-2)"	2.9	7.8	5.4	3.1	12.8	1.2	3.9	14.6	8.4	8.6	16.2	2.2	19.5	12.9	2.2	2.0	19.9	10.4	11.5	5.8	5.0	6.1	16.1	0.7	7.7	2.7	4.4	3.8	1.9	3.7	30.5	12.1	0.3	17.1	2.3	13.4	0.3	8.6	22.1	1.1	16.5	23.5	1.3	3.2	1.4	18.3	1.8	3.3	1.7	16.9	9.8	13.9	8.1	9.3	1.1	0.5	1.3	0.5	0.4	2.3	0.2	0.8	0.8	0.3	0.9	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.2	9.4	0.4	8.2	0.0	0.1	0.2	0.2	0.0	0.0	0.2	3.0	0.7	0.2	0.1	0.0	1.0	0.5	0.0	25.9	0.0	0.1	0.0	0.0	0.5	0.2	0.4	0.0	0.5	0.2	0.8	0.3	5.6	0.3	0.4	0.2	0.4	25.6	2.5	10.4	0.4	0.0	1.1	0.1	0.5	0.1	0.1	0.0	0.1	0.3	0.4	0.3	0.3	0.2	0.6	0.1	0.1	0.1	1.3	0.5	0.2	0.4	0.2	1.0	1.1	1.9	0.5	0.0	1.1	0.4	0.2	1.3	0.4	0.2	0.5	2.3	0.2	5.4	12.8	14.6	8.4	5.0	6.1	4.4	3.8	17.1	3.3	3.0	7.8	0.5	2.3	3.3	4.7	4.9	10.2	10.7	11.4	12.2	5.9	0.1	1.7	12.9	6.9	0.1	11.8	0.0	1.6	0.2	0.8	5.6	0.0	0.0	0.2	1.6	1.2	0.0	0.0	2.5	0.6	0.4	0.0	0.0	5.8	1.1	6.9	13.6	0.4	0.2	6.8	0.0	0.2	0.5	0.2	12.5	2.1	0.0	9.3	38.2
SYNJ1	"INPP5G, PARK20"	ENSG00000159082	"Synaptojanin 1"	O43426	21	32628759-32728048	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	Endocytosis	"Hydrolase, RNA-binding"	"Disease mutation, Epilepsy, Neurodegeneration, Parkinson disease, Parkinsonism"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 39.0"	"Cell type enhanced"	"Detected in many"	5	"Cone photoreceptor cells: 43.2;Rod photoreceptor cells: 40.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA011916	Enhanced		Approved	Nucleoplasm,Centrosome,Cytosol		NA	NA			"Nucleoplasm, Cytosol"	Centrosome	"HPA011916: AB_1857692"	"unprognostic (6.84e-2)"	"unprognostic (8.64e-2)"	"unprognostic (5.76e-2)"	"unprognostic (6.44e-2)"	"unprognostic (1.27e-1)"	"prognostic favorable (4.43e-4)"	"unprognostic (1.45e-1)"	"unprognostic (3.73e-3)"	"unprognostic (1.63e-1)"	"unprognostic (6.22e-3)"	"unprognostic (1.84e-2)"	"prognostic unfavorable (2.58e-4)"	"unprognostic (1.28e-1)"	"unprognostic (6.36e-2)"	"unprognostic (5.97e-2)"	"unprognostic (1.79e-1)"	"unprognostic (2.92e-1)"	5.5	6.8	13.6	5.0	25.9	20.6	4.2	19.5	39.0	4.8	4.8	6.5	0.8	3.9	4.6	5.3	3.9	4.0	5.2	5.2	18.3	18.2	7.4	5.5	6.5	5.7	16.6	18.4	4.6	4.5	10.6	10.9	9.3	33.5	3.6	5.5	7.0	3.8	4.0	4.4	5.0	4.6	5.0	7.3	6.0	4.2	9.0	5.7	3.2	6.8	1.5	4.8	4.7	3.3	0.4	3.1	11.5	6.0	0.5	3.0	1.1	5.6	2.8	5.2	5.7	9.1	7.3	10.6	11.7	6.7	7.2	6.0	6.4	2.6	2.1	3.9	7.0	9.6	5.3	9.3	6.8	8.6	6.7	8.9	14.1	9.2	3.5	4.9	5.8	12.5	4.1	5.1	12.4	6.3	5.9	11.2	7.5	10.5	12.1	9.2	5.7	5.4	4.8	3.7	6.2	6.5	5.9	11.3	7.4	7.6	4.1	5.9	4.6	14.4	9.2	5.6	7.4	7.9	7.5	12.3	11.1	5.5	8.9	6.4	6.3	7.3	4.4	8.4	11.0	8.8	3.7	3.4	7.9	1.6	6.0	2.7	0.2	2.4	2.6	3.1	0.4	2.9	2.8	11.5	0.5	5.3	1.6	3.0	1.1	13.6	25.9	19.5	28.7	18.3	18.2	16.6	18.4	33.5	5.7	6.0	4.8	2.9	2.0	4.2	21.5	7.3	5.1	4.0	2.3	1.8	43.2	13.3	5.0	1.6	14.8	7.9	4.9	0.0	1.2	7.9	3.7	2.2	3.5	3.6	8.6	9.5	2.9	8.6	19.0	8.6	2.6	7.5	1.7	1.0	2.7	19.5	2.1	3.5	4.2	5.0	40.7	6.5	3.4	16.4	10.9	2.9	31.8	6.9	4.0	4.1
SYNJ2	INPP5H	ENSG00000078269	"Synaptojanin 2"	O15056	6	157981887-158099176	"Enzymes, Predicted intracellular proteins"		"Hydrolase, RNA-binding"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	4	"brain: 62.0"	"Cell type enhanced"	"Detected in many"	8	"Pancreatic endocrine cells: 88.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"GAMG: 46.3;TIME: 37.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA031575	Approved		Approved	Microtubules,Cytosol		NA	NA			Microtubules	Cytosol	"HPA031575: AB_10604101"	"prognostic unfavorable (2.63e-4)"	"unprognostic (1.94e-2)"	"unprognostic (7.61e-2)"	"unprognostic (1.25e-2)"	"unprognostic (1.48e-2)"	"unprognostic (7.68e-2)"	"unprognostic (1.24e-1)"	"unprognostic (7.06e-2)"	"unprognostic (2.91e-1)"	"unprognostic (7.29e-3)"	"unprognostic (1.26e-1)"	"unprognostic (1.36e-1)"	"prognostic unfavorable (4.02e-6)"	"unprognostic (1.66e-2)"	"unprognostic (3.75e-2)"	"unprognostic (1.75e-1)"	"unprognostic (9.45e-2)"	2.8	3.9	12.2	4.9	25.1	15.3	6.7	3.0	18.7	3.9	8.7	50.5	3.7	5.8	5.2	9.4	6.0	4.6	8.0	8.5	17.8	10.9	3.2	4.0	2.8	4.4	46.8	8.8	2.9	6.6	1.1	2.9	2.6	33.0	5.3	8.9	1.4	13.5	5.1	4.3	3.1	5.6	6.6	62.0	3.3	7.0	6.5	24.4	3.0	4.4	1.4	5.3	5.9	3.0	3.2	1.1	9.3	1.3	2.4	3.8	0.8	5.4	19.2	1.6	2.5	1.2	4.0	8.5	10.1	20.5	12.1	14.3	9.8	4.6	0.1	6.9	19.4	46.3	5.2	3.4	6.3	14.1	7.6	3.2	10.6	10.0	10.3	2.3	3.7	11.6	2.0	3.4	18.4	4.3	16.4	21.0	5.6	8.1	2.4	5.5	2.5	4.6	4.1	1.8	17.1	10.7	2.0	6.6	4.9	4.0	6.3	12.2	0.7	7.8	4.9	1.9	6.3	3.8	2.3	37.1	9.2	9.4	21.2	12.2	1.0	2.6	0.2	17.2	5.9	6.3	4.5	1.3	1.1	1.9	0.6	3.8	1.9	2.6	1.7	1.1	3.2	2.2	1.7	9.3	2.4	0.8	1.1	2.1	0.8	12.2	25.1	3.0	18.7	17.8	10.9	46.8	8.8	33.0	24.4	3.0	3.5	2.7	16.6	19.3	0.0	10.4	10.2	10.7	6.8	17.4	0.0	5.3	3.3	36.4	22.7	10.5	15.3	0.0	30.7	4.2	14.6	30.3	4.7	4.5	1.9	0.0	16.7	7.4	3.4	37.2	1.1	4.6	10.1	10.8	14.5	1.5	88.4	3.5	6.0	1.4	0.4	0.0	6.6	0.7	1.1	15.1	13.3	5.3	14.5	32.4
TNS2	"C1-TEN, KIAA1075, TENC1"	ENSG00000111077	"Tensin 2"	Q63HR2	12	53046969-53064372	"Predicted intracellular proteins"		"Hydrolase, Protein phosphatase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	10	"Ito cells: 80.4;Leydig cells: 131.2;Peritubular cells: 107.1;Sertoli cells: 148.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"ASC diff: 41.2;ASC TERT1: 28.1;HHSteC: 21.7;HSkMC: 30.8;hTERT-RPE1: 21.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA034659	Approved					NA	Yes					"HPA034659: AB_10603349"	"unprognostic (1.04e-1)"	"unprognostic (2.58e-1)"	"unprognostic (5.21e-3)"	"unprognostic (1.86e-1)"	"unprognostic (3.59e-2)"	"unprognostic (7.26e-2)"	"unprognostic (6.29e-2)"	"unprognostic (5.42e-2)"	"unprognostic (1.48e-2)"	"unprognostic (8.97e-3)"	"prognostic favorable (1.72e-4)"	"prognostic favorable (9.32e-4)"	"unprognostic (4.46e-2)"	"unprognostic (1.09e-2)"	"unprognostic (8.46e-2)"	"unprognostic (1.47e-1)"	"unprognostic (2.76e-2)"	69.5	26.5	13.2	12.8	17.4	0.8	43.9	8.1	14.7	37.4	22.1	17.5	22.0	9.7	35.3	23.6	20.1	30.4	32.9	34.2	13.3	9.8	21.1	18.7	25.8	16.5	15.8	10.5	48.6	18.0	14.8	13.0	22.0	14.6	23.7	8.4	33.7	21.4	29.6	38.7	11.2	14.8	25.0	13.4	27.9	16.7	16.6	16.0	0.6	23.2	26.5	7.2	24.1	47.6	0.0	0.1	0.0	0.2	0.0	0.3	0.0	0.7	7.2	0.9	0.7	41.2	28.1	0.2	4.0	9.5	2.1	1.1	0.5	1.9	0.0	8.9	11.0	0.9	0.5	0.0	2.6	0.8	0.1	0.2	0.1	7.8	3.8	21.7	0.1	0.1	30.8	0.1	2.8	1.6	21.9	12.6	0.1	0.2	0.1	8.7	1.7	0.0	0.0	0.6	0.5	2.0	0.2	2.3	0.1	2.9	0.1	0.4	0.9	1.5	0.8	3.1	0.6	9.1	0.2	17.9	4.5	5.4	1.6	0.7	0.2	0.0	0.0	7.2	0.1	7.4	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.3	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	13.2	17.4	8.1	14.7	13.3	9.8	15.8	10.5	14.6	16.0	3.0	18.8	0.0	7.4	0.0	19.6	7.3	7.6	2.7	4.5	5.2	0.0	0.4	3.3	3.6	1.9	56.1	0.0	0.0	3.7	0.3	14.3	3.4	0.0	28.2	1.9	28.6	1.2	80.4	7.1	2.9	131.2	1.3	0.0	0.0	4.2	37.3	2.5	4.2	107.1	2.2	12.0	148.8	8.8	2.3	3.6	0.0	0.7	0.0	2.4	2.2
TPTE2	TPIP	ENSG00000132958	"Transmembrane phosphoinositide 3-phosphatase and tensin homolog 2"	Q6XPS3	13	19422877-19536762	"Enzymes, Plasma proteins, Predicted membrane proteins"		Hydrolase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enriched"	"Detected in some"	12	"testis: 12.3"	"Cell type enhanced"	"Detected in some"	23	"Collecting duct cells: 1.8;Early spermatids: 3.5;Spermatocytes: 9.3;Spermatogonia: 2.5"	"Cancer enriched"	"Detected in single"	6	"testis cancer: 0.8"					"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	4	"HDLM-2: 10.1;Karpas-707: 2.9"									HPA068342			Approved	"Endoplasmic reticulum,Cytosol"		NA	NA			Cytosol	"Endoplasmic reticulum"	"HPA068342: AB_2685976"	"unprognostic (2.50e-1)"	"unprognostic (2.10e-1)"	"unprognostic (1.76e-1)"	"unprognostic (2.70e-1)"	"unprognostic (1.25e-2)"	"unprognostic (5.33e-3)"		"unprognostic (1.90e-1)"	"unprognostic (1.24e-1)"	"unprognostic (5.40e-2)"	"unprognostic (3.67e-2)"	"unprognostic (2.81e-1)"	"unprognostic (1.05e-12)"	"unprognostic (1.04e-1)"	"unprognostic (1.47e-1)"	"unprognostic (2.44e-1)"	"unprognostic (5.00e-3)"	0.0	0.1	0.4	0.2	1.0	0.0	0.1	0.7	0.8	0.0	0.1			0.4	0.0	0.3	0.0	0.0	0.0	0.0	0.3	0.7	0.0	0.0	0.0	0.3	0.4		0.0	0.0	0.0	0.1	0.1		0.0	0.1		0.2	0.2	0.0	0.0	0.1	0.0	0.2	0.2	0.2	12.3			0.0		0.6	0.0	0.0	0.5	0.4	0.0	0.1	0.5	0.7	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	10.1	0.0	0.1	0.0	0.0	0.6	0.0	0.4	0.0	0.1	0.0	0.0	0.0	0.0	0.6	0.1	2.9	0.0	0.3	0.3	0.1	0.0	0.0	0.1	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.2	0.0	1.4	0.0	0.0	0.1	0.0	0.0	1.3	0.1	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.4	0.5	0.0	0.0	0.0	0.5	0.1	0.0	0.0	0.0											0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	1.8	0.0	0.0	0.0	0.0	3.5	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.1	0.0	0.0	1.3	0.3	0.0	0.3	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.2	0.0	0.3	9.3	2.5	0.1	0.1	0.0	0.0	0.0
